The UHMS Annual Scientific Meeting's primary goal is to provide a forum for professional scientific growth and development of the participants to improve knowledge and competence in order to further patient outcome. The meeting provides a basis for exchange of ideas, both scientific and practical, among physicians, researchers, and other health care professionals.The UHMS Annual Scientific Meeting consists of abstract and poster presentations, plenary sessions, the annual Kindwall and Lambertsen Lectures, and other social events. There will be exhibits from a number of hyperbaric, diving and wound care vendors. The Annual Meeting also affords an opportunity for participants to meet and interact with past and present leaders of the Society and to become active in Society affairs.
"The Society has negotiated a special discounted room rate (room-block) with the hotel. Your patronage of this meeting hotel makes it possible for the Society/Chapter to secure the space necessary for this event at a greatly reduced cost. The hotel not only offers a discounted rate and the best networking opportunities, but staying in the group block helps the Society/Chapter meet its obligation to the hotel, avoid penalties, and keep meeting registration prices down. Any attendee who does not book under the UHMS room block will not receive the special discounted amenities."
ROOM RATE: $182.31* Reservation Cutoff date: EXTENDED to Monday, June 3, 2019 Call in reservations: 800-474-6627 Online reservations: CLICK HEREor paste the following link in your web browser address bar:https://book.passkey.com/e/49746356
We have also secured a limited amount of rooms at the government per diem rate for active military. Please contact us at uhms@uhms.org to get in this block. Military/Government attendees using their government credit card: Information regarding hotel taxes: Puerto Rico is a tax exempt territory when a traveler uses their IBA account (gov charge card). The form link below has the information for each individual traveler to obtain the proper tax exemption form you will need so you are not billed for those taxes. You can download the form at the following link: https://smartpay.gsa.gov/content/state-tax-information
You must identify yourself as being part of the Undersea and Hyperbaric Medical Society Annual Scientific Meeting.
Group rate will be offered 3 days pre and 3 days post based on last room availability.
When reservations are made, the hotel will require a deposit equal to the room rate, tax, and Resort Fee for the first and last night for each reservation. Each guest will be required to present a valid credit card upon check-in, on which an amount of sufficient pre-authorization can be obtained to cover the room, tax, and Resort Fee charges for the length of the guest’s stay, plus the anticipated use of the Resort’s ancillary services.
*Group room rate shall be subject to prevailing 2019 tax (current tax is 11%) and, should all 2019 hotel guests be subject to a mandatory resort fee, an applicable flat resort fee of no greater than $14 per room per day, also subject to tax, shall apply. Likewise, should hotel policy no longer include the mandatory levy of a one time per adult person porterage fee and a mandatory daily housekeeping gratuity then such fees shall no longer apply to UHMS meeting attendees. Should policy remain in place, said mandatory fees shall be no greater than originally (c-below) contracted:
$7 per person porterage $2.50 per room per night houskeeping gratuity
CANCELLING INDIVIDUAL RESERVATIONS: Individual room reservation cancellations will be accepted up to seven (7) days prior to the guest’s reservation arrival date without penalty. Advance deposits are refundable to guest if timely notice of cancellation is given and a cancellation number is obtained. Cancellations that occur inside the seven (7) day period shall forfeit an advanced deposit equal to the first night’s room and applicable tax.
CHECK-IN I CHECK-OUT: Guest accommodations will be available at 4:00 pm on arrival day and reserved until 11:00 am on departure day. Any attendee wishing special consideration for early arrival should call the toll free number, 888-474-6627. Any attendee wishing special consideration for late check-out should inquire at the front desk on the day of departure. Group members staying in their rooms beyond the check-out time without Resort authorization will be charged for an additional room night.
Children's Policy: There is no charge for children under the age of 17 when sharing same room with parents.
Refrigerators are available upon request for an additional $10 per night plus tax per refrigerator.
Parking: Daily self-parking fee of $15 plus tax. Daily valet parking fee of $20 per car plus tax.
Smoking and Vaping Policy: The Wyndham Grand Rio Mar Beach Resort is a smoke-free and vaping-free property as prohibited by law.
Airport transportation: Round trip shuttle service is provided to our guests through Group Services Inc. Please visit https://fareharbor.com/embeds/book/gsipuertorico-online/items/ for reservations. Please note shuttle service is not available for arrivals after 11pm - if your arrival time is after 11pm, your best bet is a taxi. If you prefer a personal car service, after hour rates go up to $264 one way.
Rollaways: Available upon request for an additional $20 per night plus tax per rollaway.
Ideally Located, Totally Unforgettable:Experience the magic of this extraordinary island from the Wyndham Grand Rio Mar Puerto Rico Golf & Beach Resort beachfront location in northeast Puerto Rico. Just steps from a private beach along the majestic Atlantic Ocean, they are the closest resort in Puerto Rico to El Yunque Rainforest. Venture just off the coast to explore the mesmerizing beauty of Bioluminescent Bay, or hop in the car for a quick ride to the historic attractions and shopping of Old San Juan and Ponce.
Natural Beauty & Tranquility: The sapphire Atlantic Ocean, verdant golf courses, and lush El Yunque Rain Forest border the 500-acre Wyndham Grand Rio Mar Puerto Rico Golf & Beach Resort, ensuring stunning vistas all around. Our laid-back beach hotel & resort in Puerto Rico hosts 400 spacious guest rooms and suites, endless activities, an array of delicious restaurants and lively bars, sparkling pools, a secluded sandy beach, and the ideal setting and services for memorable meetings and celebrations.
Perfect Paradise: Enjoy all that Wyndham Grand Rio Mar Puerto Rico Golf & Beach Resort has to offer. Renowned golf and tennis are here on site, along with myriad water sports, exciting activities for both kids and adults, a casino featuring a variety of games, and sparkling lagoon-style swimming pools. Looking for a little relaxation? Visit the serene Mandara Spa or unwind on the one-mile stretch of soft golden sand just outside our doors.
A BREATHTAKING ISLAND PLAYGROUND OF ACTIVITIES IN PUERTO RICO
Endless sunshine and warm tropical breezes complement Puerto Rico’s perfect mix of laid-back beaches and outdoor adventures. The Wyndham Grand Rio Mar Puerto Rico Golf & Beach Resort features a premier location mere steps away from a private stretch of golden sand along the Atlantic, and is the closest resort in Puerto Rico to El Yunque Rain Forest. The inspiring, otherworldly beauty of Bioluminescent Bay is in the waters just off its coast, with Bio Bay tours in Puerto Rico that can be arranged with the on-site tour company for effortless convenience. The resort is also a short drive from the historic attractions of Old San Juan, the “Second City” of Ponce, and one of the island’s most popular activities – ziplining. Renowned golf and tennis are right on site, fun and engaging activities for kids and adults alike, and sparkling lagoon-style swimming pools. When you’re ready for a break from fun in the sun, try your luck at their casino, or wind down at the luxurious, tranquil Mandara Spa.
Discover the perfect tropical playground for kids at the Wyndham Grand Rio Mar Puerto Rico Golf & Beach Resort. Our secluded beachfront setting offers countless ways to delight kids of all ages, with various kids activities in Puerto Rico. Play Marco Polo or zoom down the water slide in the Activity Pool. Experience bird watching and seasonal turtle nesting. Visit the playground or swim up to a dive-in movie. There’s no shortage of ways to make memories to last a lifetime with the most important people in your life.
At our Puerto Rico family resort, you will receive our Weekly Guest Activity schedule full of fun activities when you check in. Activities vary from day to day, possibilities include:
Island Hair Braiding
Nature Walks
Face Painting
Iguana Feeding
Dance Aerobics
Arts & Crafts
Kids’ Cooking Class
Salsa Dancing
Aqua Aerobics
Bingo
Bird Walks
SO MUCH TO DO…RIGHT AT THE RESORT
Puerto Rico offers an abundance of exciting activities across the island, but you can easily fill your days and nights with fun without ever leaving Wyndham Grand Rio Mar Puerto Rico Golf & Beach Resort. From challenging rounds of golf on breathtaking courses, to authentic and delicious dining, to pampering, relaxing treatments at Mandara Spa, there’s so much to do right here that you may never want to leave.
Discover one of Puerto Rico’s natural wonders – turtle nesting – just outside your guest room door. Seeing these remarkable sea creatures nesting and, depending upon time of year, hatching is truly extraordinary and fun for all ages. Be sure to ask about Turtle Nesting and Turtle Nest Hatching when you check in.
When you check in you’ll also get our Weekly Guest Activity schedule detailing how you can enjoy all of the interesting activities in Rio Grande, Puerto Rico that we offer. Activities vary from day to day, and may include:
Yoga Classes
Aqua Aerobics
Island Hair Braiding
Sand Sculpture
Iguana Feeding
Obstacle Race On the Beach
Volleyball
Salsa Lessons
Bingo
Papiros Cigars*
*See cigar rolling in action as you learn about and sample Puerto Rico’s own Papiros Cigars. Adults only, additional charge applies. See the concierge for details.
CHAMPIONSHIP GOLF IN PUERTO RICO WITH A PICTURESQUE SETTING
Bordered by El Yunque Rainforest’s scenic mountains, the Mameyes River, and the shimmering Atlantic Ocean, Wyndham Grand Rio Mar Puerto Rico Golf & Beach Resort is the only resort on the island to offer two championship golf courses managed by Troon Golf, the industry leader in golf club management. Our 18-hole courses are gorgeous, challenging, and absolutely perfect for a Caribbean golf vacation getaway.
The Ocean Course: Award-winning golf course architects Tom and George Fazio kept the unique features of our location in mind when designing the spectacular Ocean Course. This 6,716-yard course is situated between the mountains of El Yunque Rainforest and the majestic Atlantic Ocean, and winds languorously through lakes and the natural contours of the island with Sand Iguanas and seaside vistas at every tee. The signature 16th hole is considered one of the best in the Caribbean. Grab your clubs and get ready for formidable, breathtaking play at every turn.
The River Course: Two-time Major Champion Greg Norman designed our River Course along the serene Mameyes River. Inspired by the natural terrain of the land, the holes are integrated into existing foliage creating a lush, verdant course with stunning views of El Yunque’s mountains and the Atlantic Ocean. Ideal for all skill levels of golf in Puerto Rico, this 6,945-yard course features open greens, wide fairways, light rough, and shallow bunkers.
With an ideal combination of laid-back beaches and tropical adventure, Wyndham Grand Rio Mar Puerto Rico Golf & Beach Resort is the perfect home base from which to explore the breathtaking natural beauty of Puerto Rico. We’re steps from a blissfully private one-mile stretch of sand along the Atlantic, and are also the closest resort in Puerto Rico to El Yunque Rainforest.
Ready for an El Yunque Rainforest hike or ziplining in Puerto Rico? Our concierge is ready and waiting to connect you with the adventure of a lifetime through Group Services, Inc. (GSI), our onsite tour company. Experts on everything Puerto Rico, GSI will handle everything you need for the following exciting tours:
Spend a day getting to know the fascinating history and culture of this beautiful island. GSI provides trips to the Puerto Rico’s cultural centers, and some of the best spots to shop. Tours include:
Old & New San Juan with Historic District Shopping
While you can go to Puerto Rico without immunizations, it’s a good idea to get vaccinated. The CDC recommends that visitors to Puerto Rico be immunized for hepatitis A and B as well as typhoid. Dengue fever is also a possibility, so it’s a good idea to wear insect repellent as well. https://wwwnc.cdc.gov/travel/destinations/traveler/none/puerto-rico
AIRPORTS:
San Juan International Airport (SJU)
TRANSPORTATION FROM/TO THE AIRPORT HOTEL PREFERRED SHUTTLE SERVICE: Guest Services Inc.: Contact Group Services, Inc. at 787-888-6000 ext. 6318 for more information, or click here and book your transportation online.The Current charge for airport concierge and transportation services is $88 per person, round trip. Airport transportation is subject to a 15% service charge. Please note shuttle service is not available for arrivals after 11pm - if your arrival time is after 11pm, your best bet is a taxi. If you prefer a personal car, after hours goes up to $264 one way.
IF YOU NEED A WORD COPY of Abstract Submission Form, PLEASE CONTACT lisa@uhms.org
On behalf of the Undersea and Hyperbaric Medical Society, the UHMS Program Committee is pleased to announce its call for abstract submission to the 2019 UHMS Annual Scientific Meeting, June 27-June 29, 2019. The meeting will be held at the Wyndham Grand Rio Mar Puerto Rico Golf & Beach Resort, 6000 Rio Mar Blvd., Rio Grande, PR 00745.
For your convenience, the formatting and submission guidelines have been reprinted in the below section entitled “Abstract Formatting Guidelines.” Abstracts should be submitted via the UHMS website at www.uhms.org. For those unable to access the UHMS website or having difficulty with the online submission format, additional assistance with the submission process can be obtained by contacting the UHMS home office. Authors should ensure that all submission requirements are met, as incomplete submissions may be returned for modification or declined. Deadline for submission is April 1, 2019. Acknowledgment of receipt will be provided normally within one week.
TERMS AND CONDITIONS:
Abstract acceptance is at the full discretion of the UHMS Annual Scientific Program Committee. Only non-published works at the time of abstract submission will be considered, however, novel analysis/interpretation of published data are acceptable.
Notification regarding abstract final acceptance will be provided via e-mail no later than April 22, 2019.
The presenting author will be required to register and attend the meeting.
UHMS is will continue using digital poster presentations in lieu of the traditional cork board and printed posters. All abstracts which have been approved and accepted will be presented in PPT or PDF format and uploaded to the UHMS Poster website. Instructions for upload, FAQ and templates for poster presentations will be emailed to the presenting author upon acceptance. This information can be found at the following link, under the “Call for Abstract” section. https://www.uhms.org/asm-new
Also at the discretion of the UHMS ASM Program Committee, presenters may be invited to present their abstract orally in the general meeting, resident/trainee competition (if eligible) or the Associates session (if eligible). Notification regarding selection for oral and poster presentations will be provided no later than Monday, April 22, 2019.
ABSTRACT USE PERMISSIONS AND RIGHTS:
All abstracts submissions for presentation at the Annual Scientific Meeting constitutes consent by the author(s) for the UHMS to use the materials submitted in whole or part as it sees fit. All abstracts posters (including required PowerPoint/PDF submissions) and oral presentations (including PowerPoint slides) accepted by the UHMS Program Committee for presentation at the Annual Scientific Meeting will be published in the UHMS’ Undersea and Hyperbaric Medicine Journal and may be subsequently used and/or published by the Society in various electronic media at the discretion of the UHMS. Once accepted, no abstract, poster or oral presentation may be withdrawn or excluded from being subject to this agreement.
DEADLINES:
REGULAR ABSTRACT SUBMISSION: MONDAY, APRIL 1, 2019; MIDNIGHT ET
NOTIFICATION OF ACCEPTANCE by ASM Program Committee: APRIL 22, 2019.
NO CHANGES to an abstract will be accepted after MAY 1, 2019.
PDF OF ABSTRACT must be submitted to the UHMS website by JUNE 3, 2019.
ABSTRACT FORMATTING GUIDELINES:
LANGUAGE: All abstracts are to be written in English. The Program Committee reserves the right to alter abstracts where the English structure makes comprehension difficult.
ABSTRACT BODY FORMAT:
Must be 300 words or less, exclusive of title, author(s) names, and institutional affiliation(s). See examples at end of this document.
All submissions should be in Microsoft Word format
Only text and text tables will be accepted. No references, graphs or images may be submitted. References, graphs and images may be included on your poster submission.
Contents should include the following sections – please use these exact terms for uniformity:
Introduction / Background
Materials and Methods
Results
Summary / Conclusions
One question / Must be specific to your abstract/final poster presentation (The Q/A will be used for Evaluation of the participants for CME/Maintenance of Certification Credits (MOC) at the UHMS Online CME Portal).
TOPICS FOR PRESENTATION
You will specify one of the following categories, A thru E, that best characterizes your presentation:
Session A (Thurs) - HBO2 Theory and Mechanisms
Session B (Thurs) - Clinical HBO2
Session C (Fri) - Decompression Theory and Mechanisms
Session D (Fri) - Diving Medicine
Session E (Sat) - HBO2 Operations, Chambers and Equipment
Session F (Sat) - Top Case Reports: This session will be composed of case reports submitted for Sessions A thru E.
There you’ll find suggestions on determining whether your idea merits and abstract presentation by posing questions such as: Is this experience useful? Did we learn something from it? Does it cover an unusual aspect of an illness or suggest a novel method of treatment?
There’s much more included in the ACP link to help you compose your abstract within the parameters of introduction/background, materials/methods, results and summary/conclusions.
Remember to take your time in writing your abstract; then take a day off. Share it with your colleagues. Often you’ll receive good suggestions in refining your presentation. When you come back to draft your final version, you’ll have a fresh perspective.
IMPORTANT: Due to difference in operating system standards and character sets, mathematical formulas created in Windows often do not display correctly on MAC OS, even in PowerPoint. Please convert formulas to images.
General Guidelines:
Recommended fonts: Calibri, Arial, Times New Roman
Recommended font size: any large size font as long as it fits the slide/poster ratio below
Slide/Poster size: 40 x 22.5, which is a 16:9 ratio.
Single or multiple pages slides/may be used for poster (max 10 Slides)
Graphs and images can be embedded into your poster.
Videos and audio, you will need to upload the video and audio files as separate files. Actual files, no YouTube links. No more than 5 minutes of videos should be included in your presentation.
Video may be displayed in the following formats:
.mp4 files and .mov files encoded with the H264 codec
The poster layout should be landscape orientation.
Poster PPT templates are available for download on the ASM website
Kiosk Guidelines
Your poster sessions will be handled in Kiosk Mode. Kiosk mode means that we receive the presentation ahead of time, then combine multiple presentations into a single presentation with a menu and navigation buttons. This ensures that it is easy to swap between different posters that are on the same screen. There are some things to consider:
All navigation is done on the iPads
Please ensure that your poster is the correct size. If not, it will be forced into the correct size, and the poster may be distorted.
Making the Most of Your Presentation
Posters offer a very flexible format, and there are several methods you can use to optimize your presentation. The goal of your presentation should always be readability. You are no longer constrained to a single-page poster, so if you have a lot of information, it’s a good idea to split it up across multiple pages. You may not have more than 10 slides. There are a few key methods that can be used in conjunction with multiple pages to make your presentation interactive and flexible.
Videos
Videos can be used to add animation and content density to a presentation. Consider the following use cases:
Show a rotating molecule or some other scientific model
Make a looping video of multiple tables or charts
Show a video of your work in progress
NOTE: No more than 5 minutes of videos should be included in your presentation.
QR Tag Creation
If you wish to include a quick-response tag in your poster with embedded information, you can easily find a free website to create one. These sites take text input, and generate a QR tag image that you can download and import into your presentation.
ORAL PRESENTATIONS: IF YOU HAVE AN ORAL PRESENTATION, SPECIFIC GUIDELINES WERE EMAILED TO YOU WITH THE INVITE. IF YOU HAVE ANY QUESTIONS OR NEED THE INVITE INSTRUCTIONS PLEASE EMAIL US (uhms@uhms.org).
TO UPLOAD YOUR PPT OF YOUR ORAL PRESENTATION, PLEASE USE THE LINK ABOVE.
UHMS has advanced into the future of digital poster presentations. No long will you need to print or tote your poster to the Annual Scientific Meeting!
Collect your files: Be sure to include your poster file, as well as any video files, as videos sometimes do not embed properly. Your file should be saved as “your abstract#_lastname_v1” (A1_Tidd_v1) in a PPT or PPTX file (Microsoft Power Point) or a PDF file.
If your files is an update from version 1, please be sure to add the version at the end of your file (A1_Tidd_v2).
Please also designate if an oral or poster in the "special instructions."
You should be using the latest version of the Internet browsers: Firefox, Google Chrome or
In the “special instructions” section, please include any information that the UHMS program committee staff will need to know regarding your abstract
Upload all of your files, including videos, with the upload button. Note the maximum size for an upload is 100MB. If your files are greater than 100MBs, contact us at uhms@uhms.org and we will work with you directly to upload your
When the upload completes, you will see a submission confirmation page. You will also receive an email confirmation (within 15 minutes). If you don’t see either confirmation, contact us.
For any questions or problems, please contact us at: uhms@uhms.org or 919-490-5140 x 101.
Subject to Change Posted 5/20/19 (please note that there will not be any Accreditation Surveyor Training at this year's Annual Meeting)
PRE-COURSES
GENERAL SESSION DAYS
NON-PHYSICIAN BREAKOUT
BREAKS/EXHIBITS
SOCIAL EVENTS
COMMITTEE MEETINGS
START TIME
END TIME
EVENT
LOCATION
TUESDAY, June 25
4:00 PM
11:00 PM
UHMS Board of Directors Meeting (Private Meeting)
WEDNESDAY, June 26
8:00 AM
5:00 PM
Pre-Course: How to Prepare for Accreditation
Caribbean 1
8:00 AM
5:00 PM
Pre-Course: Treatment of Decompression Illness in Recreational Diving
Caribbean 2
8:00 AM
5:30 PM
Pre-Course: Hyperbaric Oxygen Safety: Clinical and Technical Issues
Caribbean 3
4:45 PM
7:45 PM
HBO2 Therapy Committee Meeting
Canary
5:30 PM
7:30 PM
Associate's Council Meeting
Pelican
7:00 PM
9:00 PM
WELCOME RECEPTION
Ocean Terrace/Rio Mar Foyer
THURSDAY, June 27
7:00 AM
8:00 AM
CONTINENTAL BREAKFAST / EXHIBITS
Rio Mar 5
7:00 AM
8:00 AM
Safety Committee Meeting
Heron
8:00 AM
8:30 AM
President's Address: Nick Bird, MD
Rio Mar 6-10
8:30 AM
10:00 AM
Plenary Session: Controversies in the Hyperbaric Management of Late Radiation Injuries
Rio Mar 6-10
8:30-9:00
Late Radiation Tissue Injury Below the Clavicles: Considerations with IMRT and the Fibroatrophic Model: John Feldmeier, DO
9:00-9:30
Answering the criticism and challenges to HBO2 in the treatment of radiated patients: Robert Marx, DDS
9:30-10:00
Panel Discussion
10:00 AM
10:30 AM
BREAK / EXHIBITS
Rio Mar 5
10:00 AM
12:00 PM
Accreditation Council Meeting
Heron
10:00 AM
11:00 AM
ACEP UHM Section Meeting
Canary
10:30 AM
11:30 AM
Session A: HBO2 Theory & Mechanisms
Rio Mar 6-10
10:30-10:45
A1: HBO2 therapy reduces mortality, hepatic inflammation and improves renal mitochondrial function in a model of severe polymicrobial sepsis. Perdrizet GA, Halbach JL, Prieto JM, Wang, AW, Hawisher D, Cauvi DM, Reys T, Okerblom J, Ramierz-Sanchez I, Villarreal F, Patel HH, Bickler SW, De Maio A, Singh P, Li L Presenting Author: George A. Perdrizet MD
10:45-11:00
A3: A hyperbaric, high-oxygen environment promotes injured rat muscle recovery by angiogenesis through reactive nitrogen species. Yamamoto N, Oyaizu T, Enomoto M, Horie M, Yagishita K Presenting Author: Naoki Yamamoto MD
11:00-11:15
A4: Hyperbaric oxygen inhibits hyperglycemia-induced NLRP3 inflammasome and microparticle formation in neutrophils. Thom SR, Bhopale VM, WaliaD Presenting Author: Stephen Thom MD
11:15-11:30
A5: Prevalence and pattern of cardiac injury identified by late gadolinium-enhancement of cardiac magnetic resonance image in acute moderate to severe CO poisoning with elevated high sensitivity troponin I: Prospective observational study. Cha YS, Kwon W, Son JW, Lee CH, Han SI Presenting Author: Yong Sung Cha MD
11:00 AM
12:00 PM
GME Committee Meeting
Canary
11:30 AM
12:00 PM
Poster Session A: Posters A1-A7
A1: HBO2 therapy reduces mortality, hepatic inflammation and improves renal mitochondrial function in a model of severe polymicrobial sepsis. Perdrizet GA, Halbach JL, Prieto JM, Wang, AW, Hawisher D, Cauvi DM, Reys T, Okerblom J, Ramierz-Sanchez I, Villarreal F, Patel HH, Bickler SW, De Maio A, Singh P, and Li L. Presenting Author: George A. Perdrizet MD
A2: A hyperbaric and high-oxygen environment accelerates IL-6 synthesis via RNS in rat contused skeletal muscle. Oyaizu T, Enomoto M, Horie M, Yamamoto N, Yagishita K Presenting Author: Takuya Oyaizu MD
A3: A hyperbaric, high-oxygen environment promotes injured rat muscle recovery by angiogenesis through reactive nitrogen species. Yamamoto N, Oyaizu T, Enomoto M, Horie M, Yagishita K Presenting Author: Naoki Yamamoto MD
A4: Hyperbaric oxygen inhibits hyperglycemia-induced NLRP3 inflammasome and microparticle formation in neutrophils. Thom SR, Bhopale VM, WaliaD Presenting Author: Stephen Thom MD
A5: Prevalence and pattern of cardiac injury identified by late gadolinium-enhancement of cardiac magnetic resonance image in acute moderate to severe CO poisoning with elevated high sensitivity troponin I: Prospective observational study. Cha YS, Kwon W, Son JW, Lee CH, Han SI Presenting Author: Yong Sung Cha MD A6: Effects of HBO2 on the osteogenic differentiation of human adipose-derived stem cells. Camporesi EM, Zavan B, Gardin C, Bellin G, Rizzato A, Vezzani G, Bosco G Presenting Author: Enrico M. Camporesi MD
A7: Inflammatory hypoxia: A new, unifying target for HBO2 therapy. Perdrizet GA Presenting Author: George A. Perdrizet, MD
Poster Session B-1: Posters B1-B15 B1: Hyperbaric oxygen therapy for the treatment of perianal fistulas in Crohn’s disease (HOT-TOPIC): preliminary results. Lansdorp CA, Gecse KB, Buskens CJ, Löwenberg M, Stoker J, Bemelman WA, D’Haens GRAM, van Hulst RA Presenting Author: Nina (Corine Alida) Lansdorp MD
B2: The myopic shift associated with hyperbaric oxygen administration is reduced when using a mask delivery system compared to a hood - a randomized controlled trial. Bennett MH, Hui B, See HG, Au-Yeung KL, Tan C, Watson S Presenting Author: Michael Bennett MD
B3: Efficacy and safety of postoperative radiotherapy with hyperbaric oxygen therapy for keloids. Guo D Presenting Author: Dazhi Guo MDB4: Effect of hyperbaric oxygen therapy for central retinal artery occlusion. Han SI, Kim YS Presenting Author: Yoonseop Kim MD
B5: Prospective data collection through a hyperbaric outcomes registry: Preliminary results. Buckey JC, Ptak JA, Kertis JA, Rees JR Presenting Author: Jay C. Buckey MD
B6: Efficacy and safety of hyperbaric oxygen at 2.4 ATA in the management of radiation cystitis: A retrospective study. Ajayi OD, Masters TC, Westgard BC, Logue CJ, Walter JW, Hendriksen SM Presenting Author: David Ajayi MD
B7: Prehospital diagnosis and direct transfer to the hyperbaric chamber of carbon monoxide-intoxicated patients: a quality improvement initiative. Camporesi EM, Martani L, Cantadori L, Paganini M, Rubini A, Bosco G Presenting Author: Enrico M. Camporesi MD
B8: The impact of hyperbaric oxygen on treating idiopathic sudden sensorineural hearing loss. McCoy ME, Helwig NE, Logue C Presenting Author: Christopher Logue, MD
B9: Quality of life in patients with delayed effects of radiation treated with hyperbaric oxygen therapy. Famenini S, Schroeder M, Sethuraman K Presenting Author: Sam Famenini B10: Retinal artery and vein occlusions successfully treated with hyperbaric oxygen: Case reports. Johnson DR, Cooper JS Presenting Author: Jeffrey Cooper MD
B11: Late radiation cystitis treated with hyperbaric oxygen a randomized controlled trial. Oscarsson N, Müller B, Rosén A, Seeman-Lodding H Presenting Author: Nicklas Oscarsson MD
B12: Osteonecrosis in children and adolescents with acute lymphoblastic leukemia (ALL): Improvement with HBO2 in early diagnosis. Camporesi EM, Biddeci G, Bosco G, Gigante C, Garetto G, Abowali H, Putti MC Presenting Author: Enrico M. Camporesi MD
B13: Transient myopia and associated patient factors in patients undergoing elective hyperbaric oxygen therapy. Mihai A, Wojcik S, Seargent S, Pacelli L, Heyboer M Presenting Author: Aurel Mihai MD
B14: Does hyperbaric oxygen therapy affect etonogestrel levels from a Nexplanon implant? Kertis JA, Ptak JA, Reetz SB, Fisher TJ, Geno KA, DeJesus CL, Cremers S, Buckey JC Presenting Author: Judy A. Kertis RN/CHRN
B15: Current myringotomy training practices across hyperbaric and undersea medicine training programs. Brett KD, Coffey CD, Bracken D, Witucki, P Presenting Author: Kaighley Brett MD
Rio Mar 1-4
1:00 PM
2:00 PM
Kindwall Keynote: HBO2 in Chronic Radiation-Injured Tissue and Osteoradionecrosis in Today’s Radiation Schemes: Needed Now Even More. Robert Marx, DDS
Rio Mar 6-10
2:00 PM
3:00 PM
Session B: Clinical HBO2
Rio Mar 6-10
2:00-2:10
B1: Hyperbaric oxygen therapy for the treatment of perianal fistulas in Crohn’s disease (HOT-TOPIC): preliminary results. Lansdorp CA, Gecse KB, Buskens CJ, Löwenberg M, Stoker J, Bemelman WA, D’Haens GRAM, van Hulst RA Presenting Author: Nina (Corine Alida) Lansdorp MD
2:10-2:20
B2: The myopic shift associated with hyperbaric oxygen administration is reduced when using a mask delivery system compared to a hood – a randomized controlled trial. Bennett MH, Hui B, See HG, Au-Yeung KL, Tan C, Watson S Presenting Author: Michael Bennett MD
2:20-2:30
B3: Efficacy and safety of postoperative radiotherapy with hyperbaric oxygen therapy for keloids. Guo D Presenting Author: Dazhi Guo MD
2:30-2:40
B4: Effect of hyperbaric oxygen therapy for central retinal artery occlusion. Han SI, Kim YS Presenting Author: Yoonseop Kim MD
2:40-2:50
B5: Prospective data collection through a hyperbaric outcomes registry: Preliminary results. Buckey JC, Ptak JA, Kertis JA, Rees JR Presenting Author: Jay C. Buckey MD
2:50-3:00
B6: Efficacy and safety of hyperbaric oxygen at 2.4 ATA in the management of radiation cystitis:A retrospective study. Ajayi OD, Masters TC, Westgard BC, Logue CJ, Walter JW, Hendriksen SM Presenting Author: David Ajayi MD
3:00 PM
3:30 PM
BREAK / EXHIBITS
Rio Mar 5
3:00 PM
5:00 PM
Editorial Board Meeting
Heron
3:30 PM
4:00 PM
Poster Session B-2: Posters B16-B27
B16: Ketamine sedation for hyperbaric oxygen therapy in hypotensive patients. Mihai A, Heyboer M Presenting Author: Aurel Mihai MD
B17: Effects of hypoxia on N100 and P300 event-related potentials during visuospatial attention control. Hutcheon EA, Nunes AS, Ribrary U, Ferguson SA, Claydon VE, Doesburg SM Presenting Author: Sherri Ferguson B18: BK viral-induced hemorrhagic cystitis and the role of HBO2 therapy. Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill DO
B19: Clinical and radiographic improvement in bisphosphonate-related osteonecrosis of the mandible with hyperbaric oxygen therapy: A case report. Shields RC, Toups GN, Price DL Presenting Author: Raymond C. Shields MD
B20: Well-controlled diabetics safely receive serial hyperbaric oxygen treatments without serial blood glucose checks. Mihai A, Morgan M, Sharma D, Santiago W, Heyboer M Presenting Author: Aurel Mihai MD B21: The use of hyperbaric oxygen therapy to treat an anaerobic retroperitoneal abscess with extension into the mediastinum. Long JS, Foster JM, Cooper JS Presenting Author: Jeffrey Cooper MD B22: Uneventful serial hyperbaric oxygen treatments in setting of cerebral vasoconstriction syndrome. Mihai A, Sharma D, Boes T, Morgan M, Santiago W, Heyboer M Presenting Author: Aurel Mihai MD
B23: An innovative design employing Medicare claims data to demonstrate a cost savings for hyperbaric oxygen in the treatment of radiation cystitis and proctitis. Feldmeier JJ, Kirby JP, Gelly HB, Robins MS, DaVanzo JE, and Gruhn P Presenting Author: John J. Feldmeier DO
B24: WITHDRAWN
B25: Case report: The role of HBO2 therapy in a spider bite. Borges H, Oliveira N, Paz MA, Santos PE Presenting Author: Hugo Leonardo De Lima Borges MD
B26: Case report: HBO2 therapy avoiding amputation in serious osteomyelitis of ankle. Borges H, Oliveira N, Paz MA, Santos PE Presenting Author: Hugo Leonardo De Lima Borges MD
B27: Variations in study outcomes relative to intention-to-treat and per-protocol data analysis techniques in the evaluation of efficacy for treatment of venous leg ulcers with dehydrated human amnion/chorion membrane allograft. Bianchi C, Tettelbach W, Istwan N, Hubbs B, Kot K, Harris S, Fetterolf D. Presenting Author: William Tettelbach MD
Rio Mar 1-4
4:00 PM
5:00 PM
Plenary Session: Physiology and Science in Hyperbaric Medicine
Rio Mar 6-10
4:00-4:30
Stem cells and hyperbaric oxygen therapy: Stephen Thom, MD
4:30-5:00
Research that we need to do in the field of hyperbaric medicine and some thoughts on how to achieve this goal: John Feldmeier, DO
5:00 PM
6:00 PM
Education Committee Meeting
Pelican
6:00 PM
7:00 PM
Exhibitor Wine & Cheese Reception
Rio Mar 5
FRIDAY, June 28
7:00 AM
8:00 AM
CONTINENTAL BREAKFAST / EXHIBITS
Rio Mar 5
7:00 AM
8:00 AM
Past President’s Breakfast
Canary
8:00 AM
10:00 AM
Plenary Session: DCI Theory & Mechanisms
Rio Mar 6-10
8:00-9:00
CNS Oxygen toxicity: Where are we now? Jay Dean, PhD
9:00-9:30
Navy dive operations: Lessons learned about planning, DCS prevention and treatment: Pete Witucki, MD
9:30-10:00
Wearable diving technology: Ki Chon, MD
10:00 AM
10:30 AM
BREAK / EXHIBITS
Rio Mar 5
10:30 AM
11:30 AM
Session C: Decompression Theory and Mechanisms
Rio Mar 6-10
10:30-10:40
C1: A predictive model of serious decompression sickness following loss of spacecraft cabin pressure. Gernhardt ML, Abercromby AFJ Presenting Author: Michael Gernhardt PhD
C2: Modeling decompression stress associated with surface interval freediving in recreational diving. Gernhardt ML, Bekdash OS Presenting Author: Michael L. Gernhardt PhD
10:40-10:50
C3: Albumin-derived perfluorocarbon-based nanocapsules as an effective preventive therapy of decompression illness: Well-proven wine in new bottles. Mayer D, Guerrero F, Goanvec C, Ljubcovic M, Mayer C, Kirsch M, Ferenz KB Presenting Author: Dirk Mayer MD
10:50-11:00
C4: Validation of an exhaled nitric oxide model of pulmonary hyperoxic stress. Fothergill DM, Ross WL, Florian JP Presenting Author: David Fothergill PhD
11:00-11:10
C5: Tetranomial probabilistic modeling of serious, mild, marginal and no decompression sickness. King AE, Andriano NR, Howle LE, Vann RD Presenting Author: Amy King
11:10-11:20
C6: The protective effects of synthetic ketone ester BD-AcAc2 on rats with decompression sickness. Zhang K, Xu WG Presenting Author: Kun Zhang MD
11:20-11:30
C7: Development and limited validation of the XVal-He-9_040 Thalmann algorithm parameter set for computing decompression schedules for extended duration 1.3 atm PO2 He-O2 diving. Doolette DJ, Murphy FG, Gerth WA Presenting Author: David J Doolette PhD
10:00 AM
11:00 AM
ECCHO Working Group Meeting
Heron
10:00 AM
11:00 AM
Publication Committee Meeting
Canary
11:00 AM
1:00 PM
ACHM-UHMS Meeting
Heron
11:30 AM
12:00 PM
Poster Session C: Posters C1-C11
C1: A predictive model of serious decompression sickness following loss of spacecraft cabin pressure. Gernhardt ML, Abercromby AFJ Presenting Author: Michael Gernhardt PhD
C2: Modeling decompression stress associated with surface interval freediving in recreational diving. Gernhardt ML, Bekdash OS Presenting Author: Michael L. Gernhardt PhD
C3: Albumin-derived perfluorocarbon-based nanocapsules as an effective preventive therapy of decompression illness: Well-proven wine in new bottles. Mayer D, Guerrero F, Goanvec C, Ljubcovic M, Mayer C, Kirsch M, Ferenz KB Presenting Author: Dirk Mayer MD
C4: Validation of an exhaled nitric oxide model of pulmonary hyperoxic stress. Fothergill DM, Ross WL, Florian JP Presenting Author: Dr. David Fothergill PhD
C5: Tetranomial probabilistic modeling of serious, mild, marginal and no decompression sickness. King AE, Andriano NR, Howle LE, Vann RD Presenting Author: Amy King
C6: The protective effects of synthetic ketone ester BD-AcAc2 on rats with decompression sickness. Zhang K, Xu WG Presenting Author: Kun Zhang MD C7: Development and limited validation of the XVal-He-9_040 Thalmann algorithm parameter set for computing decompression schedules for extended duration 1.3 atm PO2 He-O2 diving. Doolette DJ, Murphy FG, Gerth WA Presenting Author: David J Doolette PhD
C8: The biphasic effects of autophagy on decompression bubble-induced endothelial injuries. Zhang K, Xu WG Presenting Author: Kun Zhang MD
C9: Benefits of escin for decompression sickness in Bama pigs by endothelia-targeting protection. Qing l, Xu WG Presenting Author: Weigang Xu MD
C10: Experimental testing of cross corrections to decompression tables for dives at altitude. Weis TW, Dong TW, Natoli MJ, Lance RM, Howle LE, Pieper CF, Freiberger JJ, Derrick BJ, Moon RE Presenting Author: Richard E Moon MD
C11: Cognitive control performance during increasing ambient pressure: Event-related brain potential study. Fujii T Presenting Author: Tatsufumi Fujii PhD
D1: Ketogenic diet for reduction of CNS oxygen toxicity in working divers (KetOX Study): Pilot study. Allen J, Orabi M, Bahaadin Al-Jarani, Gonzalez S, Dong TW, Natoli MJ, Richardson C, Brown G, Walker AJ, Schinazi EA, Kuchibhatla M, D’Agostino DP, Keuski BM, Moon RE, Freiberger JJ, Derrick BJ Presenting Author: Justin Allen DO
D2: Comparison of dysbaric osteonecrosis severity in the u/w sheep model after a 24-hour dive at 33 fsw followed by either a 15-, 30-, or 45-minute oxygen pre-breathe before dropout decompression. Lamers JL, Sobakin AS Presenting Author: Jake Lamers
D3: Manned validation of U.S. Navy Diving Manual, Revision 7, VVal-79 air decompression schedules for short bottom times in the 130-140 fsw range. Andrew BT, Doolette DJ Presenting Author: Brian T. Andrew MD
D4: Improving safety of submarine escape and rescue from 60 and 70 fsw Eldridge MW, Sobakin AS Presenting Author: Aleksey Sobakin PhD
D5: A graphical user interface for expediting bubble-counting analysis of post-dive echocardiograms and statistics for vetting crowdsourcing contributions. Barrentine B, Le DQ, Germonpré P, Balestra C, Tillmans F, Denoble PJ, Freiberger JJ, Moon RE,Dayton PA, Papadopoulou V Presenting Author: David Q Le
D6: Detecting pulmonary oxygen toxicity using exhaled breath analysis: Wet and dry diving are not the same. Wingelaar TT, Brinkman P, van Ooij PJAM, Maitland-Van der Zee AH, van Hulst RA Presenting Author: Thijs Wingelaar MD
D7: A robust image-processing method for selecting frames during late ventricular diastole in post-dive echocardiography without ECG gating. Markley E, Le DQ, Germonpré P, Balestra C, Tillmans F, Denoble PJ, Freiberger JJ, Moon RE, Dayton PA, Papadopoulou V Presenting Author: David Q Le
D8: Acute bone necrosis in cases of decompression sickness with refractory pain despite hyperbaric treatment. Calderon, J. Mansilla, Y. Cabrera, M. Mansilla, C. Estrada. J Presenting Author: Jorge Calderon MD
D9: Dysbaric osteonecrosis among the artisanal diving fishermen in Yucatan, Mexico Popa D, Chin W, Huchim-Lara O, Medak A, Hughes T, Grover I. Presenting Author: Daniel Popa, MD
D10: Manual dexterity and finger skin temperature is reduced in cold water and is not preserved with whole-body active heating. Wheelock CE, Hess HW, Hostler D Presenting Author: Courtney Wheelock
D11: A deep-learning approach for automated bubble counting in 2D echocardiography of divers. Le DQ, Kierski TM, Markley E, Germonpré P, Balestra C, Tillmans F, Denoble PJ, Freiberger JJ, Moon RE, Dayton PA, Papadopoulou V Presenting Author: David Q Le
D12: Sea harvester diving in Yucatan and Quintana Roo, Mexico: 1988-2018. Sanchez EC, Gomez D, Rivas F, Medina A, Lopez J, García G, Torres S, Diaz R, Paredes H, Denoble P. Presenting Author: J Dario Gomez Castillo MD
D13: The effect of sudden drop in partial pressure of oxygen during ascent on heart function. Ferguson SA, Poburko D, Claydon VE, Koehle M, Ruben PC Presenting Author: Sherri Ferguson
D14: Pulmonary edema in special operations assessments. Tanaka HL, Wightman JM, Ott MC Presenting Author: Hideaki L. Tanaka MD
D15: The effect of oxygen and nitrogen on nitrogen narcosis severity. Ferguson SA, Hutcheon EA, Doesburg SM Presenting Author: Sherri Ferguson
Rio Mar 1-4
1:00 PM
2:00 PM
Lambertsen Keynote: Decompression sickness as an inflammatory disease. Simon Mitchell, MBBS, PhD
Rio Mar 6-10
2:00 PM
3:00 PM
QUARC Committee Meeting
Heron
2:00 PM
5:00 PM
Surveyor Refresher Training
Caribbean 3
2:00 PM
3:00 PM
Session D: Diving Medicine
Rio Mar 6-10
2:00-2:10
D1: Ketogenic diet for reduction of CNS oxygen toxicity in working divers (KetOX Study): Pilot study. Allen J, Orabi M, Bahaadin Al-Jarani, Gonzalez S, Dong TW, Natoli MJ, Richardson C, Brown G, Walker AJ, Schinazi EA, Kuchibhatla M, D’Agostino DP, Keuski BM, Moon RE, Freiberger JJ, Derrick BJ Presenting Author: Justin Allen DO
2:10-2:20
D2: Comparison of dysbaric osteonecrosis severity in the u/w sheep model after a 24-hour dive at 33 fsw followed by either a 15-, 30-, or 45-minute oxygen pre-breathe before dropout decompression. Lamers JL, Sobakin AS Presenting Author: Jake Lamers
2:20-2:30
D3: Manned validation of U.S. Navy Diving Manual, Revision 7, VVal-79 air decompression schedules for short bottom times in the 130-140 fsw range. Andrew BT, Doolette DJ Presenting Author: Brian T. Andrew MD
2:30-2:40
D4: Improving safety of submarine escape and rescue from 60 and 70 FSW Eldridge MW, Sobakin AS Presenting Author: Aleksey Sobakin PhD
2:40-2:50
D5: A graphical user interface for expediting bubble-counting analysis of post-dive echocardiograms and statistics for vetting crowdsourcing contributions. Barrentine B, Le DQ, Germonpré P, Balestra C, Tillmans F, Denoble PJ, Freiberger JJ, Moon RE,Dayton PA, Papadopoulou V Presenting Author: David Q Le
2:50-3:00
D6: Detecting pulmonary oxygen toxicity using exhaled breath analysis: Wet and dry diving are not the same. Wingelaar TT, Brinkman P, van Ooij PJAM, Maitland-Van der Zee AH, van Hulst RA Presenting Author: Thijs Wingelaar MD
3:00 PM
3:30 PM
BREAK / EXHIBITS
Rio Mar 5
3:00 PM
4:00 PM
Research Committee Meeting
Heron
3:30 PM
4:00 PM
Poster Session D-2: Posters D16-D28
D16: Self-paced exercise performance is attenuated following four hours of cold water immersion irrespective of breathing gas type. Hess HW, Schlader ZJ, Johnson BD, Hostler D Presenting Author: Hayden W. Hess
D17: Does the use of normobaric oxygen in Swedish working divers underestimate the incidence of decompression illness? Hagberg M, Ornahgen H Presenting Author: Mats Hagberg MD
D18: Optimizing oxygenation, hemodynamics and metabolism during diving by using underwater near-infrared spectroscopy (NIRS). Whelan H, Ari C, Prost R, Sugar J, D'Agostino D, Quirk B, Dituri J, Harper Z, Aderman T, Fahlman A, McKnight C, Tyack P, Shorter A, Popa B, Williams T, Chapman S Presenting Author: Harry T. Whelan MD
D19: Count model of DCI among fishermen divers. Peluso E, Chin W, Huchim O Presenting Author: Walter Chin RN/CHRN
D21: Cancer and diving: data from 124 UK sport divers. St Leger Dowse M, Morgan B, Smerdon GR Presenting Author: Marguerite St Leger DowseD22: Pathophysiology of dysbaric osteonecrosis. Kawashima M, Kawashima M, Tamura H, Takao K, Yamaguchi T, Miyata K, Kitano M Presenting Author: Mahito Kawashima MD
D23: Thermoregulation in environmental conditions expected in a disabled pressurized rescue module. Schlader ZJ, Stooks J, Johnson BD, Hostler D Presenting Author: Zachary J. Schlader PhD
D24: Required sample sizes for testing cardiovascular effects of normobaric scuba regulator breathing without immersion: A pilot trial. Kovacs CR, Buzzacott P Presenting Author: Christopher Kovacs PhD
D25: A technical review of ultrasound use in decompression research. Le DQ, Dayton PA, Tillmans F, Freiberger JJ, Moon RE, Denoble PJ, Papadopoulou V Presenting Author: David Q Le
D26: Retreatment with a TT6A1M for neurological decompression illness in patients with a poor response to standard treatment with a USN TT6. McEldrew P, Siegel M, LeGros TL, Wyatt A, and Van Meter K Presenting Author: Patrick McEldrew, MD
D27: Dive profiles and physiologic parameters of safety divers at a breath-hold diving competition. Derksen B, Lang M, Lindholm P, Van Hoesen K Presenting Author: Brenna Derksen MD
D28: No change in total mood disturbance during a simulated disabled pressurized rescue module scenario. Johnson BD, Hess HW, Stooks J, Hostler D, Schlader ZJ Presenting Author: Blair Johnson PhD
Rio Mar 1-4
4:00 PM
5:00 PM
Plenary Session: Altitude Decompression Sickness
Rio Mar 6-10
4:00-4:30
Combating flier’s “bends” during unpressurized flight and explosive decompression in World War II: Jay Dean, PhD
4:30-5:00
USAF hypobaric exposures experience: Marc Robins, DO
5:00 PM
6:00 PM
UHMS Business Meeting - Open meeting
Rio Mar 6-10
5:030 PM
7:30 PM
Specialty Council Meeting (Toups) PRIVATE Meeting
Pelican
SATURDAY, June 29
7:00 AM
8:00 AM
CONTINENTAL BREAKFAST / EXHIBITS
Rio Mar 5
8:00 AM
5:00 PM
Non-Physician "Associates" Breakout Session (not approved for physician CME credits)
Caribbean 2-3
8:00 AM
10:00 AM
Plenary Session: The Regulatory And Reimbursement Challenges Facing Nations And How These Have Been Addressed
Rio Mar 6-10
8:00-8:25
Canada: Ken LeDez, MD
8:25-8:50
United Kingdom: Pieter Bothma, MD
8:50-9:15
United States: Caroline Fife, MD
9:15-9:40
Australia: Michael Bennett, MD
9:40-10:00
Panel Discussion
10:00 AM
10:30 AM
BREAK / EXHIBITS
Rio Mar 5
10:30 AM
11:30 AM
Session E: HBO2 Operations, Chambers, and Equipment
Rio Mar 6-10
10:30-10:40
E1: Use of point of care ultrasounds for the rapid diagnosis of central retinal artery occlusion. McCarthy P, Hendriksen SM, Masters TC, Westgard BC, Walter JW, Osterman A, Reardon RF, Logue CJ Presenting Author: Christopher Logue MD
10:40-10:50
E2: Comparison of radial artery catheter blood pressure with automatic non-invasive blood pressure at 35 fsw on 100% O2. Orabi M, Allen J, Gonzalez S, Natoli MJ, Freiberger JJ, Derrick BJ Presenting Author: Maia Orabi MD
10:50-11:00
E3: Reliability of a continuous glucose monitor during hyperbaric oxygen exposure: Interim analysis. Huang E, Savaser D, Castle J, Manulik B, Demirel S, Bliss B, Fitzpatrick P Presenting Author: Enoch Huang MD E4: Safety of a continuous glucose monitoring device during hyperbaric exposure. Bliss C, Huang E, Savaser D Presenting Author: Chae Bliss CHT
E6: Culturally competent hyperbaric patient care. Marosek N, Melnyczenko A Presenting Author: Nicholas Marosek RN/CHRN
11:20-11:30
E7: Implementation and evaluation of an interdisciplinary, simulation-based educational curriculum in hyperbaric medicine. Paetow G, Guber K, Raleigh S, TenBrink W, Driehorst M, Brown L, Jensen A, Omodt S, Olives T, Hart D, Logue C Presenting Author: Christopher Logue MD
E8: Interdisciplinary simulation for the detection of latent risk threats in a hyperbaric medicine department. Paetow G, TenBrink W, Driehorst M, Brown L, Jensen A, Omodt S, Hart D, Logue C Presenting Author: Christopher Logue MD
11:30 AM
12:00 PM
Poster Session E: Poster E1-E14
E1: Use of point of care ultrasounds for the rapid diagnosis of central retinal artery occlusion. McCarthy P, Hendriksen SM, Masters TC, Westgard BC, Walter JW, Osterman A, Reardon RF, Logue CJ Presenting Author: Christopher Logue MD
E2: Comparison of radial artery catheter blood pressure with automatic non-invasive blood pressure at 35 fsw on 100% O2. Orabi M, Allen J, Gonzalez S, Natoli MJ, Freiberger JJ, Derrick BJ Presenting Author: Maia Orabi MD
E3: Reliability of a continuous glucose monitor during hyperbaric oxygen exposure: Interim analysis. Huang E, Savaser D, Castle J, Manulik B, Demirel S, Bliss B, Fitzpatrick P Presenting Author: Enoch Huang MD
E4: Safety of a continuous glucose monitoring device during hyperbaric exposure. Bliss C, Huang E, Savaser D Presenting Author: Chae Bliss CHT
E6: Culturally competent hyperbaric patient care. Marosek N, Melnyczenko A Presenting Author: Nicholas Marosek RN/CHRN
E7: Implementation and evaluation of an interdisciplinary, simulation-based, educational curriculum in hyperbaric medicine. Paetow G, Guber K, Raleigh S, TenBrink W, Driehorst M, Brown L, Jensen A, Omodt S, Olives T,Hart D, Logue C Presenting Author: Christopher Logue MDE8: Interdisciplinary simulation for the detection of latent risk threats in a hyperbaric medicine department. Paetow G, TenBrink W, Driehorst M, Brown L, Jensen A, Omodt S, Hart D, Logue C Presenting Author: Christopher Logue MD
E9: U.S. involvement in the Thai cave rescue. Tanaka HL Presenting Author: Hideaki L Tanaka MD
E10: Lithium-ion battery explosion leading to a traumatic femur fracture in cave diver. Covington DB, Ohama M, Millan S, Pitkin A Presenting Author: Derek Covington MD
E11: Successful cardiac defibrillation during hyperbaric oxygen therapy in a patient with severe carbon monoxide poisoning. Allen JA, Shah KR, Moon RE Presenting Author: Justin Allen DO
E12: Pilot study on the feasibility of utilization of an Epi-Pen under pressure in a multiplace chamber. Savaser DJ, Huang ET, Bliss C Presenting Author: Davut Savaser MD
E13: Emergency response by hyperbaric personnel. Vidafar M Presenting Author: Michael Vidafar CHT
E14: Oxygen exhaust sign improvement. Vidafar M Presenting Author: Michael Vidafar CHT
Rio Mar 1-4
10:00 AM
11:00 PM
Chapter President's Committee Meeting
Pelican
10:00 AM
12:00 PM
Diving Committee Meeting
Canary
11:00 AM
12:00 PM
Membership Committee Meeting
Pelican
12:00 PM
1:00 PM
LUNCH
Ocean Terrace/Rio Mar Foyer
12:00 PM
1:00 PM
Associates Luncheon (limited to 50)
Caribbean 1
1:00 PM
2:00 PM
Plenary Session:
Rio Mar 6-10
1:00-1:30
HBO2 and Inflammatory Bowel Disease Update: Jay Buckey, MD
1:30-2:00
Diving, operational & environmental physiology of the Thai cave rescue: Richard Walker, MD
2:00 PM
3:00 PM
Session F: Top Case Reports
Rio Mar 6-10
2:00-2:10
F1: Tension pneumocephalus: Iatrogenic subarachnoid air embolism treated with hyperbaric oxygen therapy. Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill DO
2:10-2:20
F2: Carbon monoxide poisoning; Mixed-acid cocktail suicide attempt. Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill DO
2:20-2:30
F3: A case of delayed mortality after severe arterial gas embolism secondary to myocardial infarction from triple-vessel coronary artery thrombosis. Derksen BJ, Hayden SR, Grover I, Sadler CA Presenting Author: Charlotte Sadler MD
2:30-2:40
F4: De novo cataract formation in non-diabetics. Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill MD
2:40-2:50
F5: A rare case report of coronary gas embolism after percutaneous lung biopsy. Allen JA, Mammarappallil JG Presenting Author: Justin Allen DO
2:50-3:00
F6: Successful treatment of laryngotracheal radionecrosis with hyperbaric oxygen therapy in a patient presenting with persistent hemoptysis and cough. Savaser DJ, Huang ET Presenting Author: Davut Savaser MD
3:00 PM
3:30 PM
BREAK / EXHIBITS
Rio Mar 5
3:30 PM
4:00 PM
Poster Session F: Posters F1-F15
F1: Tension pneumocephalus: Iatrogenic subarachnoid air embolism treated with hyperbaric oxygen therapy. Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill DO
F2: Carbon monoxide poisoning; Mixed-acid cocktail suicide attempt Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill DO
F3: A case of delayed mortality after severe arterial gas embolism secondary to myocardial infarction from triple-vessel coronary artery thrombosis. Derksen BJ, Hayden SR, Grover I, Sadler CA Presenting Author: Brenna Derksen MD
F4: De novo cataract formation in non-diabetics. Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill MD
F5: A rare case report of coronary gas embolism after percutaneous lung biopsy Allen JA, Mammarappallil JG Presenting Author: Justin Allen DO
F6: Successful treatment of laryngotracheal radionecrosis with hyperbaric oxygen therapy in a patient presenting with persistent hemoptysis and cough. Savaser DJ, Huang ET Presenting Author: Davut Savaser MD
F7: Hyperbaric oxygen treatment for delayed radiation-induced esophageal stricture. Dullum D Presenting Author: Diane Dullum RN/CHRN
F8: Diving with Osler-Weber-Rendu disease: A rare case provoking thoughts. Swenker R, van Ooij PJ Presenting Author: Rob Swenker MD
F9: Hyperbaric oxygen treatment of patient with tracheal-esophageal device and recent thoracic surgery. Mihai A, Morgan M, Sharma D, Boes T, Santiago W, Heyboer M Presenting Author: Aurel Mihai MD
F10: Successful treatment of medication-related jaw osteonecrosis with hyperbaric oxygen therapy .using a Marx protocol-like approach. Hodgson J Presenting Author: Joni Hodgson DO
F11: Hyperbaric oxygen treatment status post gamma knife surgery improves progressively worsening neurological symptoms. Mihai A, Morgan M, Sharma D, Santiago W, Heyboer M. Presenting Author: Aurel Mihai MD
F12: Against most odds: A case study, limb salvage. Crapella L
Presenting Author: Lise Crapella ACNP/PA
F13: Innovative use of dehydrated human amnion/chorion membrane in conjunction with hyperbaric oxygen therapy to treat a non-healing nasal wound subsequent to squamous cell carcinoma resection and radiation: A case study. Henderson JA, Jones MW, Houle SS Presenting Author: Jessica Henderson DO
F14: Case report: High-throughput enterocutaneous fistula and the role of HBO2 therapy. Borges H, Oliveira N, Paz MA, Santos PE Presenting Author: Hugo Leonardo De Lima Borges MD
F15: A case of vertigo in a recreational scuba diver. Agostinelli N Presenting Author: Nicole Agostinelli MD
Rio Mar 1-4
4:00 PM
5:00 PM
Plenary Session: Topics in Undersea and Hyperbaric MedicineRio Mar 6-10
4:00-4:30
Top articles in HBO2: Justin Allen, DO, Fellow, Duke, Durham, NC
4:30-5:00
Top articles in Undersea Medicine: Aurel Mihai, MD, Fellow, SUNY, Syracuse, NY
THURSDAY, JUNE 27 - SATURDAY, JUNE 29 PDF copy Subject to change Posted 5/21/18
Subject to Change Posted 5/20/19 (please note that there will not be any Accreditation Surveyor Training at this year's Annual Meeting)
GENERAL SESSION DAYS
NON-PHYSICIAN BREAKOUT
BREAKS/EXHIBITS
SOCIAL EVENTS
START TIME
END TIME
EVENT
LOCATION
THURSDAY, June 27
7:00 AM
8:00 AM
CONTINENTAL BREAKFAST / EXHIBITS
Rio Mar 5
8:00 AM
8:30 AM
President's Address: Nick Bird, MD
Rio Mar 6-10
8:30 AM
10:00 AM
Plenary Session: Controversies in the Hyperbaric Management of Late Radiation Injuries
Rio Mar 6-10
8:30-9:00
Late Radiation Tissue Injury Below the Clavicles: Considerations with IMRT and the Fibroatrophic Model: John Feldmeier, DO
9:00-9:30
Answering the criticism and challenges to HBO2 in the treatment of radiated patients: Robert Marx, DDS
9:30-10:00
Panel Discussion
10:00 AM
10:30 AM
BREAK / EXHIBITS
Rio Mar 5
10:30 AM
11:30 AM
Session A: HBO2 Theory & Mechanisms
Rio Mar 6-10
10:30-10:45
A1: HBO2 therapy reduces mortality, hepatic inflammation and improves renal mitochondrial function in a model of severe polymicrobial sepsis. Perdrizet GA, Halbach JL, Prieto JM, Wang, AW, Hawisher D, Cauvi DM, Reys T, Okerblom J, Ramierz-Sanchez I, Villarreal F, Patel HH, Bickler SW, De Maio A, Singh P, Li L Presenting Author: George A. Perdrizet MD
10:45-11:00
A3: A hyperbaric, high-oxygen environment promotes injured rat muscle recovery by angiogenesis through reactive nitrogen species. Yamamoto N, Oyaizu T, Enomoto M, Horie M, Yagishita K Presenting Author: Naoki Yamamoto MD
11:00-11:15
A4: Hyperbaric oxygen inhibits hyperglycemia-induced NLRP3 inflammasome and microparticle formation in neutrophils. Thom SR, Bhopale VM, WaliaD Presenting Author: Stephen Thom MD
11:15-11:30
A5: Prevalence and pattern of cardiac injury identified by late gadolinium-enhancement of cardiac magnetic resonance image in acute moderate to severe CO poisoning with elevated high sensitivity troponin I: Prospective observational study. Cha YS, Kwon W, Son JW, Lee CH, Han SI Presenting Author: Yong Sung Cha MD
11:30 AM
12:00 PM
Poster Session A: Posters A1-A7
A1: HBO2 therapy reduces mortality, hepatic inflammation and improves renal mitochondrial function in a model of severe polymicrobial sepsis. Perdrizet GA, Halbach JL, Prieto JM, Wang, AW, Hawisher D, Cauvi DM, Reys T, Okerblom J, Ramierz-Sanchez I, Villarreal F, Patel HH, Bickler SW, De Maio A, Singh P, and Li L. Presenting Author: George A. Perdrizet MD
A2: A hyperbaric and high-oxygen environment accelerates IL-6 synthesis via RNS in rat contused skeletal muscle. Oyaizu T, Enomoto M, Horie M, Yamamoto N, Yagishita K Presenting Author: Takuya Oyaizu MD
A3: A hyperbaric, high-oxygen environment promotes injured rat muscle recovery by angiogenesis through reactive nitrogen species. Yamamoto N, Oyaizu T, Enomoto M, Horie M, Yagishita K Presenting Author: Naoki Yamamoto MD
A4: Hyperbaric oxygen inhibits hyperglycemia-induced NLRP3 inflammasome and microparticle formation in neutrophils. Thom SR, Bhopale VM, WaliaD Presenting Author: Stephen Thom MD
A5: Prevalence and pattern of cardiac injury identified by late gadolinium-enhancement of cardiac magnetic resonance image in acute moderate to severe CO poisoning with elevated high sensitivity troponin I: Prospective observational study. Cha YS, Kwon W, Son JW, Lee CH, Han SI Presenting Author: Yong Sung Cha MD A6: Effects of HBO2 on the osteogenic differentiation of human adipose-derived stem cells. Camporesi EM, Zavan B, Gardin C, Bellin G, Rizzato A, Vezzani G, Bosco G Presenting Author: Enrico M. Camporesi MD
A7: Inflammatory hypoxia: A new, unifying target for HBO2 therapy. Perdrizet GA Presenting Author: George A. Perdrizet, MD
Rio Mar 1-4
12:00 PM
1:00 PM
LUNCH
Ocean Terrace/Rio Mar Foyer
12:30 PM
1:00 PM
Poster Session B-1: Posters B1-B15 B1: Hyperbaric oxygen therapy for the treatment of perianal fistulas in Crohn’s disease (HOT-TOPIC): preliminary results. Lansdorp CA, Gecse KB, Buskens CJ, Löwenberg M, Stoker J, Bemelman WA, D’Haens GRAM, van Hulst RA Presenting Author: Nina (Corine Alida) Lansdorp MD
B2: The myopic shift associated with hyperbaric oxygen administration is reduced when using a mask delivery system compared to a hood - a randomized controlled trial. Bennett MH, Hui B, See HG, Au-Yeung KL, Tan C, Watson S Presenting Author: Michael Bennett MD
B3: Efficacy and safety of postoperative radiotherapy with hyperbaric oxygen therapy for keloids. Guo D Presenting Author: Dazhi Guo MDB4: Effect of hyperbaric oxygen therapy for central retinal artery occlusion. Han SI, Kim YS Presenting Author: Yoonseop Kim MD
B5: Prospective data collection through a hyperbaric outcomes registry: Preliminary results. Buckey JC, Ptak JA, Kertis JA, Rees JR Presenting Author: Jay C. Buckey MD
B6: Efficacy and safety of hyperbaric oxygen at 2.4 ATA in the management of radiation cystitis: A retrospective study. Ajayi OD, Masters TC, Westgard BC, Logue CJ, Walter JW, Hendriksen SM Presenting Author: David Ajayi MD
B7: Prehospital diagnosis and direct transfer to the hyperbaric chamber of carbon monoxide-intoxicated patients: a quality improvement initiative. Camporesi EM, Martani L, Cantadori L, Paganini M, Rubini A, Bosco G Presenting Author: Enrico M. Camporesi MD
B8: The impact of hyperbaric oxygen on treating idiopathic sudden sensorineural hearing loss. McCoy ME, Helwig NE, Logue C Presenting Author: Christopher Logue, MD
B9: Quality of life in patients with delayed effects of radiation treated with hyperbaric oxygen therapy. Famenini S, Schroeder M, Sethuraman K Presenting Author: Sam Famenini B10: Retinal artery and vein occlusions successfully treated with hyperbaric oxygen: Case reports. Johnson DR, Cooper JS Presenting Author: Jeffrey Cooper MD
B11: Late radiation cystitis treated with hyperbaric oxygen a randomized controlled trial. Oscarsson N, Müller B, Rosén A, Seeman-Lodding H Presenting Author: Nicklas Oscarsson MD
B12: Osteonecrosis in children and adolescents with acute lymphoblastic leukemia (ALL): Improvement with HBO2 in early diagnosis. Camporesi EM, Biddeci G, Bosco G, Gigante C, Garetto G, Abowali H, Putti MC Presenting Author: Enrico M. Camporesi MD
B13: Transient myopia and associated patient factors in patients undergoing elective hyperbaric oxygen therapy. Mihai A, Wojcik S, Seargent S, Pacelli L, Heyboer M Presenting Author: Aurel Mihai MD
B14: Does hyperbaric oxygen therapy affect etonogestrel levels from a Nexplanon implant? Kertis JA, Ptak JA, Reetz SB, Fisher TJ, Geno KA, DeJesus CL, Cremers S, Buckey JC Presenting Author: Judy A. Kertis RN/CHRN
B15: Current myringotomy training practices across hyperbaric and undersea medicine training programs. Brett KD, Coffey CD, Bracken D, Witucki, P Presenting Author: Kaighley Brett MD
Rio Mar 1-4
1:00 PM
2:00 PM
Kindwall Keynote: HBO2 in Chronic Radiation-Injured Tissue and Osteoradionecrosis in Today’s Radiation Schemes: Needed Now Even More. Robert Marx, DDS
Rio Mar 6-10
2:00 PM
3:00 PM
Session B: Clinical HBO2
Rio Mar 6-10
2:00-2:10
B1: Hyperbaric oxygen therapy for the treatment of perianal fistulas in Crohn’s disease (HOT-TOPIC): preliminary results. Lansdorp CA, Gecse KB, Buskens CJ, Löwenberg M, Stoker J, Bemelman WA, D’Haens GRAM, van Hulst RA Presenting Author: Nina (Corine Alida) Lansdorp MD
2:10-2:20
B2: The myopic shift associated with hyperbaric oxygen administration is reduced when using a mask delivery system compared to a hood – a randomized controlled trial. Bennett MH, Hui B, See HG, Au-Yeung KL, Tan C, Watson S Presenting Author: Michael Bennett MD
2:20-2:30
B3: Efficacy and safety of postoperative radiotherapy with hyperbaric oxygen therapy for keloids. Guo D Presenting Author: Dazhi Guo MD
2:30-2:40
B4: Effect of hyperbaric oxygen therapy for central retinal artery occlusion. Han SI, Kim YS Presenting Author: Yoonseop Kim MD
2:40-2:50
B5: Prospective data collection through a hyperbaric outcomes registry: Preliminary results. Buckey JC, Ptak JA, Kertis JA, Rees JR Presenting Author: Jay C. Buckey MD
2:50-3:00
B6: Efficacy and safety of hyperbaric oxygen at 2.4 ATA in the management of radiation cystitis:A retrospective study. Ajayi OD, Masters TC, Westgard BC, Logue CJ, Walter JW, Hendriksen SM Presenting Author: David Ajayi MD
3:00 PM
3:30 PM
BREAK / EXHIBITS
Rio Mar 5
3:30 PM
4:00 PM
Poster Session B-2: Posters B16-B27
B16: Ketamine sedation for hyperbaric oxygen therapy in hypotensive patients. Mihai A, Heyboer M Presenting Author: Aurel Mihai MD
B17: Effects of hypoxia on N100 and P300 event-related potentials during visuospatial attention control. Hutcheon EA, Nunes AS, Ribrary U, Ferguson SA, Claydon VE, Doesburg SM Presenting Author: Sherri Ferguson B18: BK viral-induced hemorrhagic cystitis and the role of HBO2 therapy. Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill DO
B19: Clinical and radiographic improvement in bisphosphonate-related osteonecrosis of the mandible with hyperbaric oxygen therapy: A case report. Shields RC, Toups GN, Price DL Presenting Author: Raymond C. Shields MD
B20: Well-controlled diabetics safely receive serial hyperbaric oxygen treatments without serial blood glucose checks. Mihai A, Morgan M, Sharma D, Santiago W, Heyboer M Presenting Author: Aurel Mihai MD B21: The use of hyperbaric oxygen therapy to treat an anaerobic retroperitoneal abscess with extension into the mediastinum. Long JS, Foster JM, Cooper JS Presenting Author: Jeffrey Cooper MD B22: Uneventful serial hyperbaric oxygen treatments in setting of cerebral vasoconstriction syndrome. Mihai A, Sharma D, Boes T, Morgan M, Santiago W, Heyboer M Presenting Author: Aurel Mihai MD
B23: An innovative design employing Medicare claims data to demonstrate a cost savings for hyperbaric oxygen in the treatment of radiation cystitis and proctitis. Feldmeier JJ, Kirby JP, Gelly HB, Robins MS, DaVanzo JE, and Gruhn P Presenting Author: John J. Feldmeier DO
B24: WITHDRAWN
B25: Case report: The role of HBO2 therapy in a spider bite. Borges H, Oliveira N, Paz MA, Santos PE Presenting Author: Hugo Leonardo De Lima Borges MD
B26: Case report: HBO2 therapy avoiding amputation in serious osteomyelitis of ankle. Borges H, Oliveira N, Paz MA, Santos PE Presenting Author: Hugo Leonardo De Lima Borges MD
B27: Variations in study outcomes relative to intention-to-treat and per-protocol data analysis techniques in the evaluation of efficacy for treatment of venous leg ulcers with dehydrated human amnion/chorion membrane allograft. Bianchi C, Tettelbach W, Istwan N, Hubbs B, Kot K, Harris S, Fetterolf D. Presenting Author: William Tettelbach MD
Rio Mar 1-4
4:00 PM
5:00 PM
Plenary Session: Physiology and Science in Hyperbaric Medicine
Rio Mar 6-10
4:00-4:30
Stem cells and hyperbaric oxygen therapy: Stephen Thom, MD
4:30-5:00
Research that we need to do in the field of hyperbaric medicine and some thoughts on how to achieve this goal: John Feldmeier, DO
6:00 PM
7:00 PM
Exhibitor Wine & Cheese Reception
Rio Mar 5
FRIDAY, June 28
7:00 AM
8:00 AM
CONTINENTAL BREAKFAST / EXHIBITS
Rio Mar 5
8:00 AM
10:00 AM
Plenary Session: DCI Theory & Mechanisms
Rio Mar 6-10
8:00-9:00
CNS Oxygen toxicity: Where are we now? Jay Dean, PhD
9:00-9:30
Navy dive operations: Lessons learned about planning, DCS prevention and treatment: Pete Witucki, MD
9:30-10:00
Wearable diving technology: Ki Chon, MD
10:00 AM
10:30 AM
BREAK / EXHIBITS
Rio Mar 5
10:30 AM
11:30 AM
Session C: Decompression Theory and Mechanisms
Rio Mar 6-10
10:30-10:40
C1: A predictive model of serious decompression sickness following loss of spacecraft cabin pressure. Gernhardt ML, Abercromby AFJ Presenting Author: Michael Gernhardt PhD
C2: Modeling decompression stress associated with surface interval freediving in recreational diving. Gernhardt ML, Bekdash OS Presenting Author: Michael L. Gernhardt PhD
10:40-10:50
C3: Albumin-derived perfluorocarbon-based nanocapsules as an effective preventive therapy of decompression illness: Well-proven wine in new bottles. Mayer D, Guerrero F, Goanvec C, Ljubcovic M, Mayer C, Kirsch M, Ferenz KB Presenting Author: Dirk Mayer MD
10:50-11:00
C4: Validation of an exhaled nitric oxide model of pulmonary hyperoxic stress. Fothergill DM, Ross WL, Florian JP Presenting Author: David Fothergill PhD
11:00-11:10
C5: Tetranomial probabilistic modeling of serious, mild, marginal and no decompression sickness. King AE, Andriano NR, Howle LE, Vann RD Presenting Author: Amy King
11:10-11:20
C6: The protective effects of synthetic ketone ester BD-AcAc2 on rats with decompression sickness. Zhang K, Xu WG Presenting Author: Kun Zhang MD
11:20-11:30
C7: Development and limited validation of the XVal-He-9_040 Thalmann algorithm parameter set for computing decompression schedules for extended duration 1.3 atm PO2 He-O2 diving. Doolette DJ, Murphy FG, Gerth WA Presenting Author: David J Doolette PhD
11:30 AM
12:00 PM
Poster Session C: Posters C1-C11
C1: A predictive model of serious decompression sickness following loss of spacecraft cabin pressure. Gernhardt ML, Abercromby AFJ Presenting Author: Michael Gernhardt PhD
C2: Modeling decompression stress associated with surface interval freediving in recreational diving. Gernhardt ML, Bekdash OS Presenting Author: Michael L. Gernhardt PhD
C3: Albumin-derived perfluorocarbon-based nanocapsules as an effective preventive therapy of decompression illness: Well-proven wine in new bottles. Mayer D, Guerrero F, Goanvec C, Ljubcovic M, Mayer C, Kirsch M, Ferenz KB Presenting Author: Dirk Mayer MD
C4: Validation of an exhaled nitric oxide model of pulmonary hyperoxic stress. Fothergill DM, Ross WL, Florian JP Presenting Author: Dr. David Fothergill PhD
C5: Tetranomial probabilistic modeling of serious, mild, marginal and no decompression sickness. King AE, Andriano NR, Howle LE, Vann RD Presenting Author: Amy King
C6: The protective effects of synthetic ketone ester BD-AcAc2 on rats with decompression sickness. Zhang K, Xu WG Presenting Author: Kun Zhang MD C7: Development and limited validation of the XVal-He-9_040 Thalmann algorithm parameter set for computing decompression schedules for extended duration 1.3 atm PO2 He-O2 diving. Doolette DJ, Murphy FG, Gerth WA Presenting Author: David J Doolette PhD
C8: The biphasic effects of autophagy on decompression bubble-induced endothelial injuries. Zhang K, Xu WG Presenting Author: Kun Zhang MD
C9: Benefits of escin for decompression sickness in Bama pigs by endothelia-targeting protection. Qing l, Xu WG Presenting Author: Weigang Xu MD
C10: Experimental testing of cross corrections to decompression tables for dives at altitude. Weis TW, Dong TW, Natoli MJ, Lance RM, Howle LE, Pieper CF, Freiberger JJ, Derrick BJ, Moon RE Presenting Author: Richard E Moon MD
C11: Cognitive control performance during increasing ambient pressure: Event-related brain potential study. Fujii T Presenting Author: Tatsufumi Fujii PhD
Rio Mar 1-4
12:00 PM
1:00 PM
LUNCH
Ocean Terrace/Rio Mar Foyer
12:30 PM
1:00 PM
Poster Session D-1: Posters D1-D15
D1: Ketogenic diet for reduction of CNS oxygen toxicity in working divers (KetOX Study): Pilot study. Allen J, Orabi M, Bahaadin Al-Jarani, Gonzalez S, Dong TW, Natoli MJ, Richardson C, Brown G, Walker AJ, Schinazi EA, Kuchibhatla M, D’Agostino DP, Keuski BM, Moon RE, Freiberger JJ, Derrick BJ Presenting Author: Justin Allen DO
D2: Comparison of dysbaric osteonecrosis severity in the u/w sheep model after a 24-hour dive at 33 fsw followed by either a 15-, 30-, or 45-minute oxygen pre-breathe before dropout decompression. Lamers JL, Sobakin AS Presenting Author: Jake Lamers
D3: Manned validation of U.S. Navy Diving Manual, Revision 7, VVal-79 air decompression schedules for short bottom times in the 130-140 fsw range. Andrew BT, Doolette DJ Presenting Author: Brian T. Andrew MD
D4: Improving safety of submarine escape and rescue from 60 and 70 fsw Eldridge MW, Sobakin AS Presenting Author: Aleksey Sobakin PhD
D5: A graphical user interface for expediting bubble-counting analysis of post-dive echocardiograms and statistics for vetting crowdsourcing contributions. Barrentine B, Le DQ, Germonpré P, Balestra C, Tillmans F, Denoble PJ, Freiberger JJ, Moon RE,Dayton PA, Papadopoulou V Presenting Author: David Q Le
D6: Detecting pulmonary oxygen toxicity using exhaled breath analysis: Wet and dry diving are not the same. Wingelaar TT, Brinkman P, van Ooij PJAM, Maitland-Van der Zee AH, van Hulst RA Presenting Author: Thijs Wingelaar MD
D7: A robust image-processing method for selecting frames during late ventricular diastole in post-dive echocardiography without ECG gating. Markley E, Le DQ, Germonpré P, Balestra C, Tillmans F, Denoble PJ, Freiberger JJ, Moon RE, Dayton PA, Papadopoulou V Presenting Author: David Q Le
D8: Acute bone necrosis in cases of decompression sickness with refractory pain despite hyperbaric treatment. Calderon, J. Mansilla, Y. Cabrera, M. Mansilla, C. Estrada. J Presenting Author: Jorge Calderon MD
D9: Dysbaric osteonecrosis among the artisanal diving fishermen in Yucatan, Mexico Popa D, Chin W, Huchim-Lara O, Medak A, Hughes T, Grover I. Presenting Author: Daniel Popa, MD
D10: Manual dexterity and finger skin temperature is reduced in cold water and is not preserved with whole-body active heating. Wheelock CE, Hess HW, Hostler D Presenting Author: Courtney Wheelock
D11: A deep-learning approach for automated bubble counting in 2D echocardiography of divers. Le DQ, Kierski TM, Markley E, Germonpré P, Balestra C, Tillmans F, Denoble PJ, Freiberger JJ, Moon RE, Dayton PA, Papadopoulou V Presenting Author: David Q Le
D12: Sea harvester diving in Yucatan and Quintana Roo, Mexico: 1988-2018. Sanchez EC, Gomez D, Rivas F, Medina A, Lopez J, García G, Torres S, Diaz R, Paredes H, Denoble P. Presenting Author: J Dario Gomez Castillo MD
D13: The effect of sudden drop in partial pressure of oxygen during ascent on heart function. Ferguson SA, Poburko D, Claydon VE, Koehle M, Ruben PC Presenting Author: Sherri Ferguson
D14: Pulmonary edema in special operations assessments. Tanaka HL, Wightman JM, Ott MC Presenting Author: Hideaki L. Tanaka MD
D15: The effect of oxygen and nitrogen on nitrogen narcosis severity. Ferguson SA, Hutcheon EA, Doesburg SM Presenting Author: Sherri Ferguson
Rio Mar 1-4
1:00 PM
2:00 PM
Lambertsen Keynote: Decompression sickness as an inflammatory disease. Simon Mitchell, MBBS, PhD
Rio Mar 6-10
2:00 PM
3:00 PM
Session D: Diving Medicine
Rio Mar 6-10
2:00-2:10
D1: Ketogenic diet for reduction of CNS oxygen toxicity in working divers (KetOX Study): Pilot study. Allen J, Orabi M, Bahaadin Al-Jarani, Gonzalez S, Dong TW, Natoli MJ, Richardson C, Brown G, Walker AJ, Schinazi EA, Kuchibhatla M, D’Agostino DP, Keuski BM, Moon RE, Freiberger JJ, Derrick BJ Presenting Author: Justin Allen DO
2:10-2:20
D2: Comparison of dysbaric osteonecrosis severity in the u/w sheep model after a 24-hour dive at 33 fsw followed by either a 15-, 30-, or 45-minute oxygen pre-breathe before dropout decompression. Lamers JL, Sobakin AS Presenting Author: Jake Lamers
2:20-2:30
D3: Manned validation of U.S. Navy Diving Manual, Revision 7, VVal-79 air decompression schedules for short bottom times in the 130-140 fsw range. Andrew BT, Doolette DJ Presenting Author: Brian T. Andrew MD
2:30-2:40
D4: Improving safety of submarine escape and rescue from 60 and 70 FSW Eldridge MW, Sobakin AS Presenting Author: Aleksey Sobakin PhD
2:40-2:50
D5: A graphical user interface for expediting bubble-counting analysis of post-dive echocardiograms and statistics for vetting crowdsourcing contributions. Barrentine B, Le DQ, Germonpré P, Balestra C, Tillmans F, Denoble PJ, Freiberger JJ, Moon RE,Dayton PA, Papadopoulou V Presenting Author: David Q Le
2:50-3:00
D6: Detecting pulmonary oxygen toxicity using exhaled breath analysis: Wet and dry diving are not the same. Wingelaar TT, Brinkman P, van Ooij PJAM, Maitland-Van der Zee AH, van Hulst RA Presenting Author: Thijs Wingelaar MD
3:00 PM
3:30 PM
BREAK / EXHIBITS
Rio Mar 5
3:30 PM
4:00 PM
Poster Session D-2: Posters D16-D28
D16: Self-paced exercise performance is attenuated following four hours of cold water immersion irrespective of breathing gas type. Hess HW, Schlader ZJ, Johnson BD, Hostler D Presenting Author: Hayden W. Hess
D17: Does the use of normobaric oxygen in Swedish working divers underestimate the incidence of decompression illness? Hagberg M, Ornahgen H Presenting Author: Mats Hagberg MD
D18: Optimizing oxygenation, hemodynamics and metabolism during diving by using underwater near-infrared spectroscopy (NIRS). Whelan H, Ari C, Prost R, Sugar J, D'Agostino D, Quirk B, Dituri J, Harper Z, Aderman T, Fahlman A, McKnight C, Tyack P, Shorter A, Popa B, Williams T, Chapman S Presenting Author: Harry T. Whelan MD
D19: Count model of DCI among fishermen divers. Peluso E, Chin W, Huchim O Presenting Author: Walter Chin RN/CHRN
D21: Cancer and diving: data from 124 UK sport divers. St Leger Dowse M, Morgan B, Smerdon GR Presenting Author: Marguerite St Leger DowseD22: Pathophysiology of dysbaric osteonecrosis. Kawashima M, Kawashima M, Tamura H, Takao K, Yamaguchi T, Miyata K, Kitano M Presenting Author: Mahito Kawashima MD
D23: Thermoregulation in environmental conditions expected in a disabled pressurized rescue module. Schlader ZJ, Stooks J, Johnson BD, Hostler D Presenting Author: Zachary J. Schlader PhD
D24: Required sample sizes for testing cardiovascular effects of normobaric scuba regulator breathing without immersion: A pilot trial. Kovacs CR, Buzzacott P Presenting Author: Christopher Kovacs PhD
D25: A technical review of ultrasound use in decompression research. Le DQ, Dayton PA, Tillmans F, Freiberger JJ, Moon RE, Denoble PJ, Papadopoulou V Presenting Author: David Q Le
D26: Retreatment with a TT6A1M for neurological decompression illness in patients with a poor response to standard treatment with a USN TT6. McEldrew P, Siegel M, LeGros TL, Wyatt A, and Van Meter K Presenting Author: Patrick McEldrew, MD
D27: Dive profiles and physiologic parameters of safety divers at a breath-hold diving competition. Derksen B, Lang M, Lindholm P, Van Hoesen K Presenting Author: Brenna Derksen MD
D28: No change in total mood disturbance during a simulated disabled pressurized rescue module scenario. Johnson BD, Hess HW, Stooks J, Hostler D, Schlader ZJ Presenting Author: Blair Johnson PhD
Rio Mar 1-4
4:00 PM
5:00 PM
Plenary Session: Altitude Decompression Sickness
Rio Mar 6-10
4:00-4:30
Combating flier’s “bends” during unpressurized flight and explosive decompression in World War II: Jay Dean, PhD
4:30-5:00
USAF hypobaric exposures experience: Marc Robins, DO
SATURDAY, June 29
7:00 AM
8:00 AM
CONTINENTAL BREAKFAST / EXHIBITS
Rio Mar 5
8:00 AM
5:00 PM
Non-Physician "Associates" Breakout Session (not approved for physician CME credits)
Caribbean 2-3
8:00 AM
10:00 AM
Plenary Session: The Regulatory And Reimbursement Challenges Facing Nations And How These Have Been Addressed
Rio Mar 6-10
8:00-8:25
Canada: Ken LeDez, MD
8:25-8:50
United Kingdom: Pieter Bothma, MD
8:50-9:15
United States: Caroline Fife, MD
9:15-9:40
Australia: Michael Bennett, MD
9:40-10:00
Panel Discussion
10:00 AM
10:30 AM
BREAK / EXHIBITS
Rio Mar 5
10:30 AM
11:30 AM
Session E: HBO2 Operations, Chambers, and Equipment
Rio Mar 6-10
10:30-10:40
E1: Use of point of care ultrasounds for the rapid diagnosis of central retinal artery occlusion. McCarthy P, Hendriksen SM, Masters TC, Westgard BC, Walter JW, Osterman A, Reardon RF, Logue CJ Presenting Author: Christopher Logue MD
10:40-10:50
E2: Comparison of radial artery catheter blood pressure with automatic non-invasive blood pressure at 35 fsw on 100% O2. Orabi M, Allen J, Gonzalez S, Natoli MJ, Freiberger JJ, Derrick BJ Presenting Author: Maia Orabi MD
10:50-11:00
E3: Reliability of a continuous glucose monitor during hyperbaric oxygen exposure: Interim analysis. Huang E, Savaser D, Castle J, Manulik B, Demirel S, Bliss B, Fitzpatrick P Presenting Author: Enoch Huang MD E4: Safety of a continuous glucose monitoring device during hyperbaric exposure. Bliss C, Huang E, Savaser D Presenting Author: Chae Bliss CHT
E6: Culturally competent hyperbaric patient care. Marosek N, Melnyczenko A Presenting Author: Nicholas Marosek RN/CHRN
11:20-11:30
E7: Implementation and evaluation of an interdisciplinary, simulation-based educational curriculum in hyperbaric medicine. Paetow G, Guber K, Raleigh S, TenBrink W, Driehorst M, Brown L, Jensen A, Omodt S, Olives T, Hart D, Logue C Presenting Author: Christopher Logue MD
E8: Interdisciplinary simulation for the detection of latent risk threats in a hyperbaric medicine department. Paetow G, TenBrink W, Driehorst M, Brown L, Jensen A, Omodt S, Hart D, Logue C Presenting Author: Christopher Logue MD
11:30 AM
12:00 PM
Poster Session E: Poster E1-E14
E1: Use of point of care ultrasounds for the rapid diagnosis of central retinal artery occlusion. McCarthy P, Hendriksen SM, Masters TC, Westgard BC, Walter JW, Osterman A, Reardon RF, Logue CJ Presenting Author: Christopher Logue MD
E2: Comparison of radial artery catheter blood pressure with automatic non-invasive blood pressure at 35 fsw on 100% O2. Orabi M, Allen J, Gonzalez S, Natoli MJ, Freiberger JJ, Derrick BJ Presenting Author: Maia Orabi MD
E3: Reliability of a continuous glucose monitor during hyperbaric oxygen exposure: Interim analysis. Huang E, Savaser D, Castle J, Manulik B, Demirel S, Bliss B, Fitzpatrick P Presenting Author: Enoch Huang MD
E4: Safety of a continuous glucose monitoring device during hyperbaric exposure. Bliss C, Huang E, Savaser D Presenting Author: Chae Bliss CHT
E6: Culturally competent hyperbaric patient care. Marosek N, Melnyczenko A Presenting Author: Nicholas Marosek RN/CHRN
E7: Implementation and evaluation of an interdisciplinary, simulation-based, educational curriculum in hyperbaric medicine. Paetow G, Guber K, Raleigh S, TenBrink W, Driehorst M, Brown L, Jensen A, Omodt S, Olives T,Hart D, Logue C Presenting Author: Christopher Logue MDE8: Interdisciplinary simulation for the detection of latent risk threats in a hyperbaric medicine department. Paetow G, TenBrink W, Driehorst M, Brown L, Jensen A, Omodt S, Hart D, Logue C Presenting Author: Christopher Logue MD
E9: U.S. involvement in the Thai cave rescue. Tanaka HL Presenting Author: Hideaki L Tanaka MD
E10: Lithium-ion battery explosion leading to a traumatic femur fracture in cave diver. Covington DB, Ohama M, Millan S, Pitkin A Presenting Author: Derek Covington MD
E11: Successful cardiac defibrillation during hyperbaric oxygen therapy in a patient with severe carbon monoxide poisoning. Allen JA, Shah KR, Moon RE Presenting Author: Justin Allen DO
E12: Pilot study on the feasibility of utilization of an Epi-Pen under pressure in a multiplace chamber. Savaser DJ, Huang ET, Bliss C Presenting Author: Davut Savaser MD
E13: Emergency response by hyperbaric personnel. Vidafar M Presenting Author: Michael Vidafar CHT
E14: Oxygen exhaust sign improvement. Vidafar M Presenting Author: Michael Vidafar CHT
Rio Mar 1-4
12:00 PM
1:00 PM
LUNCH
Ocean Terrace/Rio Mar Foyer
12:00 PM
1:00 PM
Associates "Non-physicians" Luncheon
Caribbean 1
1:00 PM
2:00 PM
Plenary Session:
Rio Mar 6-10
1:00-1:30
HBO2 and Inflammatory Bowel Disease Update: Jay Buckey, MD
1:30-2:00
Diving, operational & environmental physiology of the Thai cave rescue: Richard Walker, MD
2:00 PM
3:00 PM
Session F: Top Case Reports
Rio Mar 6-10
2:00-2:10
F1: Tension pneumocephalus: Iatrogenic subarachnoid air embolism treated with hyperbaric oxygen therapy. Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill DO
2:10-2:20
F2: Carbon monoxide poisoning; Mixed-acid cocktail suicide attempt. Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill DO
2:20-2:30
F3: A case of delayed mortality after severe arterial gas embolism secondary to myocardial infarction from triple-vessel coronary artery thrombosis. Derksen BJ, Hayden SR, Grover I, Sadler CA Presenting Author: Charlotte Sadler MD
2:30-2:40
F4: De novo cataract formation in non-diabetics. Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill MD
2:40-2:50
F5: A rare case report of coronary gas embolism after percutaneous lung biopsy. Allen JA, Mammarappallil JG Presenting Author: Justin Allen DO
2:50-3:00
F6: Successful treatment of laryngotracheal radionecrosis with hyperbaric oxygen therapy in a patient presenting with persistent hemoptysis and cough. Savaser DJ, Huang ET Presenting Author: Davut Savaser MD
3:00 PM
3:30 PM
BREAK / EXHIBITS
Rio Mar 5
3:30 PM
4:00 PM
Poster Session F: Posters F1-F15
F1: Tension pneumocephalus: Iatrogenic subarachnoid air embolism treated with hyperbaric oxygen therapy. Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill DO
F2: Carbon monoxide poisoning; Mixed-acid cocktail suicide attempt Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill DO
F3: A case of delayed mortality after severe arterial gas embolism secondary to myocardial infarction from triple-vessel coronary artery thrombosis. Derksen BJ, Hayden SR, Grover I, Sadler CA Presenting Author: Brenna Derksen MD
F4: De novo cataract formation in non-diabetics. Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill MD
F5: A rare case report of coronary gas embolism after percutaneous lung biopsy Allen JA, Mammarappallil JG Presenting Author: Justin Allen DO
F6: Successful treatment of laryngotracheal radionecrosis with hyperbaric oxygen therapy in a patient presenting with persistent hemoptysis and cough. Savaser DJ, Huang ET Presenting Author: Davut Savaser MD
F7: Hyperbaric oxygen treatment for delayed radiation-induced esophageal stricture. Dullum D Presenting Author: Diane Dullum RN/CHRN
F8: Diving with Osler-Weber-Rendu disease: A rare case provoking thoughts. Swenker R, van Ooij PJ Presenting Author: Rob Swenker MD
F9: Hyperbaric oxygen treatment of patient with tracheal-esophageal device and recent thoracic surgery. Mihai A, Morgan M, Sharma D, Boes T, Santiago W, Heyboer M Presenting Author: Aurel Mihai MD
F10: Successful treatment of medication-related jaw osteonecrosis with hyperbaric oxygen therapy .using a Marx protocol-like approach. Hodgson J Presenting Author: Joni Hodgson DO
F11: Hyperbaric oxygen treatment status post gamma knife surgery improves progressively worsening neurological symptoms. Mihai A, Morgan M, Sharma D, Santiago W, Heyboer M. Presenting Author: Aurel Mihai MD
F12: Against most odds: A case study, limb salvage. Crapella L
Presenting Author: Lise Crapella ACNP/PA
F13: Innovative use of dehydrated human amnion/chorion membrane in conjunction with hyperbaric oxygen therapy to treat a non-healing nasal wound subsequent to squamous cell carcinoma resection and radiation: A case study. Henderson JA, Jones MW, Houle SS Presenting Author: Jessica Henderson DO
F14: Case report: High-throughput enterocutaneous fistula and the role of HBO2 therapy. Borges H, Oliveira N, Paz MA, Santos PE Presenting Author: Hugo Leonardo De Lima Borges MD
F15: A case of vertigo in a recreational scuba diver. Agostinelli N Presenting Author: Nicole Agostinelli MD
Rio Mar 1-4
4:00 PM
5:00 PM
Plenary Session: Topics in Undersea and Hyperbaric MedicineRio Mar 6-10
4:00-4:30
Top articles in HBO2: Justin Allen, DO, Fellow, Duke, Durham, NC
4:30-5:00
Top articles in Undersea Medicine: Aurel Mihai, MD, Fellow, SUNY, Syracuse, NY
Hyperbaric Facility Accreditation Program Design I & II
Derall Garrett
1145-1245
Lunch
1245-1330
Physician point of view
Henry Schwartz
1330-1415
Nurse point of view
Debra Gonzalez
1415-1500
Technologist point of view
Tom Workman
1500-1515
Break
1515-1545
Organizational Planning
Derall Garrett
1545-1600
Discussion/Questions
1600
Adjourn
Hyperbaric Oxygen Safety: Clinical and Technical Issues
TIME
LECTURE
FACULTY
0800 - 0815
Introductions: / Welcome
Marc Robins, DO Andrew Melnyczenko, CHT
0815 - 0915
Safety considerations in hyperbaric medicine: Lessons from aviation, space, and other industries
Gary Toups, MD
0915 - 1015
The role of the medical director in the safety program
Marc Robins, DO
1015 - 1030
Break
1030 - 1050
How to implement the nursing guidelines of care to improve safety in your HBO program
Annette Gwilliam, RN, BSN, CWON, CWS, ACHRN
1050 - 1110
Human factors that impact safety in hyperbaric
Richard “Gus” Gustavson, MPH, RN, CHRNC-A, CWCN, CHT-A, CRT
1110 - 1130
Optimizing the pediatric hyperbaric oxygen therapy plan: Tandem therapy
Nicholas Marosek, CHRN, ACCRN
1130 - 1200
Panel Q&A from the morning session
Moderator: Andrew Melnyczenko, CHT
1200 - 1300
Lunch
1300 - 1345
Safety-related trends revealed from the UHMS Facility Accreditation Program
Tom Workman, CHT
1345 - 1430
Assessing the safety of diver recompression chamber facilities. A retrospective review of the most common safety concerns encountered at a range of recompression facilities over a period of 13 years
Francois Burman
1430 - 1445
Break
1445 - 1530
Safety versus Compliance
Kip Posey, CHT
1530 - 1600
International survey of equipment used in hyperbaric facilities
Marc Pullis, EMT, CHT
1600 - 1645
Biomedical devices in the hyperbaric environment
Ian Millar, MD
1645 - 1715
Panel Q & A from the afternoon session
Moderator: Ian Millar, MD
1715 - 1730
Closing/ Course evaluations / Questions
Marc Robins, DO Andrew Melnyczenko, CHT
Treatment of Decompression Illness in Recreational Diving
Time
Lecture
Faculty
08:00-08:30
Current UHMS guidelines
Nick Bird
08:30-09:00
Polling, hidden results: DCI treatment principles (see the list of Q&A in Appendix)
Petar Denoble
09:00-09:30
Current practice in France
Sébastien de Maistre
09:30-10:00
Current practice in China
Wei-gang Xu
10:00-10:30
Coffee Break
10:30-11:00
Australian experience
David Wilkinson
11:00-11:30
Could normobaric oxygen be accepted as a definitive treatment?
Richard Moon
11:30-12:00
Use of short tables in treatment of DCI
Brenna Derksen
12:00-12:30
Treatment of severe DCS cases
Ian Grover
12:30-13:30
Lunch break
13:30-13:45
Use of deep tables in US Navy
David Southerland
13:45-14:30
Is it ever too late to treat?
Jake Freiberger
14:30-15:00
Flying after treatment
Jim Chimiak
15:00-15:30
Return to diving after DCI
Jake Freiberger
15:30-15:45
coffee break
15:45-16:45
Polling, public results: DCI treatment principles. Discussion of each question. Comparison of pre- and post- answers
A1: HBO2 therapy reduces mortality, hepatic inflammation and improves renal mitochondrial function in a model of severe polymicrobial sepsis. Perdrizet GA, Halbach JL, Prieto JM, Wang, AW, Hawisher D, Cauvi DM, Reys T, Okerblom J, Ramierz-Sanchez I, Villarreal F, Patel HH, Bickler SW, De Maio A, Singh P, Li L Presenting Author: George A. Perdrizet MD
10:45-11:00
A2: A hyperbaric and high-oxygen environment accelerates IL-6 synthesis via RNS in rat contused skeletal muscle. Oyaizu T, Enomoto M, Horie M, Yamamoto N, Yagishita K Presenting Author: Takuya Oyaizu MD
11:00-11:15
A3: A hyperbaric, high-oxygen environment promotes injured rat muscle recovery by angiogenesis through reactive nitrogen species. Yamamoto N Presenting Author: Naoki Yamamoto MD
11:15-11:30
A4: Hyperbaric oxygen (HBO2) inhibits hyperglycemia-induced NLRP3 inflammasome and microparticle formation in neutrophils. Thom SR, Bhopale VM, WaliaD Presenting Author: Stephen Thom MD
11:30 AM
12:00 PM
Poster Session A: Posters A1-A7:
A1: HBO2 therapy reduces mortality, hepatic inflammation and improves renal mitochondrial function in a model of severe polymicrobial sepsis. Perdrizet GA, Halbach JL, Prieto JM, Wang, AW, Hawisher D, Cauvi DM, Reys T, Okerblom J, Ramierz-Sanchez I, Villarreal F, Patel HH, Bickler SW, De Maio A, Singh P, and Li L. Presenting Author: George A. Perdrizet MD
A2: A hyperbaric and high-oxygen environment accelerates IL-6 synthesis via RNS in rat contused skeletal muscle. Oyaizu T, Enomoto M, Horie M, Yamamoto N, Yagishita K Presenting Author: Takuya Oyaizu MD
A3: A hyperbaric, high-oxygen environment promotes injured rat muscle recovery by angiogenesis through reactive nitrogen species. Yamamoto N Presenting Author: Naoki Yamamoto MD
A4: Hyperbaric oxygen (HBO2) inhibits hyperglycemia-induced NLRP3 inflammasome and microparticle formation in neutrophils. Thom SR, Bhopale VM, WaliaD Presenting Author: Stephen Thom MD
A5: Prevalence and pattern of cardiac injury identified by late gadolinium-enhancement of cardiac magnetic resonance image in acute moderate to severe CO poisoning with elevated high sensitivity troponin I: Prospective observational study. Cha YS, Kwon W, Son JW, Lee CH, Han SI Presenting Author: Yong Sung Cha MD
A6: Effects of HBO2 on the osteogenic differentiation of human adipose-derived stem cells. Camporesi EM, Zavan B, Gardin C, Bellin G, Rizzato A, Vezzani G, Bosco G Presenting Author: Enrico M. Camporesi MD
A7: Inflammatory hypoxia: A new, unifying target for HBO2 therapy. Perdrizet GA Presenting Author: George A. Perdrizet, MD
12:30 PM
1:00 PM
Poster Session B-1: Posters B1-B15
B1: Hyperbaric oxygen therapy for the treatment of perianal fistulas in Crohn’s disease (HOT-TOPIC): preliminary results. Lansdorp CA, Gecse KB, Buskens CJ, Löwenberg M, Stoker J, Bemelman WA, D’Haens GRAM, van Hulst RA Presenting Author: Nina (Corine Alida) Lansdorp MD
B2: The myopic shift associated with hyperbaric oxygen administration is reduced when using a mask delivery system compared to a hood - a randomised controlled trial. Bennett MH, Hui B, See HG, Au-Yeung KL, Tan C, Watson S Presenting Author: Michael Bennett MD
B3: Efficacy and safety of postoperative radiotherapy with hyperbaric oxygen therapy for keloid. Guo D Presenting Author: Dazhi Guo MD
B4: Effect of Hyperbaric oxygen therapy for retinal artery occlusion. Han SI, Kim YS Presenting Author: Yoonseop Kim MD
B5: Prospective data collection through a hyperbaric outcomes registry: Preliminary results. Buckey JC, Ptak JA, Kertis JA, Rees JR Presenting Author: Jay C. Buckey MD
B6: The impact of hyperbaric oxygen on treating Idiopathic Sudden Sensorineural Hearing Loss. McCoy ME, Helwig NE, Logue C Presenting Author: Meghan McCoy ACNP/PA “Recipient of the 2019 Assocites Achievement Scholarship”
B7: Prehospital diagnosis and direct transfer to the hyperbaric chamber of carbon monoxide intoxicated patients: a quality improvement initiative. Camporesi EM, Martani L, Cantadori L, Paganini M, Rubini A, Bosco G Presenting Author: Enrico M. Camporesi MD
B8: Efficacy and safety of hyperbaric oxygen at 2.4 ATA in the management of radiation cystitis: A retrospective study. Ajayi OD, Masters TC, Westgard BC, Logue CJ, Walter JW, Hendriksen SM Presenting Author: David Ajayi MD
B9: Quality of life in patients with delayed effects of radiation treated with hyperbaric oxygen therapy. Famenini S, Schroeder M, Sethuraman K Presenting Author: Sam Famenini
B10: Retinal artery and vein occlusions successfully treated with hyperbaric oxygen: Case reports. Johnson DR, Cooper JS Presenting Author: Jeffrey Cooper MD
B11: Late radiation cytitis treated with hyperbaric oxygen a randomized controlled trial. Oscarsson N, Müller B, Rosén A, Seeman-Lodding H Presenting Author: Nicklas Oscarsson MD
B12: Osteonecrosis (ON) in children and adolescents with acute lymphoblastic leukemia (ALL): improvement with HBO2 in early diagnosis. Camporesi EM, Biddeci G, Bosco G, Gigante C, Garetto G, Abowali H, Putti MC Presenting Author: Enrico M. Camporesi MD
B13: Transient myopia and associated patient factors in patients undergoing elective hyperbaric oxygen therapy. Mihai A, Wojcik S, Seargent S, Pacelli L, Heyboer M Presenting Author: Aurel Mihai MD
B14: Does hyperbaric oxygen therapy (HBO2 therapy) affect etonogestrel levels from a Nexplanon implant? Kertis JA, Ptak JA, Reetz SB, Fisher TJ, Geno KA, DeJesus CL, Cremers S, Buckey JC Presenting Author: Judy A. Kertis RN/CHRN
B15: Current myringotomy training practices across hyperbaric and undersea medicine training programs. Brett KD, Coffey CD, Bracken D, Witucki, P Presenting Author: Kaighley Brett MD
2:00 PM
3:00 PM
Session B: Clinical HBO2
2:00-2:10
B1: Hyperbaric oxygen therapy for the treatment of perianal fistulas in Crohn’s disease (HOT-TOPIC): preliminary results. Lansdorp CA, Gecse KB, Buskens CJ, Löwenberg M, Stoker J, Bemelman WA, D’Haens GRAM, van Hulst RA Presenting Author: Nina (Corine Alida) Lansdorp MD
2:10-2:20
B2: The myopic shift associated with hyperbaric oxygen administration is reduced when using a mask delivery system compared to a hood - a randomised controlled trial. Bennett MH, Hui B, See HG, Au-Yeung KL, Tan C, Watson S Presenting Author: Michael Bennett MD
2:20-2:30
B3: Efficacy and safety of postoperative radiotherapy with hyperbaric oxygen therapy for keloid. Guo D Presenting Author: Dazhi Guo MD
2:30-2:40
B4: Effect of Hyperbaric oxygen therapy for retinal artery occlusion. Han SI, Kim YS Presenting Author: Yoonseop Kim MD
2:40-2:50
B5: Prospective data collection through a hyperbaric outcomes registry: Preliminary results. Buckey JC, Ptak JA, Kertis JA, Rees JR Presenting Author: Jay C. Buckey MD
2:50-3:00
B6: The impact of hyperbaric oxygen on treating Idiopathic Sudden Sensorineural Hearing Loss. McCoy ME, Helwig NE, Logue C Presenting Author: Meghan McCoy ACNP/PA “Recipient of the 2019 Associates Achievement Scholarship”
3:30 PM
4:00 PM
Poster Session B-2: Posters B16-B27
B16: Ketamine sedation for hyperbaric oxygen therapy in hypotensive patients. Mihai A, Heyboer M Presenting Author: Aurel Mihai MD
B17: Effects of hypoxia on N100 and P300 event related potentials during visuospatial attention control. Hutcheon EA, Nunes AS, Ribrary U, Ferguson SA, Claydon VE, Doesburg SM Presenting Author: Sherri Ferguson
B18: BK viral induced hemorrhagic cystitis and the role of HBO2 therapy. Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill DO
B19: Clinical and radiographic improvement in bisphosphonate-related osteonecrosis of the mandible with hyperbaric oxygen therapy: A case report. Shields RC, Toups GN, Price DL Presenting Author: Raymond C. Shields MD
B20: Well controlled diabetics safely receive serial hyperbaric oxygen treatments without serial blood glucose checks. Mihai A, Morgan M, Sharma D, Santiago W, Heyboer M Presenting Author: Aurel Mihai MD
B21: The use of hyperbaric oxygen therapy to treat an anaerobic retroperitoneal abscess with extension into the mediastinum. Long JS, Foster JM, Cooper JS Presenting Author: Jeffrey Cooper MD
B22: Uneventful serial hyperbaric oxygen treatments in setting of cerebral vasoconstriction syndrome. Mihai A, Sharma D, Boes T, Morgan M, Santiago W, Heyboer M Presenting Author: Aurel Mihai MD
B23: An innovative design employing medicare claims data to demonstrate a cost savings for hyperbaric oxygen in the treatment of radiation cystitis and proctitis. Feldmeier JJ, Kirby JP, Gelly HB, Robins MS, DaVanzo JE, and Gruhn P Presenting Author: John J. Feldmeier DO
B24: WITHDREW
B25: Case Report: The role of HBOT in a spider bite Borges H, Oliveira N, Paz MA, Santos PE Presenting Author: Hugo Leonardo De Lima Borges MD
B26: Case report: HBO2 therapy avoiding amputation in serious osteomyelitis of ankle. Borges H, Oliveira N, Paz MA, Santos PE Presenting Author: Hugo Leonardo De Lima Borges MD
B27: Variations in study outcomes relative to intention-to-treat and per-protocol data analysis techniques in the evaluation of efficacy for treatment of venous leg ulcers with dehydrated human amnion/chorion membrane allograft. Bianchi C, Tettelbach W, Istwan N, Hubbs B, Kot K, Harris S, Fetterolf D. Presenting Author: William Tettelbach MD
FRIDAY, June 28
10:30 AM
11:30 AM
Session C: Decompression Theory and Mechanisms
10:30-10:45
C1: A predictive model of serious decompression sickness follwing loss of spacecraft cabin pressure. Gernhardt ML, Abercromby AFJ Presenting Author: Michael Gernhardt PHD
10:45-11:00
C2: Modelling decompression stress associated with surface interval free diving in recreational diving. Gernhardt ML, Bekdash OS Presenting Author: Michael L. Gernhardt PHD
11:00-11:15
C3: Albumin-derived perfluorocarbon-based nanocapsules as an effective preventive therapy of decompression illness: well-proven wine in new bottles. Mayer D, Guerrero F, Goanvec C, Ljubcovic M, Mayer C, Kirsch M, Ferenz KB Presenting Author: Dirk Mayer MD
11:15-11:30
C4: Validation of an exhaled nitric oxide model of pulmonary hyperoxic stress. Fothergill DM, Ross WL, Florian JP Presenting Author: Dr. David Fothergill PHD
11:30 AM
12:00 PM
Poster Session C: Posters C1-C11
C1: A predictive model of serious decompression sickness follwing loss of spacecraft cabin pressure. Gernhardt ML, Abercromby AFJ Presenting Author: Michael Gernhardt PHD
C2: Modelling decompression stress associated with surface interval free diving in recreational diving. Gernhardt ML, Bekdash OS Presenting Author: Michael L. Gernhardt PHD
C3: Albumin-derived perfluorocarbon-based nanocapsules as an effective preventive therapy of decompression illness: well-proven wine in new bottles. Mayer D, Guerrero F, Goanvec C, Ljubcovic M, Mayer C, Kirsch M, Ferenz KB Presenting Author: Dirk Mayer MD
C4: Validation of an exhaled nitric oxide model of pulmonary hyperoxic stress. Fothergill DM, Ross WL, Florian JP Presenting Author: Dr. David Fothergill PHD
C5: Tetranomial probabilistic modeling of serious, mild, marginal, and no decompression sickness. King AE, Andriano NR, Howle LE, Vann RD Presenting Author: Amy King
C6: The protective effects of synthetic ketone ester BD-AcAc2 on decompression sickness rats. Zhang K, Xu WG Presenting Author: Kun Zhang MD
C7: Development and limited validation of the XVal-He-9_040 Thalmann Algorithm parameter set for computing decompression schedules for extended duration 1.3 atm PO2 He-O2 diving. Doolette DJ, Murphy FG, Gerth WA Presenting Author: David J Doolette PHD
C8: The biphasic effects of autophagy on decompression bubble-induced endothelial injuries. Zhang K, Xu WG Presenting Author: Kun Zhang MD
C9: Benefits of escin for decompression sickness in Bama pigs by endothelia-targeting protection. Qing l, Xu WG Presenting Author: Weigang Xu MD
C10: Experimental testing of cross corrections to decompression tables for dives at altitude. Weis TW, Dong TW, Natoli MJ, Lance RM, Howle LE, Pieper CF, Freiberger JJ, Derrick BJ, Moon RE Presenting Author: Richard E Moon MD
C11: Cognitive control performance during increasing ambient pressure: Event related brain potential study. Fujii T Presenting Author: Tatsufumi Fujii PHD
12:30 PM
1:00 PM
Poster Session D-1: Posters D1-D15
D1: Ketogenic diet for reduction of CNS oxygen toxicity in working divers (KetOX Study): Pilot Study. Allen J, Orabi M, Bahaadin Al-Jarani, Gonzalez S, Dong TW, Natoli MJ, Richardson C, Brown G, Walker AJ, Schinazi EA, Kuchibhatla M, D’Agostino DP, Keuski BM, Moon RE, Freiberger JJ, Derrick BJ Presenting Author: Justin Allen DO
D2: Comparison of dysbaric osteonecrosis severity in the uw sheep model after a 24 hour dive at 33 FSW followed by either a 15-min, 30-min, 45-min oxygen pre-breathes before dropout decompression. Lamers JL, Sobakin AS Presenting Author: Aleksey Sobakin PHD
D3: Manned validation of U.S. Navy Diving Manual, Revision 7, VVal-79 Air Decompression Schedules for Short Bottom Times in the 130-140 fsw Range. Andrew BT, Doolette DJ Presenting Author: Brian T. Andrew MD
D4: Improving safety of submarine escape and rescue from 60 and 70 FSW Eldridge MW, Sobakin AS Presenting Author: Aleksey Sobakin PHD
D5: A graphical user interface for expediting bubble-counting analysis of post-dive echocardiograms and statistics for vetting crowdsourcing contributions. Barrentine B, Le DQ, Germonpré P, Balestra C, Tillmans F, Denoble PJ, Freiberger JJ, Moon RE, Dayton PA, Papadopoulou V Presenting Author: David Q Le
D6: Detecting pulmonary oxygen toxicity using exhaled breath analysis: wet and dry diving are not the same. Wingelaar TT, Brinkman P, van Ooij PJAM, Maitland-Van der Zee AH, van Hulst RA Presenting Author: Thijs Wingelaar MD
D7: A robust image-processing method for selecting frames during late ventricular diastole in post-dive echocardiography without ECG gating. Markley E, Le DQ, Germonpré P, Balestra C, Tillmans F, Denoble PJ, Freiberger JJ, Moon RE, Dayton PA, Papadopoulou V Presenting Author: David Q Le
D8: Acute bone necrosis in cases of decompression sickness with refractory pain despite hyperbaric treatment. Calderon, J. Mansilla, Y. Cabrera, M. Mansilla, C. Estrada. J Presenting Author: Jorge Calderon MD
D9: Dysbaric osteonecrosis among the artisanal diving fishermen in Yucatan, Mexico Popa D, Chin W, Huchim-Lara O, Medak A, Hughes T, Grover I. Presenting Author: Daniel Popa, MD
D10: Manual dexterity and finger skin temperature is reduced in cold water and is not preserved with whole body active heating. Wheelock CE, Hess HW, Hostler D Presenting Author: Courtney Wheelock
D11: A deep-learning approach for automated bubble counting in 2D echocardiography of divers. Le DQ, Kierski TM, Markley E, Germonpré P, Balestra C, Tillmans F, Denoble PJ, Freiberger JJ, Moon RE, Dayton PA, Papadopoulou V Presenting Author: David Q Le
D12: Sea harvester diving in Yucatan and Quintana Roo, Mexico: 1988-2018. Sanchez EC, Gomez D, Rivas F, Medina A, Lopez J, García G, Torres S, Diaz R, Paredes H, Denoble P. Presenting Author: E. Cuauhtémoc Sanchez MD
D13: The effect of sudden drop in partial pressure of oxygen during ascent on heart function. Ferguson SA, Poburko D, Claydon VE, Koehle M, Ruben PC Presenting Author: Sherri Ferguson
D14: Pulmonary Edema in Special Operations Assessments. Tanaka HL, Wightman JM, Ott MC Presenting Author: Hideaki L. Tanaka MD
D15: The effect of oxygen and nitrogen on nitrogen narcosis severity. Ferguson SA, Hutcheon EA, Doesburg SM Presenting Author: Sherri Ferguson
2:00 PM
3:00 PM
Session D: Diving Medicine
2:00-2:10
D1: Ketogenic diet for reduction of CNS oxygen toxicity in working divers (KetOX Study): Pilot Study. Allen J, Orabi M, Bahaadin Al-Jarani, Gonzalez S, Dong TW, Natoli MJ, Richardson C, Brown G, Walker AJ, Schinazi EA, Kuchibhatla M, D’Agostino DP, Keuski BM, Moon RE, Freiberger JJ, Derrick BJ Presenting Author: Justin Allen DO
2:10-2:20
D2: Comparison of dysbaric osteonecrosis severity in the uw sheep model after a 24 hour dive at 33 FSW followed by either a 15-min, 30-min, 45-min oxygen pre-breathes before dropout decompression. Lamers JL, Sobakin AS Presenting Author: Aleksey Sobakin PHD
2:20-2:30
D3: Manned validation of U.S. Navy Diving Manual, Revision 7, VVal-79 Air Decompression Schedules for Short Bottom Times in the 130-140 fsw Range. Andrew BT, Doolette DJ Presenting Author: Brian T. Andrew MD
2:30-2:40
D4: Improving safety of submarine escape and rescue from 60 and 70 FSW Eldridge MW, Sobakin AS Presenting Author: Aleksey Sobakin PHD
2:40-2:50
D5: A graphical user interface for expediting bubble-counting analysis of post-dive echocardiograms and statistics for vetting crowdsourcing contributions. Barrentine B, Le DQ, Germonpré P, Balestra C, Tillmans F, Denoble PJ, Freiberger JJ, Moon RE, Dayton PA, Papadopoulou V Presenting Author: David Q Le
2:50-3:00
D6: Detecting pulmonary oxygen toxicity using exhaled breath analysis: wet and dry diving are not the same. Wingelaar TT, Brinkman P, van Ooij PJAM, Maitland-Van der Zee AH, van Hulst RA Presenting Author: Thijs Wingelaar MD
3:30 PM
4:00 PM
Poster Session D-2: Posters D16-D28
D16: Self-paced exercise performance is attenuated following four hours cold water immersion irrespective of breathing gas type. Hess HW, Schlader ZJ, Johnson BD, Hostler D Presenting Author: Hayden W. Hess
D17: Does the use of normobaric oxygen in Swedish working divers underestimate the incidence of decompression illness? Hagberg M, Ornahgen H Presenting Author: Mats Hagberg MD
D18: Optimizing oxygenation, hemodynamics and metabolism during diving by using underwater near-infrared spectroscopy (NIRS). Whelan H, Ari C, Prost R, Sugar J, D'Agostino D, Quirk B, Dituri J, Harper Z, Aderman T, Fahlman A, McKnight C, Tyack P, Shorter A, Popa B, Williams T, Chapman S Presenting Author: Harry T. Whelan MD
D19: Count model of DCI among fishermen divers. Peluso E, Chin W, Huchim O Presenting Author: Walter Chin RN/CHRN
D20: Lionfish stings in Cozumel, 8 year follow up. Gomez-Castillo JD Presenting Author: J Dario Gomez Castillo MD
D21: Cancer and diving: data from 124 UK sport divers. St Leger Dowse M, Morgan B, Smerdon GR Presenting Author: Marguerite St Leger Dowse
D22: Pathophysiology of dysbaric osteonecrosis. Kawashima M, Kawashima M, Tamura H, Takao K, Yamaguchi T, Miyata K and ** Kitano M Presenting Author: Mahito Kawashima MD
D23: Thermoregulation in environmental conditions expected in a disabled pressurized rescue module. Schlader ZJ, Stooks J, Johnson BD, Hostler D Presenting Author: Zachary J. Schlader PHD
D24: Required sample sizes for testing cardiovascular effects of normobaric scuba regulator breathing without immersion: A pilot trial. Kovacs CR, Buzzacott P Presenting Author: Christopher Kovacs PHD
D25: A technical review of ultrasound use in decompression research. Le DQ, Dayton PA, Tillmans F, Freiberger JJ, Moon RE, Denoble PJ, Papadopoulou V Presenting Author: David Q Le
D26: Retreatment with a TT6A1M for neurological decompression illness in patients with a poor response to standard treatment with a USN TT6. McEldrew P, Siegel M, LeGros TL, Wyatt A, and Van Meter K Presenting Author: Patrick McEldrew, MD MD
D27: Dive profiles and physiologic parameters of safety divers at a breath-hold diving competition. Derksen B, Lang M, Lindholm P, VanHoesen K Presenting Author: Brenna Derksen MD
D28: No change in total mood disturbance during a simulated disabled pressurized rescue module scenerio. Johnson BD, Hess HW, Stooks J, Hostler D, Schlader ZJ Presenting Author: Blair Johnson PHD
SATURDAY, June 29
10:30 AM
11:30 AM
Session E: HBO2 Operations, Chambers, and Equipment
10:30-10:40
E1: Use of point of care ultrasounds for the rapid diagnosis of central retinal artery occulusion. McCarthy P, Hendriksen SM, Masters TC, Westgard BC, Walter JW, Osterman A, Reardon RF, Logue CJ Presenting Author: Patrick McCarthy MD
10:40-10:50
E2: Comparison of radial artery catheter blood pressure with automatic non-invasive blood pressure at 35 fsw on 100% O2. Orabi M, Allen J, Gonzalez S, Natoli MJ, Freiberger JJ, Derrick BJ Presenting Author: Maia Orabi MD
10:50-11:00
E3: Reliability of a continuous glucose monitor during hyperbaric oxygen exposure: Interim analysis. Huang E, Savaser D, Castle J, Manulik B, Demirel S, Bliss B, Fitzpatrick P Presenting Author: Enoch Huang MD
E4: Safety of a continuous glucose monitoring device during hyperbaric exposure. Bliss C, Huang E, Savaser D Presenting Author: Chae Bliss CHT
E6: Culturally competent hyperbaric patient care. Marosek N, Melnyczenko A Presenting Author: Nicholas Marosek RN/CHRN
11:20-11:30
E7: Implementation and evaluation of an interdisciplinary, simulation-based, educational curriculum in hyperbaric medicine. Paetow G, Guber K, Raleigh S, TenBrink W, Driehorst M, Brown L, Jensen A, Omodt S, Olives T, Hart D, Logue C Presenting Author: Christopher Logue MD
E8: Interdisciplinary simulation for the detection of latent risk threats in a hyperbaric medicine department. Paetow G, TenBrink W, Driehorst M, Brown L, Jensen A, Omodt S, Hart D, Logue C Presenting Author: Christopher Logue MD
11:30 AM
12:00 PM
Poster Session E: Poster E1-E14
E1: Use of point of care ultrasounds for the rapid diagnosis of central retinal artery occulusion. McCarthy P, Hendriksen SM, Masters TC, Westgard BC, Walter JW, Osterman A, Reardon RF, Logue CJ Presenting Author: Patrick McCarthy MD
E2: Comparison of radial artery catheter blood pressure with automatic non-invasive blood pressure at 35 fsw on 100% O2. Orabi M, Allen J, Gonzalez S, Natoli MJ, Freiberger JJ, Derrick BJ Presenting Author: Maia Orabi MD
E3: Reliability of a continuous glucose monitor during hyperbaric oxygen exposure: Interim analysis. Huang E, Savaser D, Castle J, Manulik B, Demirel S, Bliss B, Fitzpatrick P Presenting Author: Enoch Huang MD
E4: Safety of a continuous glucose monitoring device during hyperbaric exposure. Bliss C, Huang E, Savaser D Presenting Author: Chae Bliss CHT
E6: Culturally competent hyperbaric patient care. Marosek N, Melnyczenko A Presenting Author: Nicholas Marosek RN/CHRN
E7: Implementation and evaluation of an interdisciplinary, simulation-based, educational curriculum in hyperbaric medicine. Paetow G, Guber K, Raleigh S, TenBrink W, Driehorst M, Brown L, Jensen A, Omodt S, Olives T, Hart D, Logue C Presenting Author: Christopher Logue MD
E8: Interdisciplinary simulation for the detection of latent risk threats in a hyperbaric medicine department. Paetow G, TenBrink W, Driehorst M, Brown L, Jensen A, Omodt S, Hart D, Logue C Presenting Author: Christopher Logue MD
E9: US involvement in the Thai cave rescue. Tanaka HL Presenting Author: Hideaki L Tanaka MD
E10: Lithium-ion battery explosion leading to a traumtic femur fracture in cave diver. Covington DB, Ohama M, Millan S, Pitkin A Presenting Author: Derek Covington MD
E11: Successful cardiac defibrillation during hyperbaric oxygen therapy in a patient with severe carbon monoxide poisoning. Allen JA, Shah KR, Moon RE Presenting Author: Justin Allen DO
E12: Pilot study on the feasibility of utilization of an Epi-Pen® under pressure in a multi-place chamber. Savaser DJ, Huang ET, Bliss C Presenting Author: Davut Savaser MD
E13: Emergency response by hyperbaric personnel. Vidafar M Presenting Author: Michael Vidafar CHT
E14: Oxygen (O2) exhaust sign improvement. Vidafar M Presenting Author: Michael Vidafar CHT
2:00 PM
3:00 PM
Session F: Top Case Reports
2:00-2:10
F1: Tension pneumocephalus: iatrogenic subarachnoid air embolism treated with hyberbaric oxygen therapy (HBO2 therapy). Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill DO
2:10-2:20
F2: Carbon monoxide poisoning; Mixed-acid cocktail suicide attempt Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill DO
2:20-2:30
F3: A case of delayed mortality after severe arterial gas embolism secondary to myocardial infarction from triple vessel coronary artery thrombosis. Derksen BJ, Hayden SR, Grover I, Sadler CA Presenting Author: Brenna Derksen MD
2:30-2:40
F4: De-Novo cataract formation in non-diabetics. Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill MD
2:40-2:50
F5: A rare case report of coronary gas embolism after percutaneous lung biopsy Allen JA, Mammarappallil JG Presenting Author: Justin Allen MD
2:50-3:00
F6: Successful treatment of laryngotracheal radionecrosis with hyperbaric oxygen therapy in a patient presenting with persistent hemoptysis and cough. Savaser DJ, Huang ET Presenting Author: Davut Savaser MD
3:30 PM
4:00 PM
Poster Session F: Posters F1-F15
F1: Tension pneumocephalus: iatrogenic subarachnoid air embolism treated with hyberbaric oxygen therapy (HBO2 therapy). Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill DO
F2: Carbon monoxide poisoning; Mixed-acid cocktail suicide attempt Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill DO
F3: A case of delayed mortality after severe arterial gas embolism secondary to myocardial infarction from triple vessel coronary artery thrombosis. Derksen BJ, Hayden SR, Grover I, Sadler CA Presenting Author: Brenna Derksen MD
F4: De-Novo cataract formation in non-diabetics. Gaskill Z, Hardy K, Kassem J, Kelly M, Lambert D Presenting Author: Zachary Gaskill MD
F5: A rare case report of coronary gas embolism after percutaneous lung biopsy Allen JA, Mammarappallil JG Presenting Author: Justin Allen MD
F6: Successful treatment of laryngotracheal radionecrosis with hyperbaric oxygen therapy in a patient presenting with persistent hemoptysis and cough. Savaser DJ, Huang ET Presenting Author: Davut Savaser MD
F8: Diving with Osler–Weber–Rendu disease; A rare case provoking thoughts Swenker R, van Ooij PJ Presenting Author: Rob Swenker MD
F9: Hyperbaric oxygen treatment of patient with tracheal-esophageal device & recent thoracic surgery. Mihai A, Morgan M, Sharma D, Boes T, Santiago W, Heyboer M Presenting Author: Aurel Mihai MD
F10: Successful treatment of medication-related jaw osteonecrosis with hyperbaric oxygen therapy using marx protocol-like approach. Hodgson J Presenting Author: Joni Hodgson DO
F11: Hyperbaric oxygen treatment status post gamma knife surgery improves progressively worsening neurological symptoms. Mihai A, Morgan M, Sharma D, Santiago W, Heyboer M. Presenting Author: Aurel Mihai MD
F12: Against most odds: A case study, limb salvage. Crapella L Presenting Author: Lise Crapella ACNP/PA
F13: Innovative use of dehydrated human amnion/chorion membrane (dhacm) in conjunction with hyperbaric oxygen therapy to treat a non-healing nasal wound subsequent to squamous cell carcinoma resection and radiation: A case study. Henderson JA, Jones MW, Houle SS Presenting Author: Jessica Henderson DO
F14: Case report: High-throughput enterocutaneous fistula and the role of HBO2 therapy. Borges H, Oliveira N, Paz MA, Santos PE Presenting Author: Hugo Leonardo De Lima Borges MD
F15: A case of vertigo in a recreational scuba diver. Agostinelli N Presenting Author: Nicole Agostinelli MD
LECTURE TITLE: HBO2 in Chronic Radiation-Injured Tissue and Osteoradionecrosis in Today’s Radiation Schemes: Needed Now Even More
ABOUT THE LECTURE:
Today’s radiotherapy schemes, particularly intensity modulated radiation therapy (IMRT), are often used as primary therapy for head and neck cancers. Used together with chemotherapy it has produced a higher incidence of radiation-induced complications. The wider fields, higher doses, and radio sensitizing chemotherapy has caused a more severe and wider spread of osteoradionecrosis (ORN), now even including the previously rare ORN of the maxilla as well as permanent mucositis, skin necrosis, dysphagia, and even some facial nerve palsies.
The role of HBO2 remains the same adjunct to surgical debridements but requires the full 30/10 HBO2 protocol to be conducted at the proven parameters at 2.4 ATA , 90 minutes on 100% O2 with air breaks and without interruption in the treatment sequence.
After resection or debridement of the necrotic bone, the resultant bony defect can be reconstructed today using tissue engineering in most cases as a single modality or together with a smaller amount of autogenous bone, thereby reducing the morbidity of treatment. Additionally, these bone grafting techniques produce a quality of normal viable bone suitable for dental implants to replace teeth lost in the ORN disease process, aiding the patient’s return to a more normal quality of life.
ABOUT DR. MARX:
Robert E. Marx, DDS, is Professor of Surgery and Chief of the Division of Oral and Maxillofacial Surgery at the University of Miami Miller School of Medicine as well as Chief of Surgery at Jackson South Community Hospital in Miami. He is well known as an educator, researcher, and innovative surgeon. Dr. Marx has pioneered new concepts and treatments for pathologies of the oral and maxillofacial area as well as new techniques in reconstructive surgery, including stem cell therapies.
His many prestigious awards, including the Harry S. Archer Award, the William J. Giles Award, the Paul Bert Award, the Donald B. Osbon Award, and the Daniel Laskin Award, attest to his accomplishments and commitment to the field of oral and maxillofacial surgery.
His textbook “Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment” has won the American Medical Writers Associations Prestigious Book of the Year Award. His other textbooks, “Platelet Rich Plasma: Dental and Craniofacial Applications,” “Tissue Engineering,” “Oral and Intravenous Bisphosphonates Induced Osteonecrosis” and an “Atlas of Bone Harvesting” have been best sellers. He is also a writer of fiction medical mystery novels. His first publication “Deadly Prescription” is currently an Amazon best seller.
ERIC P. KINDWALL, MD MEMORIAL LECTURE About Dr. Kindwall:
Dr. Kindwall is known by so many as the "Father of Hyperbaric Medicine.” Whether you knew him personally or simply by reputation, we have all benefited from his efforts, passion, wisdom, knowledge, energy and vision. Dr. Kindwall has played a great role in growing and shaping the specialty of Undersea and Hyperbaric Medicine. He was likewise instrumental in molding the UHMS into what it is today. Dr. Kindwall began diving in 1950. He cultivated his interest in the field and during the Vietnam War served as the Assistant Director of the U.S. Navy School of Submarine Medicine. He also was the Senior Officer responsible for the Diving Medicine Program. In 1969, after leaving the Navy, Dr. Kindwall became Chief of the Department of Hyperbaric Medicine at St. Luke’s Medical Center, Milwaukee, Wis. Shortly after the Undersea Medical Society was created in the mid-1960s, Dr. Kindwall identified the need for standardized education in the field. He created the UMS Education and Standards Committee to help elevate course content and ensure instructor competence. This committee later became our Education Committee. When the AMA initiated its Continuing Medical Education program, Dr. Kindwall persuaded the organization to recognize the UMS as a grantor of CME credits. In 1972, Dr. Kindwall felt that the Society’s members would benefit from improved communication. He created our first newsletter and was named editor. Dr. Kindwall chose the name Pressure because clinical hyperbaric medicine was rapidly developing. Even though the UHMS had not yet incorporated "Hyperbaric” into the Society’s name, he wanted a title for the newsletter that would encompass all who worked with increased atmospheric pressure. He stated: "The Society’s goal then, as it is now, is to serve all who deal with the effects of increased barometric pressure.” That same year, Dr. Kindwall recognized the need to have a relationship with Medicare to help provide insight on reputable clinical management. The UMS followed this lead, and a Medicare Panel was created. The recommendations were presented to the U.S. Public Health Service. The challenge was that no reliable hyperbaric medicine clinical guidelines were available that addressed appropriate applications of Hyperbaric Medicine. To remedy this deficit, the UMS Executive Committee created an Ad Hoc Committee on hyperbaric oxygen therapy. Dr. Kindwall was named Chair. The committee created the first Hyperbaric Oxygen Therapy Committee Report. Again, this text was published 10 years before the UHMS incorporated "Hyperbaric” into its name. The report was sent to HCFA and the Blues and became their source document for reimbursement. Dr. Kindwall updated the text two more times and thus was the Editor and Chair of the Committee and text for three of its 12 editions. Dr. Kindwall later worked to expand the available information on the specialty by creating one of the first complete texts on the field. He created Hyperbaric Medicine Practice in 1994 and later updated and revised his text two more times. The Society’s first journal, Hyperbaric Oxygen Review, has also has been influenced by Dr. Kindwall. His love for research and education was clear: He became the initial editor, creating a journal that at first consisted of review articles and one original contribution. Over the years,it has grown to one full of original research. Dr. Kindwall’s presence is felt in so many of the UHMS’ activities and initiatives. Much of what we all take for granted – what is just "there” and "available” – has his touch and influence. Some of us have been blessed to have had a closer impact by Dr. Kindwall’s life, but I think that I can easily say that each of us has been influenced in some way.
::/introtext:: ::fulltext::::/fulltext::
CHRISTIAN J. LAMBERTSEN MEMORIAL LECTURE
FRIDAY, JUNE 28: 1:00 pm - 2:00 pm
GUEST SPEAKER: SIMON MITCHELL, MBBS, PHD
LECTURE TITLE: Decompression Sickness As An Inflammatory Disease
ABOUT THE LECTURE:
It has long been considered that decompression sickness (DCS) is a disorder in which bubbles formed from dissolved gas in blood and / or tissue during or after ascent from a compressed-gas dive are the primary vectors of injury. The existence of such bubbles and their potential to cause or contribute to at least some of the manifestations of DCS have been proven. However, uncertainties remain. While the risk of developing symptoms of DCS correlates with numbers of venous bubbles detected using Doppler or echocardiography after diving, the correlation is not as strong as one might expect if bubbles were the only contributor to tissue injury. There are various potential explanations for this, including the possibility that a variably expressed secondary process of inflammation may contribute to the clinical picture. We have known for some time that intravascular bubbles, or the damage they may cause to vascular endothelium, appear to activate formed elements of blood and plasma proteins. Thus, bubbles may directly or indirectly activate platelets, leukocytes, the complement and kinin systems, and coagulation. There is some evidence that these activations contribute to development of some manifestations of DCS. More recently there has been intense interest in the role of proinflammatory intravascular microparticles (circulating fragments of formed elements of blood) in the pathophysiology of DCS. Microparticles may form during diving and increase after any dive, but perhaps moreso in divers exhibiting DCS symptoms. The relationship between bubble and microparticle formation is uncertain. There is some evidence that microparticles may produce harmful effects relevant to the pathophysiology of DCS, and there has been controversial speculation that microparticles may be a primary cause of some DCS manifestations. This presentation will review the pathophysiology of DCS with a particular focus on the potential role of inflammatory processes. Related unanswered questions and uncertainties will be identified.
ABOUT DR. MITCHELL: Professor Simon Mitchell, MB ChB, PhD, DipAdvDHM, DipOccMed, FUHM, FANZCA. Professor of Anesthesiology, School of Medicine, University of Auckland
Dr. Mitchell is a physician and scientist with specialist training in diving medicine and anesthesiology. He is widely published, with more than 150 papers or book chapters. He co-authored the 5th edition of “Diving and Subaquatic Medicine” and has two chapters on decompression illness in the most recent edition of Bennett and Elliott. He has twice been Vice President of the Undersea and Hyperbaric Medical Society and in 2010 received the society’s Behnke Award for contributions to the science of diving and hyperbaric medicine. In the past Simon was a naval diving medical officer and medical director of the Wesley Centre for Hyperbaric Medicine in Brisbane. He now works as a consultant anesthesiologist at Auckland City Hospital, and Professor in Anesthesiology at the University of Auckland. He provides on-call cover for diving and hyperbaric emergencies at the North Shore Hospital Hyperbaric Unit in Auckland. Simon is Editor-In-Chief of Diving and Hyperbaric Medicine Journal.
Simon’s diving career has included more than 6,000 dives spanning sport, scientific, commercial, and military diving. He has been a lead member of teams that were the first to dive and identify three deep wrecks of high historical significance in Australia and New Zealand. At the time of one of these dives (2002) the 600-foot depth represented the deepest wreck dive ever undertaken. He was elected to Fellowship of the Explorers Club of New York in 2006, and was the DAN Rolex Diver of the Year in 2015.
CHRISTIAN J. LAMBERTSEN, MD, DSc (Hon) MEMORIAL LECTURE About Dr. Lambertsen:
Dr. Christian J. Lambertsen received a B.S. Degree from Rutgers University in 1938 and a M.D. Degree from the University of Pennsylvania in 1943. During his medical school period, he invented and first used forms of the initial U.S. self-contained closed-circuit oxygen rebreathing apparatus, for neutral buoyancy underwater swimming and diving. As a student, he aided the early Office of Strategic Services (O.S.S.) in establishing the first cadres of U.S. military operational combat swimmers. Dr. Lambertsen became a U.S. Army medical officer on graduation from medical school in early 1943, and immediately joined the O.S.S. Maritime Unit on active duty through its period of function in World War II. He joined the University of Pennsylvania Medical Faculty in 1946, and became Professor of Pharmacology in 1952. While a faculty member he combined diving research and further underwater rebreathing equipment developments for the Army and Navy. In 1967 he served as Founding President of the Undersea Medical Society (now Undersea and Hyperbaric Medical Society.) Dr. Lambertsen is recognized by the Naval Special Warfare community as "The Father of U.S. Combat Swimming.” His hand has touched every aspect of military and commercial diving. Dr. Lambertsen’s active contributions to diving began during WWII and became even more progressive in the post-war period through the evolutions of the U.S. Navy Deep Submergence and Naval Special Warfare developmental programs.
Overview: Provide an overview of activities, plans, and outcomes from initiatives carried out by UHMS home office, officers and committees.
Objectives:
Name two of the position statements published in the last year.
Describe what the UHMS has done to improve its editorial review process
About Dr. Bird:
Dr. Nicholas Bird is a regional medical director for Duke Urgent Care and is board-certified in both family medicine and undersea and hyperbaric medicine. He splits his time between clinical practice and administrative responsibilities, and has a passion for improving health care delivery to optimize patient access, education and outcomes. Prior to joining the Duke medical staff, he was the chief medical officer and CEO of Divers Alert Network and an internationally recognized expert on diving injuries, accidents and medical treatment. Outside of work, he enjoy traveling, and diving the warm waters of the world. He has been a PADI SCUBA instructor for more than 25 years. He also enjoys reading Clive Cussler novels, cooking and golfing, when time permits. He lives in Durham, NC with his wife, Kim. They have three children, a grandson, and a crazy Jack Russell terrier.
Controversies in the Hyperbaric Management of Late Radiation Injuries
8:30-9:00:
Late Radiation Tissue Injury Below the Clavicles: Considerations with IMRT and the Fibroatrophic Model John Feldmeier, DO
In this session, Dr. Feldmeier will join with Dr. Robert Marx to address several recent articles calling into question the role of hyperbaric oxygen in treating LRTI’s (Late Radiation Tissue Injuries). While Dr. Marx will concentrate on the application of Hyperbaric Oxygen to osteoradionecrosis (ORN) of the mandible and maxilla and soft tissue injuries of the head and neck, Dr. Feldmeier will concentrate on injuries to organs and tissues below the clavicle. Special emphasis will be given to radiation cystitis and proctitis. The technique of modern radiation therapy targeting including IMRT (Intensity Modulated Radiation) will be briefly discussed. A recently proclaimed and popular model of delayed radiation injury is called the Fibroatrophic Model. It de-emphasizes vascular damage as the major contributor to LRTI. This model will be discussed from 2 perspectives: 1. Its validity and 2. Even if accepted in part or in toto, how a strong case for the use of hyperbaric oxygen can be made. At the conclusion of both Dr. Marx’s and Dr. Feldmeier’s plenary sessions, a panel discussion will occur.
About Dr. Feldmeier: Dr. Feldmeier received his D.O. degree from The Philadelphia College of Osteopathic Medicine in 1979 with USAF sponsorship and completed residency training in Radiation Oncology at the University of Texas Health Science Center at San Antonio, Texas in 1985. He received a fellowship certificate from the USAF Hyperbaric Medicine Fellowship Training Program at Brooks Air Force Base in San Antonio, Texas and was a staff physician there from 1980 to 1982. Dr. Feldmeier was simultaneously the Chief of Radiation Oncology and Chairman of the Hyperbaric Medicine Department at Wright-Patterson Air Force Base Medical Center in Dayton, Ohio before separating from the USAF in 1985. Dr. Feldmeier has served as the Chief of Radiation Oncology at the University of Texas Health Science Center in San Antonio, Grace Hospital in Detroit, MI and the Chairman of Radiation Oncology at the University of Toledo Medical Center from which he retired in 2013 with the award of Professor Emeritus. Dr. Feldmeier has authored numerous publications in both radiation oncology and hyperbaric medicine. He has been the editor of the Undersea & Hyperbaric Medical Society (UHMS) Hyperbaric Oxygen Therapy Committee Report. He served as review editor of Undersea and Hyperbaric Medicine. He is a Fellow of Undersea and Hyperbaric Medicine and Past- President of the UHMS. He currently co-chairs the UHMS Research Committee. He is a Fellow of the American College of Radiation Oncology. He is a medical consultant to International ATMO. He is the only physician in the U.S. board certified in both Radiation Oncology and Undersea and Hyperbaric Medicine.
9:00-9:30:
Answering the criticism and challenges to HBO2 in the treatment of radiated patients Robert Marx, DDS
About the Lecture: Hyperbaric Oxygen Therapy (HBO2 therapy) remains a time honored scientifically proven adjunct to surgery in the head and neck radiated patient. Data will be presented identifying the proper dosage of HBO2 therapy as well as the surgeries often required in these patients. HBO2 therapy’s improvement of late radiation effects (L9.9) reduce the complications in a variety of needed surgeries such as bone grafting the jaws, tissue flaps, and placement of dental implants. HBO2 therapy is also critical in the successful resolution of osteoradionecrosis without redo surgeries.
About Dr. Marx: Robert E. Marx, DDS, is Professor of Surgery and Chief of the Division of Oral and Maxillofacial Surgery at the University of Miami Miller School of Medicine as well as Chief of Surgery at Jackson South Community Hospital in Miami. He is well known as an educator, researcher, and innovative surgeon. Dr. Marx has pioneered new concepts and treatments for pathologies of the oral and maxillofacial area as well as new techniques in reconstructive surgery, including stem cell therapies. His many prestigious awards, including the Harry S. Archer Award, the William J. Giles Award, the Paul Bert Award, the Donald B. Osbon Award, and the Daniel Laskin Award, attest to his accomplishments and commitment to the field of oral and maxillofacial surgery. His textbook “Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment” has won the American Medical Writers Associations Prestigious Book of the Year Award. His other textbooks, “Platelet Rich Plasma: Dental and Craniofacial Applications,” “Tissue Engineering,” “Oral and Intravenous Bisphosphonates Induced Osteonecrosis” and an “Atlas of Bone Harvesting” have been best sellers. He is also a writer of fiction medical mystery novels. His first publication “Deadly Prescription” is currently an Amazon best seller.
9:30-10:00:
Panel discussion
Physiology and Science in Hyperbaric Medicine
4:00-4:30:
Stem cells and hyperbaric oxygen therapy Stephen Thom, MD
The first scientific papers reporting effects of hyperbaric oxygen therapy (HBOT) on stem cell biology were published just 12 years ago and now they number over 100. This presentation will summarize the latest data on stem cell physiological responses to HBOT. Oxygen acts as a critical regulator of stem cells, and HBOT has a variety of effects on stem cell mobilization dynamics, metabolism, engraftment, and can influence paracrine roles with tissue repair. Some effects appear with the initial HBOT exposure while others develop when repeated hyperoxia-normoxia cycling occurs. Mechanisms and data on clinical utilization will be presented, as well as current questions and future directions.
About Dr. Thom: Dr. Thom received his MD and PhD (microbial physiology) degrees from the University of Rochester in 1981. He served as professor of emergency medicine and chief of hyperbaric medicine at the University of Pennsylvania for 27 years and in July 2013 took a position at University of Maryland. He is a practicing emergency medicine physician and also carries out research in several areas. He is lead/senior author on over 130 peer reviewed papers and 40 reviews or textbook chapters on oxygen and other gas toxicities. Research interests include the role of stem cells in diabetic wound healing and cell responses to hyperoxia, pathophysiology of decompression sickness, carbon dioxide and carbon monoxide (CO). His lab group was the first to describe vasculogenic stem cell mobilization by hyperbaric oxygen therapy and he currently directs projects to assess the role of stem cells in diabetic skin wound healing. He was president of the UHMS from 1996-1998, and chair of the hyperbaric oxygen therapy committee from 1991-1993. Dr. Thom has been the recipient of the Albert R. Behnke award of the UHMS in 1996 and 2008, the Paul Bert award from UHMS in 2007, the Edgar End award of the Gulf Coast Chapter of the UHMS in 1988, and the C. Longoni award from the Italian Undersea and Hyperbaric Medical Society in 1998.
4:30-5:00:
Research that We Need to do in the Field of Hyperbaric Medicine and Some Thoughts on How to Achieve this Goal John Feldmeier, DO (Co-chairman of the UHMS Research Committee)
It is no surprise to our membership that as a discipline, hyperbaric medicine has not achieved a consistently successful track record in accomplishing research to further advance the application of our treatment modality or even for that matter to firmly solidify those indications that we accept as “Approved.” CMS and commercial insurers are actively involved in removing re-imbursements for pharmaceuticals, devices and procedures unless their proponents can make a solid argument for their benefit based on good and adequate science. It is likely that payments for our clinical efforts are going to be put under even greater scrutiny unless new and corroborating science is done and published with a quality that is readily acceptable to payors and potential referring physicians alike. As a small field, we do not have the luxury of large sums of money available to support the conduct large research protocols involving randomized controlled trials. We can, however, learn from the major cooperative oncologic trial groups and employ registries to achieve the necessary quality of science. A number of promising new applications deserve scrutiny and some of our long-standing indications need better support. This talk will be designed to identify several areas where research must be done for the good of our patients and our discipline and will consider some methods by which these studies can be accomplished.
About Dr. Feldmeier: Dr. Feldmeier received his D.O. degree from The Philadelphia College of Osteopathic Medicine in 1979 with USAF sponsorship and completed residency training in Radiation Oncology at the University of Texas Health Science Center at San Antonio, Texas in 1985. He received a fellowship certificate from the USAF Hyperbaric Medicine Fellowship Training Program at Brooks Air Force Base in San Antonio, Texas and was a staff physician there from 1980 to 1982. Dr. Feldmeier was simultaneously the Chief of Radiation Oncology and Chairman of the Hyperbaric Medicine Department at Wright-Patterson Air Force Base Medical Center in Dayton, Ohio before separating from the USAF in 1985. Dr. Feldmeier has served as the Chief of Radiation Oncology at the University of Texas Health Science Center in San Antonio, Grace Hospital in Detroit, MI and the Chairman of Radiation Oncology at the University of Toledo Medical Center from which he retired in 2013 with the award of Professor Emeritus. Dr. Feldmeier has authored numerous publications in both radiation oncology and hyperbaric medicine. He has been the editor of the Undersea & Hyperbaric Medical Society (UHMS) Hyperbaric Oxygen Therapy Committee Report. He served as review editor of Undersea and Hyperbaric Medicine. He is a Fellow of Undersea and Hyperbaric Medicine and Past- President of the UHMS. He currently co-chairs the UHMS Research Committee. He is a Fellow of the American College of Radiation Oncology. He is a medical consultant to International ATMO. He is the only physician in the U.S. board certified in both Radiation Oncology and Undersea and Hyperbaric Medicine.
Friday, June 28
DCI Theory & Mechanisms
8:00-9:00:
CNS Oxygen toxicity: Where are we now? Jay Dean, PhD
Hyperbaric oxygen (HBO2) is breathed during hyperbaric oxygen therapy and during certain undersea pursuits in diving and submarine operations. What limits exposure to HBO2 in these situations is acute onset of central nervous system oxygen toxicity (CNS-OT) following a latent period of safe oxygen breathing. CNS-OT presents as various non-convulsive signs and symptoms (S/Sx), many of which appear to be of brainstem origin that involve cranial nerve nuclei, autonomic centers and cardiorespiratory centers, which ultimately spread to higher cortical centers and terminate in recurring bouts of generalized tonic-clonic seizures. The initial latent period makes breathing HBO2 practical in hyperbaric and undersea medicine; however, the safe latent period is highly variable between individuals and within the same individual on different days, making it difficult to predict onset of toxic indications. Consequently, currently accepted guidelines for safe HBO2 exposure in undersea medicine and HBO2 therapy are highly conservative. During this lecture, I will review the results of research on CNS-OT, focusing on work done during the past two decades on behalf of the Office of Naval Research (ONR) Undersea Medicine Program (one of four National Naval Responsibility Initiatives) and the Naval Sea Systems Command (NAVSEA). Topics that will be covered include the following: the pathophysiology of the S/Sx that define CNS-OT; conditions that increase the risk for developing acute toxic indications during exposure to HBO2; innovative animal (in vitro and in vivo) and human research methods adapted for use during HBO2 that have provided insight on the neural mechanisms underlying CNS-OT; brain regions that are thought to be involved in seizure genesis and propagation; and current strategies under investigation for predicting an impending seizure (“physiomarkers”) and delaying onset of CNS-OT (antiepileptic drug therapy, antiadrenergic drug therapy, ketone metabolic therapy and hyperbaric oxidative preconditioning) with the goal of longer and safer dives without impaired performance (author’s research funded by ONR Undersea Medicine).
About Dr. Dean: Dr. Jay B. Dean is a professor of Molecular Pharmacology & Physiology at the University of South Florida in Tampa. He currently teaches respiratory physiology in the Morsani College of Medicine and directs the USF Hyperbaric Biomedical Research Laboratory, which is funded by the ONR’s Undersea Medicine Program to study the pathophysiology of CNS oxygen toxicity. Dean is a devoted historian of aeromedical research during World War II, a topic he has researched extensively since his days as a PhD graduate student at Ohio State. Dean hails from Mason, Michigan, and received his training from Central Michigan University (BS 1979, Biology), Michigan Technological University (MS 1981, Biol. Sci.), The Ohio State University (PhD 1986, Physiology), and did his postdoctoral training in neurophysiology and respiratory control at the University of North Carolina-Chapel Hill (1986-91). Jay lives in Land O’Lakes, Florida with his wife, Janet, who teaches biology and oceanography at Pasco Hernando State College.
9:00-9:30:
US Navy Diving: DCS Lessons Learned Pete Witucki, MD
This lecture will be a discussion of the past, present and future of decompression illness mitigation within the United States Navy.
About Dr. Witucki: Dr. Witucki is board certified in Undersea and Hyperbaric Medicine as well as Emergency Medicine. He practices both specialties at the University of California San Diego. He served as an Undersea Medical Officer in the United States Navy and retired in 2017 after 26 years of service.
9:30-10:00:
Wearable diving technology Ki Chon, MD
About the Lecture: There has been an emergence over the past several years of novel wearable devices that can potentially be applied to underwater physiological monitoring. This lecture will present an overview of various wearable sensors that have been developed for dry conditions that can potentially be used for underwater applications. Moreover, various signal processing and machine learning algorithms will also be discussed that have been developed for accurate detection of vital signs and for combating motion artifacts from wearable devices.
About Dr. Chon: Ki H. Chon received the B.S. degree in electrical engineering from the University of Connecticut, Storrs; the M.S. degree in biomedical engineering from the University of Iowa, Iowa City; and the M.S. degree in electrical engineering and the Ph.D. degree in biomedical engineering from the University of Southern California, Los Angeles. He spent three years as an NIH Post-Doctoral fellow at the Harvard-MIT Division of Health Science and Technology, one year as a Research Assistant Professor in the Department of Molecular Pharmacology, Physiology, and Biotechnology at Brown University, Providence, Rhode Island, and four years as an Assistant and Associate Professor in the Department of Electrical Engineering at the City College of the City University of New York. He then moved to the Department of Biomedical Engineering at SUNY Stony Brook as an Associate Professor and was promoted to a full professor. Most recently, he was a Professor and Chair of Biomedical Engineering at Worcester Polytechnic Institute, Worcester, MA. He is currently the John and Donna Krenicki Professor and Head of Biomedical Engineering at University of Connecticut, Storrs, CT. His current research interests include medical instrumentation, biomedical signal processing, wearable sensors and devices including use of smart phones for vital signs and monitoring cardiac arrhythmias, development of hydrophobic vital sign sensors and identification and modeling of physiological systems.
Altitude Decompression Sickness
4:00-4:30:
Combating flier’s “bends” during unpressurized flight and explosive decompression in World War II Jay Dean. PhD
The air war of 1939-45 was a “physiological war” because the Allies sought extreme altitudes in unpressurized warplanes to gain the tactical advantage in aerial combat. How high? In 1940, the Allies predicted the air war; thus WWII would be won by the side that waged combat operations at 40,000 feet. Altitude flying and fighting at 40,000 feet became the goal that would inspire America’s aeromedical research program for the war’s duration.
Accordingly, reducing the risk of decompression sickness (DCS) at altitudes above 30,000-35,000 feet in unpressurized aircraft became a major research challenge for the physiologists of the U.S. Army Air Forces (USAAF) and U.S. Navy (USN). In April 1944, America deployed its first pressurized bomber (Boeing B-29 Superfortress) in the Pacific theater of operations to alleviate the physiological problems caused by hypobaric pressure, anoxia and cold. Pressurized flight, however, created a new problem: Namely, it was unknown how aircrews would respond to explosive decompression at high altitude following structural failure of their ship’s pressure cabin (6.5 psig). Would the incidence of DCS increase compared to slower rates of decompression in unpressurized airplanes?
In this lecture, Dr. Dean will revisit the research and mitigation strategies for dealing with “flier’s bends” or “aeroembolism” during unpressurized flight and following explosive decompression during pressurized flight. Topics covered include the following:
discovery of flier’s bends during altitude chamber “flights” by Dr. Harry G. Armstrong at Wright Field, Dayton, Ohio (1934-1938);
development of oxygen prebreathing (OPB) to “denitrogenate” prior to altitude flying above 30,000 feet in altitude chambers and aircraft (1938-1945: Wright Field Aero Medical Lab and Mayo Aero Medical Unit with Boeing and Lockheed Aircraft Companies);
Dr. Fred A. Hitchcock’s pioneering research on the physiology of explosive decompression (1941-45: The Ohio State University Laboratory of Aviation Physiology); and more.
Ultimately, the air war of 1939-1945 would be mostly fought and won below 40,000 feet; however, the equipment and procedures developed during the war years were immediately available for higher altitude flight during the post-war jet era.
About Dr. Dean: Dr. Jay B. Dean is a professor of Molecular Pharmacology & Physiology at the University of South Florida in Tampa. He currently teaches respiratory physiology in the Morsani College of Medicine and directs the USF Hyperbaric Biomedical Research Laboratory, which is funded by the ONR’s Undersea Medicine Program to study the pathophysiology of CNS oxygen toxicity. Dean is a devoted historian of aeromedical research during World War II, a topic he has researched extensively since his days as a PhD graduate student at Ohio State. Dean hails from Mason, Michigan, and received his training from Central Michigan University (BS 1979, Biology), Michigan Technological University (MS 1981, Biol. Sci.), The Ohio State University (PhD 1986, Physiology), and did his postdoctoral training in neurophysiology and respiratory control at the University of North Carolina-Chapel Hill (1986-91). Jay lives in Land O’Lakes, Florida with his wife, Janet, who teaches biology and oceanography at Pasco Hernando State College.
4:30-5:00:
USAF hypobaric exposures experience Marc Robins, DO
Dr. Robins will speak on DCS altitude problems faced and a history of U2 case reports. (Nothing recent has really been collected)
About Dr. Robins: Dr. Robins started his career in medicine working for the Ski Patrol in Southern Oregon at age 19 which soon led to employment as a nurses aide then as a Registered Nurse. Prior to medical school he worked as an RN in the Emergency Department at a level 1 Trauma Center, graduating with his Doctorate in Osteopathy in 1988. Receiving a Health Professions Scholarship to pay for Medical School he did his first Residency in Family Practice at the David Grant USAF Regional Medical Center at Travis AFB, California, and then a second Residency in Aerospace Medicine with Fellowship in Occupational Medicine and a Masters in Public Health from Harvard University School of Public Health. He was awarded the Malcom Grow Air Force Outstanding Flight Surgeon of the Year Award in 1995, and completed a 20-year career as an Air Force Flight Surgeon. His assignments included European Aeromedical Evacuation Squadron, and command positions for Fighter Base Aeromedical Squadrons and the High Altitude U2 program in Beale, California, commanding medical services in six major deployments and one Humanitarian Mission. Dr. Robins culminated his career as the US Aerospace Medicine Consultant to the Australian Defence Force Medical Chief (US Surgeon General equivalent), retiring as a Colonel. He attended the NOAA Dive Medical course in 2010 and maintains an avid interest in recreational scuba diving, certifying in 2003. He is a pilot, enjoys skiing, mountain biking, motorcycle riding and rock climbing.
Saturday, June 29
The Regulatory And Reimbursement Challenges Facing Nations And How These Have Been Addressed
8:00-8:25:
Canada Ken LeDez, MD
About the Lecture: The lecture will give an overview of the hyperbaric medicine in Canada, covering a broad range of topics including:
Healthcare organization, insurance coverage, physician remuneration and audits
Approved conditions for hyperbaric oxygen treatment
Accreditation of hyperbaric facilities
Physician licensing, certification, credentialing and medical organizations
The Diploma in Hyperbaric Medicine from Royal College of Physicians and Surgeons of Canada
Medical liability coverage and technical fees
Continuing medical education requirements
Clinical hyperbaric facilities and 24-hour coverage issues
About Dr. LeDez: Dr. Ken LeDez established and is Medical Director of the Hyperbaric Medicine Service in St. John’s, Newfoundland and Labrador, Canada and Associate Professor in the Faculty of Medicine at Memorial University and former Chair of the Discipline of Anesthesia. He is a staff anesthesiologist at the Health Sciences Centre in St. John’s. Dr. LeDez has provided medical coverage for offshore saturation diving since 1992. After graduating from medical school at the University of Dundee, Scotland, Dr. LeDez undertook further training in anesthesia in the UK and Canada, completed research and clinical fellowships in Anesthesiology and Hyperbaric Medicine at the University of Toronto and later at Dalhousie University. He was a founder of the Canadian Chapter of the UHMS and its first President (now called the Canadian Undersea and Hyperbaric Medical Association – CUHMA). Ken LeDez is a former Vice-President of the UHMS, has authored multiple scientific publications in anesthesiology and hyperbaric medicine and was co-author of book chapters and the book “Gas bubble dynamics in the human body” published in 2017. In addition, Dr. LeDez is the Chair of the Hyperbaric Medicine Specialty Committee of the Royal College of Physicians and Surgeons of Canada and the editor and principle author of CUHMA’s “Guidelines to the practice of hyperbaric medicine and provision of hyperbaric oxygen treatment in Canada”. He has been involved in multiple national and international committees related to clinical standards of care and is Chair of Sub-Committee 4 of the ISO Technical Committee 121 on anesthesia, respiratory and critical care equipment.
8:25-8:50:
United Kingdom Pieter Bothma, MD
About the Lecture: The infamous postcode lottery of obtaining funding for HBO depending on where you live, has been criticized widely. It also apply to other specialties including oncology where the most expensive medication was available in some areas and in many areas it was not. While negotiating a new commissioning policy for HBO as a specialized service, NHS England agreed a block contract to treat the majority of the conditions that we prefer to treat. The policy was due to be completed in 1 to 2 years, but took seven years. This has now been replaced by the new commissioning policy which is a lot more restrictive.
About Dr. Bothma: Dr. Bothma is a Consultant in Anaesthesia, Critical-care and Hyperbaric medicine. He is Medical director of the London hyperbaric unit operating at 2 sites: in London(Whipps Cross University Hospital) and in Great Yarmouth (James Paget University hospital). He has been involved with the clinical reference group negotiating with NHS England for the last 7 years about a new commissioning policy. He regards this as the biggest investment of his time for the least benefit to anyone. He is currently chairman of the British Hyperbaric Association.
8:50-9:15:
United States Caroline Fife, MD
About the Lecture: The advent of the Quality Payment System changes the focus of the conversation about the effectiveness of hyperbaric oxygen therapy. The goal of the QPP is to decrease Medicare Spending per Beneficiary. Although the current regulatory and reimbursement pressure on HBOT is focused on decreasing utilization (both improper use but overall use), the cost component of the QPP puts hyperbaric practitioners and hospital centers at a different kind of risk. If practitioners do not engage in the Merit Based Incentive Payment System, they could experience unanticipated consequences such as being removed from provider lists by private payers. This topic will explain the confusing "cost" component of MIPS and its implications for the future of the field.
About Dr. Fife: Dr. Fife completed a family medicine residency at the University of Texas, Southwestern in Dallas followed by a two-year fellowship in undersea and hyperbaric medicine at Duke University. Until 2013 she was a Professor of Medicine at the University of Texas Health Science Center, Houston, where she initiated the Memorial Hermann Center for Wound Healing and Hyperbaric Medicine. She is now a Professor of Geriatrics at Baylor College of Medicine in Houston, and the Medical Director of the CHI St. Luke's Wound Clinic in The Woodlands, Texas. Fife is also the Chief Medical Officer of Intellicure, Inc., a health information technology company, and the Executive Director of the U.S. Wound Registry, a non-profit organization recognized by CMS as a qualified clinical data registry. The USWR develops hyperbaric and wound care-relevant quality measures which help hyperbaric practitioners meet the requirements of Medicare’s Quality Payment Program. She is a past president of the Undersea and Hyperbaric Medical Society. Past and present board activities include the Alliance of Wound Care Stakeholders (current co-chair), the American Academy of Wound Management, the Association for the Advancement of Wound Care and the American Professional Wound Care Association. She is the clinical editor of Today’s Wound Clinic, and has authored more than 100 peer-reviewed articles and book chapters as well as editing three textbooks (the Textbook of Chronic Wound Care, Wound Care Practice, and Women and Pressure: Diving and Flying). Her research contributions include altitude decompression studies that enabled the construction of the International Space Station by decreasing the time needed for oxygen pre-breathe as part of a NASA-led research consortium, the development of real-time lymphatic imaging with Dr. Eva Sevick using near infrared technology, and more recently, the use of real-world data for comparative effectiveness studies to understand what works best for patients with chronic wounds and ulcers.
9:15-9:40:
Australia Michael Bennett, MD
About the Lecture: As for most jurisdictions, Australia has faced serious challenges in this area. HBO has been under constant review for 17 years by the national Medicare system. This presentation will outline the course and outcome of these reviews.
About Professor Bennett: Professor Bennett is the Academic Head of the Department of Anaesthesia, a Senior Staff Specialist in diving and hyperbaric medicine at Prince of Wales Hospital and Conjoint Professor in the faculty of Medicine, University of New South Wales in Sydney, Australia. He graduated from the University of New South Wales in 1979 and spent his early post-graduate training at the Prince Henry/Prince of Wales Hospitals before undertaking training in Anaesthesia in the UK. He returned to Sydney in 1990 as a retrieval specialist on the Lifesaver Helicopter and here developed an interest in both diving and hyperbaric medicine. He was medical director of the Department of Diving and Hyperbaric Medicine at POWH from 1993 to 2007. He also has a strong interest in clinical epidemiology and is an experienced clinician and researcher. In 2002 he was the recipient of the Behnke Award for outstanding scientific achievement from the Undersea and Hyperbaric Medical Society. Since 2004 he has been highly involved in the teaching of Evidence-based Medicine within the Medical faculty at UNSW and in 2005 was appointed co-director of the Quality Medical Practice Program there. He is the author of over 140 peer-reviewed publications including 15 Cochrane reviews of the evidence in Diving and Hyperbaric Medicine. Prof. Bennett was the convener of the Australia and New Zealand Hyperbaric Medicine Group Introductory Course in Diving and Hyperbaric Medicine from its inception in 1999 to 2014. He is an executive member of the Australia and New Zealand College of Anaesthetists (ANZCA) special interest group in diving and hyperbaric medicine and chair of the ANZCA DHM subcommittee responsible for the ANZCA Diploma of Advanced DHM. He is a past Vice-President of the UHMS and currently the Past President of SPUMS.
9:40-10:00:
Panel discussion
1:00-1:30:
HBO2 and Inflammatory Bowel Disease Update Jay Buckey, MD
About the Lecture: This talk will cover new developments in the treatment of inflammatory bowel disease with hyperbaric oxygen. Inflammatory bowel disease involves both hypoxia and inflammation, and hyperbaric oxygen can have effects on both of those factors. Also, hyperbaric oxygen can affect the microbiome, which is another potential mechanism for HBO2’s effects in IBD.
About Dr. Buckey: Jay C. Buckey, MD is a Professor of Medicine at the Geisel School of Medicine at Dartmouth and the medical director of the Center for Hyperbaric Medicine at Dartmouth-Hitchcock Medical Center.
1:30-2:00:
Diving, operational & environmental physiology of the Thai cave rescue Richard Walker, MD
About the Lecture: This lecture looks at the physiological concerns for the Thai cave rescue, both the soccer team members and the rescuers, as well as some of the operational concerns of the divers themselves. We examine the nature of specialty dive environments and how these environments drive the needed skills, equipment and experience required for successful expeditions as well as how this differs from normal dive operations. In addition, we examine the unique hazards to the rescuers and the psychological stresses and preparation needed for conducting dive operations in this environment.
About Dr. Walker:Dr. Walker is an experienced diver and instructor with over 33 years diving, including over 20 years as a cave, wreck, mixed gas and rebreather instructor and has participated in numerous expedition dives. In addition, Dr. Walker is boarded in both Emergency Medicine and Undersea/Hyperbaric Medicine with experience teaching military and civilian personnel to work in austere environments. He has experience working on projects for NASA where he worked on DCS mitigation during EVA for the Constellation project, for the Air Force where he was on the committee working to address the U2 High Flight DCS problem and on numerous underwater projects and expeditions both for research and exploration. He currently is the chair of the department of emergency medicine at UT and teaches emergency medicine and hyperbaric medicine in Memphis TN.
Topics in Undersea and Hyperbaric Medicine
4:00-4:30:
Top articles in HBO2 Justin Allen, DO Fellow, Duke, Durham, NC
About the Lecture:
Review recent literature published since July 2018 to present.
Perform a critical analysis of the articles, including implications on future practice of hyperbaric medicine.
About Dr. Allen: Dr. Allen is originally from Hobart, Indiana. He graduated from Wabash College (BA, biology) in 2011 and completed medical school at the Lake Erie College of Osteopathic Medicine (Doctor of Osteopathic Medicine) in 2015. He completed an internal medicine residency at Lakeland Health in Saint Joseph, Michigan, in 2018 and is currently a fellow in undersea and hyperbaric medicine at Duke University Medical Center in Durham, N.C. He will be pursuing a career as a full-time nocturnist at Duke Raleigh Hospital and will practice clinical hyperbaric medicine part-time. Outside of medicine, he is a competitive runner, part-time triathlete, and occasional snowboarder. Most recently, he finished 10th at the 2019 U.S. Duathlon national championships and qualified for team USA for the 2020 Duathlon World Championships. He also enjoys traveling with his fiancée, Kaitlyn, who he will marry this December in Cancun.
4:30-5:00:
Top articles in Undersea Medicine Aurel Mihai, MD Fellow, SUNY, Syracuse, NY
About the Lecture:
DCS models and frameworks
Oxygen toxicity
Reviews and guidelines
Noteworthy short articles
About Dr. Mihai: Aurel Mihai (pronounced uh-REL ME-high) is current fellow of undersea and hyperbaric medicine at SUNY Upstate Medical University in Syracuse, NY. His primary training is in family medicine. His interest in undersea medicine is mainly in recreational and public safety diving, primarily in mitigating risk for aging divers and divers with comorbidities.
In order to receive continuing education for the UHMS ASM you must complete and submit an evaluation.
Accreditation Statement: The Undersea and Hyperbaric Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statements: The Undersea and Hyperbaric Medical Society designates this live activity for a maximum of 22AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing CEU is approved by the Florida Board of Registered Nursing Provider #50-10881. ASM Credit hours 22. Licenses Types Approved:
Advanced Registered Nurse Practitioner
Clinical Nurse Specialist
Licensed Practical Nurse
Registered Nurse
Certified Nursing Assistant
Respiratory Care Practitioner Critical Care
Respiratory Care Practitioner Non-Critical Care
Registered Respiratory Therapist
Certified Respiratory Therapist
NBDHMT: This live activity is approved for 22 Category A credit hours by National Board of Diving and Hyperbaric Medical Technology, 9 Medical Park, Suite 330, Columbia, South Carolina 29203. Full Disclosure Statement: All faculty members and planners participating in continuing medical education activities sponsored by Undersea and Hyperbaric Medical Society are expected to disclose to the participants any relevant financial relationships with commercial interests. Full disclosure of faculty and planner relevant financial relationships will be made at the activity.
Disclaimer: The information provided at this CME activity is for Continuing Medical Education purposes only. The lecture content, statements or opinions expressed however, do not necessarily represent those of the Undersea and Hyperbaric Medical Society
MAINTENANCE OF CERTIFICATION (MOC):
“MOC ABPM: This activity has been approved by the American Board of Preventive Medicine for up to 18 MOC credits. Claiming ABPM MOC credit is appropriate for those who are ABPM diplomates.”
WEDNESDAY, JUNE 26: 8am-5pm Program Chair: Derall Garrett, CHT
The purpose of this course is to provide an overview of the UHMS Clinical Hyperbaric Facility Accreditation Program, its structure, survey processes and "insider tips” on preparing to undergo an accreditation survey. Experienced surveyor faculty members will provide a comprehensive overview of the process to streamline preparation.
SCHEDULE: subject to change posted: 5/8/2019
TIME
LECTURE
FACULTY
8:00-8:15
Welcome/Introductions
Derall Garrett, CHT
8:15-10:15
Why Accredit Clinical Hyperbaric Facilities?
Derall Garrett, CHT
10:15-10:45
Break
10:45-11:45
Hyperbaric Facility Accreditation Program Design I & II
Derall Garrett, CHT
11:45-12:45
Lunch
12:45-1:30
Physician point of view
Hank Schwartz, MD
1:30-2:00
Organizational Planning
Derall Garrett, CHT
2:00-2:45
Technologist point of view
Tom Workman, CHT
2:45-3:00
Break
3:00-3:45
Nurse point of view
Debra Gonzalez, RN
3:45-4:00
Discussion/Questions
4:00
Adjourn
CONTINUING EDUCATION CREDITS:
Accreditation Statement: The Undersea and Hyperbaric Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statements: The Undersea and Hyperbaric Medical Society designates this live activity for a maximum of TBA AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing CEU is approved by the Florida Board of Registered Nursing Provider #50-10881. ASM Credit hours 6.25.
Licenses Types Approved:
Advanced Registered Nurse Practitioner
Clinical Nurse Specialist
Licensed Practical Nurse
Registered Nurse
Certified Nursing Assistant
Respiratory Care Practitioner Critical Care
Respiratory Care Practitioner Non-Critical Care
Registered Respiratory Therapist
Certified Respiratory Therapist
NBDHMT: This live activity is approved for 6.25 Category A credit hours by National Board of Diving and Hyperbaric Medical Technology, 9 Medical Park, Suite 330, Columbia, South Carolina 29203.
MOC ABPM: This activity has been approved by the American Board of Preventive Medicine for up to TBA MOC credits. Claiming ABPM MOC credit is appropriate for those who are ABPM diplomates.”
Full Disclosure Statement: All faculty members and planners participating in continuing medical education activities sponsored by Undersea and Hyperbaric Medical Society are expected to disclose to the participants any relevant financial relationships with commercial interests. Full disclosure of faculty and planner relevant financial relationships will be made at the activity.
Disclaimer: The information provided at this CME activity is for Continuing Medical Education purposes only. The lecture content, statements or opinions expressed however, do not necessarily represent those of the Undersea and Hyperbaric Medical Society (UHMS), its affiliates or its employees.
Hyperbaric Oxygen Safety: Clinical and Technical Issues WEDNESDAY, JUNE 26: 8am-5:30pm
Hear from the foremost medical and technical leaders in hyperbaric safety as we discuss past and present safety considerations. This event is suitable for all disciplines, as we blend the experience of physicians, nurses, and technical staff to formulate a unique safety course to suit your needs.
The purpose of this course is to provide current information related to the clinical and technical safety of clinical hyperbaric oxygen therapy. This course is organized by both regular and associate members. The sessions will be of special interest to clinicians and technical staff and is provided in response to requests from the membership for a pre-course related to safety aspects of clinical hyperbaric oxygen therapy. MOC/CME and CEU credits will be available for this course.
SCHEDULE Subject to change: posted: 2/26/19
TIME
LECTURE
FACULTY
0800 - 0815
Introductions: / Welcome
Marc Robins, DO Andrew Melnyczenko, CHT
0815 - 0915
Safety considerations in hyperbaric medicine: Lessons from aviation, space, and other industries
Gary Toups, MD
0915 - 1015
The role of the medical director in the safety program
Marc Robins, DO
1015 - 1030
Break
1030 - 1050
How to implement the nursing guidelines of care to improve safety in your HBO program
Jolene Cormier, BSc, EMT, CHT, CWS, BSN, CHRN
1050 - 1110
Human factors that impact safety in hyperbaric operations
Richard “Gus” Gustavson, MPH, RN, CHRNC-A, CWCN, CHT-A, CRT
1110 - 1130
Optimizing the pediatric hyperbaric oxygen therapy plan: Tandem therapy
Nicholas Marosek, RN, CHRN
1130 - 1200
Panel Q&A from the morning session
Moderator: Andrew Melnyczenko, CHT
1200 - 1300
Lunch
1300 - 1345
Safety-related trends revealed from the UHMS Facility Accreditation Program
Tom Workman, CHT
1345 - 1430
Assessing the safety of diver recompression chamber facilities. A retrospective review of the most common safety concerns encountered at a range of recompression facilities over a period of 13 years
Francois Burman
1430 - 1445
Break
1445 - 1530
Safety versus Compliance
Kip Posey, CHT
1530 - 1600
International survey of equipment used in hyperbaric facilities
Marc Pullis, EMT, CHT
1600 - 1645
Biomedical devices in the hyperbaric environment
Ian Millar, MD
1645 - 1715
Panel Q & A from the afternoon session
Moderator: Ian Millar, MD
1715 - 1730
Closing/ Course evaluations / Questions
Marc Robins, DO Andrew Melnyczenko, CHT
CONTINUING EDUCATION CREDITS:
Accreditation Statement: The Undersea and Hyperbaric Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statements: Physician CME: The Undersea & Hyperbaric Medical Society designates this live course for a maximum of 8AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing CEU: This live course is approved for 8 contact hours provided by Florida Board of Registered Nursing/RRT Provider #50-10881
Licenses Types Approved:
Advanced Registered Nurse Practitioner
Clinical Nurse Specialist
Licensed Practical Nurse
Registered Nurse
Certified Nursing Assistant
Respiratory Care Practitioner Critical Care
Respiratory Care Practitioner Non-Critical Care
Registered Respiratory Therapist
Certified Respiratory Therapist
NBDHMT: This live course is approved for 8 Category ‘A’ credit hours by National Board of Diving and Hyperbaric Medical Technology, 9 Medical Park, Suite 330, Columbia, South Carolina 29203.
Full Disclosure Statement: All faculty members and planners participating in continuing medical education activities sponsored by Undersea and Hyperbaric Medical Society are expected to disclose to the participants any relevant financial relationships with commercial interests. Full disclosure of faculty and planner relevant financial relationships will be made at the activity.
UHMS Disclaimer: The information provided at this CME activity is for Continuing Medical Education purposes only. The lecture content, statements or opinions expressed however, do not necessarily represent those of the Undersea and Hyperbaric Medical Society (UHMS), its affiliates or its employees.
Treatment of Decompression Illness in Recreational Diving: Is reconciliation of different treatment practices necessary?
WEDNESDAY, June 26: 8am-5pm Program chairs: Peter Denoble, MD and Jim Chimiak, MD
Standard treatment for decompression illness (DCS) and arterial gas embolism (AGE) both dive-related and iatrogenic, is recompression and hyperbaric oxygen administration. Treatment practices around the world have been mostly derived from the experience of various navies and commercial companies. In the United States, the UHMS provides guidelines based on the U.S. Navy practices with minor adjustments for the recreational diving environment. The mainstay of UHMS recommendations for initial treatment is U.S. Navy Treatment Table 6 for serious cases and Treatment Table 5 for mild cases. Both treatment tables apply maximum pressure of 2.8 bars (equivalent to 18 msw or 60 fsw depth). Some medical centers in the United States like Hawaii, NASA and Catalina use greater treatment pressures while others that operate monoplace chambers use less pressure and shorter treatment times. In another part of the world, current practice may differ. In France, treatment tables are derived from the French Navy and COMEX tables, and use nitrox and various pressure levels. COMEX 12 and U.S. Navy Table 9 are examples of short and shallow tables. In Russia, treatment pressure sometimes goes higher than 6 bars. Practitioners in China may follow U.S. practice but they have extensive experience with severe and delayed cases in fish farming. Cairns in Australia has extensive experience in treating cases from the Great Barrier Reef and flying after treatment.
A decision to recompress in a case when symptoms resolve before admission may vary. Beyond initial treatment, there are major differences in approach to follow-up treatments, auxiliary treatments and physical rehabilitation of injured divers. Additional differences appear in the recommendation for flying after treatment.
The aim of this workshop is to review variants of current clinical practices, to discuss the rationale for such practices and to consider a need for harmonization of practices.
Poll: DCI Treatment Principle
We will invite participants to take the pre-poll after the intro talk. The results will be withheld until after the post-poll is done after all talks. We have posted the questions in advance below, with hopes that it may motivate more people to register for the pre-course and that attendees may do some homework ahead. At the end of the lectures, the poll will be repeated with instantaneous show of results and discussion of each topic.
The questions to try to answer are:
Do all cases of DCI require recompression?
Are protocols shorter and/or shallower than Table 6 acceptable?
Are deeper tables justifiable or necessary?
How does delay to treatment affect decision to treat?
Follow-up treatment: when, how and for how long?
How long does patient need to be observed before discharge?
How long to wait before flying after treatment?
Poll topics and statements
Normobaric vs. hyperbaric oxygen treatment
Mild DCS cases may be treated with normobaric oxygen only, even when HBO is available
All DCI cases require HBO treatment
Mild cases that resolve with normobaric oxygen, and are symptom-free for at least six hours, do not need HBO
Serious cases that have completely resolved and have been already symptom-free for 6 hours, may be administered surface oxygen and observed for 24 hours without recompression if there is no recurrence of symptoms.
Short (Comex 12, USN T9, Kindwall) vs. standard (USN T5-T6, and equivalent) treatment protocols
Short tables are not acceptable as initial treatment for DCI
In the case when standard treatment is not available, shorter and/or shallower HBO protocols are acceptable if administered by trained personnel.
Deep tables (deeper than 60 ft)
Deep tables are not justified for any case of DCI
Deep tables are acceptable for DCI in technical diving
Deep tables are acceptable for severe DCI cases with a short delay to treatment
B & C true
Follow up treatment
There is no limit on number or protocol of follow up treatments
In mild cases, one treatment table and up to two follow up standard HBO sessions
In severe cases, two treatment tables, and standard HBO sessions as long as there is a daily improvement
In severe cases, repeat treatment tables until no improvement is achieved
B & C
B & D
Flying after treatment
If symptom-free, wait 24 hours. If with residual symptoms, wait 72 hours
Wait at least 72 hours
Wait for at least a week
Treatment of symptoms recurring during or after FAT
Any symptom during flight even if resolved on landing should be treated with HBO
Only cases with persistent symptoms on landing should be treated
Any symptom occurring within 24 hours after landing should be treated
A & C
B & C
SCHEDULE
Subject to change: posted 1/29/19
Time
Lecture
Faculty
08:00-08:30
Current UHMS guidelines
Nick Bird
08:30-09:00
Polling, hidden results: DCI treatment principles (see the list of Q&A in Appendix)
Petar Denoble
09:00-09:30
Current practice in France
Sébastien de Maistre
09:30-10:00
Current practice in China
Wei-gang Xu
10:00-10:30
Coffee Break
10:30-11:00
Australian experience
David Wilkinson
11:00-11:30
Could normobaric oxygen be accepted as a definitive treatment?
Richard Moon
11:30-12:00
Use of short tables in treatment of DCI
Brenna Derksen
12:00-12:30
Treatment of severe DCS cases
Ian Grover
12:30-13:30
Lunch break
13:30-13:45
Use of deep tables in US Navy
David Southerland
13:45-14:30
Is it ever too late to treat?
Jake Freiberger
14:30-15:00
Flying after treatment
Jim Chimiak
15:00-15:30
When to return to diving after DCI
Jake Freiberger
15:30-15:45
coffee break
15:45-16:45
Polling, public results: DCI treatment principles. Discussion of each question. Comparison of pre- and post- answers
Petar Denoble
16:45-17:00
Concluding remarks
Petar Denoble
CONTINUING EDUCATION CREDITS:
Accreditation Statement: The Undersea and Hyperbaric Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statements: The Undersea and Hyperbaric Medical Society designates this live activity for a maximum of TBAAMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing CEU is approved by the Florida Board of Registered Nursing Provider #50-10881. ASM Credit hours 7.5.
Licenses Types Approved:
Advanced Registered Nurse Practitioner
Clinical Nurse Specialist
Licensed Practical Nurse
Registered Nurse
Certified Nursing Assistant
Respiratory Care Practitioner Critical Care
Respiratory Care Practitioner Non-Critical Care
Registered Respiratory Therapist
Certified Respiratory Therapist
NBDHMT: This live activity is approved for TBA Category A credit hours by National Board of Diving and Hyperbaric Medical Technology, 9 Medical Park, Suite 330, Columbia, South Carolina 29203.
MOC ABPM: This activity has been approved by the American Board of Preventive Medicine for up to TBA MOC credits. Claiming ABPM MOC credit is appropriate for those who are ABPM diplomates.”
Full Disclosure Statement: All faculty members and planners participating in continuing medical education activities sponsored by Undersea and Hyperbaric Medical Society are expected to disclose to the participants any relevant financial relationships with commercial interests. Full disclosure of faculty and planner relevant financial relationships will be made at the activity.UHMS
Disclaimer: The information provided at this CME activity is for Continuing Medical Education purposes only. The lecture content, statements or opinions expressed however, do not necessarily represent those of the Undersea and Hyperbaric Medical Society (UHMS), its affiliates or its employees.
CANCELLATION / REFUND POLICY: $100 administrative fee will be held on all MEETING(S)/COURSE(S) cancellations from the time you register, until 60 days prior to the meeting/course date. From 59 days to one (1) month prior, 50% of fees will be held on all cancellations. NO REFUNDS will be issued one (1) month before or after the meeting/course date.
AP After Party: Saturday, June 29 (10pm-12 midnight): $25
CANCELLATION / REFUND POLICY: $100 administrative fee will be held on all MEETING(S)/COURSE(S) cancellations from the time you register, until 60 days prior to the meeting/course date. From 59 days to one (1) month prior, 50% of fees will be held on all cancellations. NO REFUNDS will be issued one (1) month before or after the meeting/course date.
OUR EXHIBIT COMPANY THIS YEAR IS: Expo Displays Caribbean Sabana Gardens Industrial Park, Lot. 13-178 Calle B Esq. Calle A, Ofic. 2 Bo. Sabana Abajo, Carolina, PR 00985 PO Box 195457, San Juan, PR 00919
Information to ship to the Wyndham Grand: Click here
INVITATION TO SPONSOR/EXHIBITOR
The 2018 UHMS Annual Scientific Meeting offers an excellent opportunity for your organization to gain visibility, network with other professionals, and to promote its products and services to a target audience of physicians, scientists, technicians, nurses and other allied health professionals. Reinforce your corporate image by signing up today.
THE UHMS 2019 ANNUAL SCIENTIFIC MEETING
The Undersea and Hyperbaric Medical Society (UHMS) is holding their 2019 Annual Scientific Meeting. The Conference venue is the Wyndham Grand Rio Mar Puerto Rico Golf & Beach Resort, 6000 Rio Mar Blvd, Rio Grande, Puerto Rico 00745. Room Rate: $182.31; Call in reservations: 800-474-6627, Online reservations: CLICK HERE or paste the following link in your web browser address bar: https://book.passkey.com/e/49746356
The meeting program will feature a number of outstanding, widely recognized professional local and international speakers and poster presentations. Our meeting attracts researchers and practitioners from all around the world and provides a wonderful opportunity to meet and extend contacts.
The meeting program will feature a number of outstanding, widely recognized professional local and international speakers and poster presentations. Our meeting attracts researchers and practitioners from all around the world and provides a wonderful opportunity to meet and extend contacts.
BACKGROUND ON THE UHMS
The Undersea and Hyperbaric Medical Society (UHMS) is an International, non-profit organization serving over 2,200 members from more than 50 countries.
Our diverse membership ranges from hyperbaric, diving and wound care physicians, scientists, nurses technicians, respiratory therapists and other allied health care professionals who work in the field of hyperbaric, wound care or diving medicine.
The UHMS is the primary source of information for hyperbaric, diving medicine and physiology worldwide. The Society was founded as the Undersea Medical Society in 1967 but in 1986 changed the name to Undersea and Hyperbaric Medical Society. The name change reflected the rapidly growing interest in hyperbaric oxygen therapy.
The UHMS' Mission is to:
improve the scientific basis of hyperbaric oxygen therapy
provide scientific information to protect the health of sport, military, public safety, and commercial divers
promote sound treatment protocols and standards of practice
provide continuing education credits.
CANCELLATION / REFUND POLICY
BEFORE MAY 1: $100 administrative fee will be held
AFTER MAY 1: 50% of registration fees will be held
NO REFUND after start of meeting
EXHIBITS
There will be exhibits running in conjunction with the meeting from Thursday, June 27, 2019 until Saturday June 29, 2019. Move in time for Exhibitors will be 3pm, Wednesday, June 26, 2019. Breakdown will be Saturday, June 29 at 4:00 pm.
You are invited to exhibit at the meeting and take the opportunity to network, make new contacts and show your products and services to attendees during morning and afternoon breaks, also, you are invited to our welcome reception (Wednesday evening – casual attire), another great networking opportunity.
OUR EXHIBIT COMPANY THIS YEAR IS:
ANNUAL SCIENTIFIC MEETING FORMAT
Wednesday, June 26: Exhibt hall: Rio Mar 5 + Cord A 7:00am-3:00pm: 3:00pm: Exhibitors Move in 7:00pm-9:00pm: Welcome Reception (all welcome) at the Ocean Terrace/Rio Mar Foyer
Thursday, June 27: Conference Sessions: 8am-6pm Exhibit Times:
The UHMS meeting provides extensive marketing, promotion and networking opportunities. To take advantage of these, UHMS offers you the following range of sponsorship opportunities. Sponsorship packages have been structured to ensure your company will be clearly identified as a leader in the industry.
SPONSOR OPPORTUNITIES
As one of our " Sponsors" you will not only be an integral part of the meeting's social events, but will also gain significant promotion. These events provide an excellent opportunity for networking in a relaxed, but professional setting. These sponsorship opportunities offer unmatched, excellent exposure to an audience of the industry professionals.
Sponsorship acknowledgment on website and any printed material
Signage displayed during the meeting
An opportunity to display promotional material (supplied by Sponsor) at the meeting
** ALL artwork must be supplied by the sponsor and emailed to lisa@uhms.org **
PLATINUM SPONSOR: $6,500
GOLD SPONSOR: $4,500
SILVER SPONSOR: $3,500 BRONZE SPONSOR: $2,500
WELCOME RECEPTION SPONSOR: $2,500
ASSOCIATES LUNCHEON SPONSOR: $1,000
ASSOCIATES SCHOLARSHIP SPONSOR (2 needed): $1,000
ASM ACCESSORIES SPONSORS
SATCHEL SPONSOR:
YOU PURCHASE
Distributed to every delegate upon registration, satchels are constantly used by delegates throughout the meeting to carry their notes and belongings and often retained as a memento after the event. Sponsorship of the satchels therefore offers excellent exposure, as the sponsor will be a constant presence for the duration of the event and beyond.
Sponsorship acknowledgment on website and any printed material
Opportunity to include promotional material in delegate satchels (this must be sent to UHMS one month prior).
500 SATCHELS MUST BE MAILED TO UHMS OFFICE ONE MONTH PRIOR TO MEETING
NOTE PADS AND PENS SPONSOR:
YOU PURCHASE
Sponsorship acknowledgment on website and any printed material
Opportunity to include promotional material in delegate satchels (this must be sent to UHMS one month prior).
500 SATCHELS MUST BE MAILED TO UHMS OFFICE ONE MONTH PRIOR TO MEETING
SATCHEL INSERT:
$ 350.00
One insert of your design. (i.e.: brochure, flyer, mug, keychain, etc...)
Opportunity to include promotional material in delegate satchels (this must be sent to UHMS one month prior).
500 SATCHELS MUST BE MAILED TO UHMS OFFICE ONE MONTH PRIOR TO MEETING
DIGITAL DISPLAY AD:
$ 450 Why not display your organization’s mission, job openings or product information on a digital display? This would be a great opportunity to promote your business! Your ad will be display on two displays, one will be featured at the registration desk and the other outside of the meeting room doors for all to view during the meeting dates. Send us your ppt, jpeg or gif.
ASM EXHIBIT BOOTHS/TABLES
Sponsors, companies and organizations are invited to exhibit at the ASM and have the opportunity to make contacts and show their products / services to a target audience during morning & afternoon breaks and the Welcome Reception.
For your benefit we are offering two types of exhibition space. Three representatives per booth/two representatives per table. An additional fee of $150 (before April 1), $180 (after April 1) per representative will be required for more than the allotted (Welcome Reception, break coffee & food). Tickets for the Banquet and any Accompany Persons tickets can be purchased at an additional fee. This information is on the online registration form, if submitting hard copy registration and wish to add additional, please contact us.
SPECIAL PACKAGE EXHIBIT DEALS: REGISTER FOR THE FOLLOWING UHMS 2019 MEETINGS AT ONE TIME AND RECEIVE AN OVERALL VALUED DISCOUNT! Contact lisa@uhms.org for more information or to register.
Annual Scientific Meeting : June 27-29: Wyndham Grand Rio Mar Puerto Rico
Gulf: September 6-7: Dallas, TX
Midwest: September 28-29: Aurora St. Luke’s Medical Center – Aurora Heil Conference Center, 3031 W Montana St., Milwaukee, Wisconsin 52215
Northeast: October 12-13: Hospital of the University of Pennsylvania Smilow Rubenstein Auditorium & Commons, 3400 Civic Center Blvd, Philadelphia, PA 19104
Pacific: November 8-10: TBD
OPTION # 1: includes 10x10 booth at the Annual Meeting & table tops at all other meetings: FEE:$3,900 before May 1 after May 1: $4,200 OPTION # 2: includes table tops at all meetings: FEE:$2,900 before May 1 after May 1: $3,200
10X10 BOOTH PACKAGE: Annual Meeting Only FEE: $2,500
This package includes:
10’ high back drape
3’ high side rails
1 – 7” x 44” identification sign
1 – 6’ draped table
2 – Plastic side chairs
1 – Wastebasket
3 – Representatives.
Please note: Any additional requirements are at the exhibitor’s expense
Booth exhibition packages will include the following benefits: -Your organization’s exhibition details included in the printed material distributed at the ASM
TABLE TOP PACKAGE: Annual Meeting Only FEE: $1,500 This package includes:
1 – 6’ draped table
2 – Plastic side chairs
1 – Wastebasket
2 – Representatives
Please note: Any additional requirements are at the exhibitor’s expense
Table exhibition packages will include the following benefits: -Your organization’s exhibition details included in the printed material distributed at the ASM
June 27th, 2019 7:00 AM through June 29th, 2019 4:30 AM
EXHIBITOR REGISTRATION
SPECIAL PACKAGE DEAL (10X10 Booth Package) SPECIAL PACKAGE DEAL (Table top Package) BASIC EXHIBIT RATES: 10x10 Booth Package (3 reps)
$3,900.00 $2,900.00 $2,500.00
BASIC EXHIBIT RATES: Tabletop Package (2 reps)
$1,500.00
SPONSORSHIP OPPORTUNITIES
PLATINUM SPONSOR (includes booth exhibit package)
$6,500.00
GOLD SPONSOR (includes table top exhibit package)
$4,500.00
SILVER SPONSOR (includes table top exhibit package)
$3,500.00
BRONZE SPONSOR (includes table top exhibit package)
$2,500.00
Welcome Reception Sponsor
$2,500.00
Associate business lunch sponsor
$1,000.00
Associate Scholarship Sponsor
$1,000.00
SATCHELS
NOTE PADS AND PENS SPONSOR: YOU PURCHASE
$0.00
SATCHEL INSERT
$350.00
Satchel Sponsor
$0.00
Exhibitor: Additional Representative for exhibit display
2021: June 10-12: Astor Crowne Plaza French Quarter, New Orleans, LA Room Rate: $209 Room reservations: 1-877-408-9661 (online link coming soon) Cutt-off date: May 18, 2021; 5 PM CST
LIVE STREAMING of the 2019 Annual Scientific Meeting
-REGISTRATION WILL OPEN JUNE 20-
Please login or register to sign up for these events Group Registrations is enabled - UHMS membership will be verified after registration - if an individual in group has been registered as a UHMS member, and is not, they will be sent an invoice for addtional fees. If you need to confirm membership, please contact us at uhms@uhms.org
HYPERBARIC OXYGEN SAFETY: CLINICAL AND TECHNICAL ISSUES: Wednesday, June 26: 8:00 am - 5:30 pm
The meeting will be broken down in two sessions, morning and afternoon, with two 15 minute breaks during each session (10:15 am and 2:30 pm). Once you register, you will be sent a Webex invite with instructions to include a unique login for each individual session you register for. Participants will be required to download the Webex application onto their device. Participants will need a computer with internet connection and speakers so they can listen to the audio (most laptops and tablets have built-in speakers). You will be required to complete an evaluation upon completion of the entire program to receive CME/CEU credits for your participation. Registration link below.
The Safety Pre-Course schedule can be viewed here: pdf of schedule
ANNUAL SCIENTIFIC MEETING: Thursday, June 26 thru Saturday, June 29:
We will be live streaming our 2019 UHMS Annual Scientific Meeting. Each day will be broken down in two sessions, morning and afternoon (Note there will be breaks within the session time frame). Once you register, you will be sent a Webex invite with instructions to include a unique login for each individual session you register for. Participants will be required to download the Webex application onto their device. Participants will need a computer with internet connection and speakers so they can listen to the audio (most laptops and tablets have built-in speakers). You will be required to complete an evaluation upon completion of the entire program to receive CME/CEU credits for your participation. Registration link below. The three day Annual Meeting schedule can be viewed here: pdf of schedule
Today’s radiotherapy schemes, particularly intensity modulated radiation therapy (IMRT), are often used as primary therapy for head and neck cancers. Used together with chemotherapy it has produced a higher incidence of radiation-induced complications. The wider fields, higher doses, and radio sensitizing chemotherapy has caused a more severe and wider spread of osteoradionecrosis (ORN), now even including the previously rare ORN of the maxilla as well as permanent mucositis, skin necrosis, dysphagia, and even some facial nerve palsies.
Dr. Kindwall is known by so many as the "Father of Hyperbaric Medicine.” Whether you knew him personally or simply by reputation, we have all benefited from his efforts, passion, wisdom, knowledge, energy and vision. Dr. Kindwall has played a great role in growing and shaping the specialty of Undersea and Hyperbaric Medicine. He was likewise instrumental in molding the UHMS into what it is today. Dr. Kindwall began diving in 1950. He cultivated his interest in the field and during the Vietnam War served as the Assistant Director of the U.S. Navy School of Submarine Medicine. He also was the Senior Officer responsible for the Diving Medicine Program. In 1969, after leaving the Navy, Dr. Kindwall became Chief of the Department of Hyperbaric Medicine at St. Luke’s Medical Center, Milwaukee, Wis. Shortly after the Undersea Medical Society was created in the mid-1960s, Dr. Kindwall identified the need for standardized education in the field. He created the UMS Education and Standards Committee to help elevate course content and ensure instructor competence. This committee later became our Education Committee. When the AMA initiated its Continuing Medical Education program, Dr. Kindwall persuaded the organization to recognize the UMS as a grantor of CME credits. In 1972, Dr. Kindwall felt that the Society’s members would benefit from improved communication. He created our first newsletter and was named editor. Dr. Kindwall chose the name Pressure because clinical hyperbaric medicine was rapidly developing. Even though the UHMS had not yet incorporated "Hyperbaric” into the Society’s name, he wanted a title for the newsletter that would encompass all who worked with increased atmospheric pressure. He stated: "The Society’s goal then, as it is now, is to serve all who deal with the effects of increased barometric pressure.” That same year, Dr. Kindwall recognized the need to have a relationship with Medicare to help provide insight on reputable clinical management. The UMS followed this lead, and a Medicare Panel was created. The recommendations were presented to the U.S. Public Health Service. The challenge was that no reliable hyperbaric medicine clinical guidelines were available that addressed appropriate applications of Hyperbaric Medicine. To remedy this deficit, the UMS Executive Committee created an Ad Hoc Committee on hyperbaric oxygen therapy. Dr. Kindwall was named Chair. The committee created the first Hyperbaric Oxygen Therapy Committee Report. Again, this text was published 10 years before the UHMS incorporated "Hyperbaric” into its name. The report was sent to HCFA and the Blues and became their source document for reimbursement. Dr. Kindwall updated the text two more times and thus was the Editor and Chair of the Committee and text for three of its 12 editions. Dr. Kindwall later worked to expand the available information on the specialty by creating one of the first complete texts on the field. He created Hyperbaric Medicine Practice in 1994 and later updated and revised his text two more times. The Society’s first journal, Hyperbaric Oxygen Review, has also has been influenced by Dr. Kindwall. His love for research and education was clear: He became the initial editor, creating a journal that at first consisted of review articles and one original contribution. Over the years,it has grown to one full of original research. Dr. Kindwall’s presence is felt in so many of the UHMS’ activities and initiatives. Much of what we all take for granted – what is just "there” and "available” – has his touch and influence. Some of us have been blessed to have had a closer impact by Dr. Kindwall’s life, but I think that I can easily say that each of us has been influenced in some way.
In this session, Dr. Feldmeier will join with Dr. Robert Marx to address several recent articles calling into question the role of hyperbaric oxygen in treating LRTI’s (Late Radiation Tissue Injuries). While Dr. Marx will concentrate on the application of Hyperbaric Oxygen to osteoradionecrosis (ORN) of the mandible and maxilla and soft tissue injuries of the head and neck, Dr. Feldmeier will concentrate on injuries to organs and tissues below the clavicle. Special emphasis will be given to radiation cystitis and proctitis. The technique of modern radiation therapy targeting including IMRT (Intensity Modulated Radiation) will be briefly discussed. A recently proclaimed and popular model of delayed radiation injury is called the Fibroatrophic Model. It de-emphasizes vascular damage as the major contributor to LRTI. This model will be discussed from 2 perspectives: 1. Its validity and 2. Even if accepted in part or in toto, how a strong case for the use of hyperbaric oxygen can be made. At the conclusion of both Dr. Marx’s and Dr. Feldmeier’s plenary sessions, a panel discussion will occur.
The first scientific papers reporting effects of hyperbaric oxygen therapy (HBOT) on stem cell biology were published just 12 years ago and now they number over 100. This presentation will summarize the latest data on stem cell physiological responses to HBOT. Oxygen acts as a critical regulator of stem cells, and HBOT has a variety of effects on stem cell mobilization dynamics, metabolism, engraftment, and can influence paracrine roles with tissue repair. Some effects appear with the initial HBOT exposure while others develop when repeated hyperoxia-normoxia cycling occurs. Mechanisms and data on clinical utilization will be presented, as well as current questions and future directions.
Hyperbaric oxygen (HBO2) is breathed during hyperbaric oxygen therapy and during certain undersea pursuits in diving and submarine operations. What limits exposure to HBO2 in these situations is acute onset of central nervous system oxygen toxicity (CNS-OT) following a latent period of safe oxygen breathing. CNS-OT presents as various non-convulsive signs and symptoms (S/Sx), many of which appear to be of brainstem origin that involve cranial nerve nuclei, autonomic centers and cardiorespiratory centers, which ultimately spread to higher cortical centers and terminate in recurring bouts of generalized tonic-clonic seizures. The initial latent period makes breathing HBO2 practical in hyperbaric and undersea medicine; however, the safe latent period is highly variable between individuals and within the same individual on different days, making it difficult to predict onset of toxic indications. Consequently, currently accepted guidelines for safe HBO2 exposure in undersea medicine and HBO2 therapy are highly conservative. During this lecture, I will review the results of research on CNS-OT, focusing on work done during the past two decades on behalf of the Office of Naval Research (ONR) Undersea Medicine Program (one of four National Naval Responsibility Initiatives) and the Naval Sea Systems Command (NAVSEA). Topics that will be covered include the following: the pathophysiology of the S/Sx that define CNS-OT; conditions that increase the risk for developing acute toxic indications during exposure to HBO2; innovative animal (in vitro and in vivo) and human research methods adapted for use during HBO2 that have provided insight on the neural mechanisms underlying CNS-OT; brain regions that are thought to be involved in seizure genesis and propagation; and current strategies under investigation for predicting an impending seizure (“physiomarkers”) and delaying onset of CNS-OT (antiepileptic drug therapy, antiadrenergic drug therapy, ketone metabolic therapy and hyperbaric oxidative preconditioning) with the goal of longer and safer dives without impaired performance (author’s research funded by ONR Undersea Medicine).
About the Lecture: There has been an emergence over the past several years of novel wearable devices that can potentially be applied to underwater physiological monitoring. This lecture will present an overview of various wearable sensors that have been developed for dry conditions that can potentially be used for underwater applications. Moreover, various signal processing and machine learning algorithms will also be discussed that have been developed for accurate detection of vital signs and for combating motion artifacts from wearable devices. 
Dr. Robins will speak on DCS altitude problems faced and a history of U2 case reports. (Nothing recent has really been collected)
About the Lecture: The lecture will give an overview of the hyperbaric medicine in Canada, covering a broad range of topics including:
About the Lecture: The infamous postcode lottery of obtaining funding for HBO depending on where you live, has been criticized widely. It also apply to other specialties including oncology where the most expensive medication was available in some areas and in many areas it was not. While negotiating a new commissioning policy for HBO as a specialized service, NHS England agreed a block contract to treat the majority of the conditions that we prefer to treat. The policy was due to be completed in 1 to 2 years, but took seven years. This has now been replaced by the new commissioning policy which is a lot more restrictive.
About the Lecture: The advent of the Quality Payment System changes the focus of the conversation about the effectiveness of hyperbaric oxygen therapy. The goal of the QPP is to decrease Medicare Spending per Beneficiary. Although the current regulatory and reimbursement pressure on HBOT is focused on decreasing utilization (both improper use but overall use), the cost component of the QPP puts hyperbaric practitioners and hospital centers at a different kind of risk. If practitioners do not engage in the Merit Based Incentive Payment System, they could experience unanticipated consequences such as being removed from provider lists by private payers. This topic will explain the confusing "cost" component of MIPS and its implications for the future of the field.
About the Lecture: As for most jurisdictions, Australia has faced serious challenges in this area. HBO has been under constant review for 17 years by the national Medicare system. This presentation will outline the course and outcome of these reviews.
About the Lecture: 
About the Lecture:
